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Neural damage caused by ischemia/stroke is initiated by excess reactive oxygen species 
(ROS). Different cell types and even same cell type, but in different regions in hippocampus are 
found to have differential susceptibility to ischemia/stroke. ROS levels have been found to be 
different in different cell types or neurons in different regions of hippocampus. However, the 
mechanism behind this scenario has not been fully understood. 
We, for the first time, used a roGFP2 based GSH sensor to monitor the OGD-RP induced 
redox change of GSH system in mitochondria and cytoplasm from 3 different cell types (HeLa cell 
culture, pyramidal cells and astrocytes found in OHSC) in real-time. We observed that GSH in 
cytoplasm was insensitive to OGD-RP, while noticeable changes were found in mitochondria. 
Mitochondrial GSH get more reduced in OGD, but more oxidized in RP, and that the magnitude 
of change either in OGD or RP is larger in pyramidal cells than in astrocytes, not significant in 
HeLa cells. Heterogeneities in ROS production, antioxidant capacity of GSH and mitochondria 
membrane potential are responsible for the redox changes of GSH system under contrasting 
pathological conditions, different cellular compartments and various cell types.  
In order to understand the differential susceptibility to OGD-RP in hippocampal CA1 and 
CA3, we study on ROS related critical molecules such NAD(P)H, H2O2 and GSH. During OGD-
RP, NAD(P)H consumption is higher in CA3 because it is used more rapidly as reducing 
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equivalents to maintain larger antioxidant pool in this subfield. Mitochondrial H2O2 and the 
oxidation degree of mitochondrial GSH are both lower in CA3 during OGD-RP. This can be 
ascribed to larger Trx2 pool in CA3 since Trx2 can scavenge H2O2 more fast and efficient than 
GSH system and is able to maintain lower H2O2 and GSH at lower oxidation degree.  
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1.0  INTRODUCTION 
1.1 REACTIVE OXYGEN SPECIES 
Neuronal damage in stroke1-3, trauma4-6, hypoxia7, Alzheimer’s disease8-12, Parkinson’s 
disease13,14, Huntington’s disease15,16, psychiatric conditions17-19 and other diseases3,20-22 is in part 
caused by oxidative stress due to excessive production of reactive oxygen species (ROS)23-25. 
Proper amounts of ROS play a critical role in cell signaling26-31, but excessive ROS leads to short-
term effects in cellular function, and longer-term changes which ultimately cause neuronal death32-
34.  
Stroke is a disease with a high risk of causing adult disability and even death35. Ischemic 
stroke is caused by the blockage of blood vessels and the decrease in blood supply to the brain, 
leading to cell death in brain since cells are deprived of oxygen and glucose36. The sequence of an 
ischemic episode during ischemic stroke followed by reperfusion (RP) is mimicked by oxygen 
glucose deprivation (OGD) and RP in vitro 37-39. Transient ischemic attack (TIA) is a short-term 
ischemia without permanent cerebral infarction. TIA had been defined as ischemic events 
occurring within 24 h until recently40. It has now been recognized that the 24-h threshold defining 
TIA is somewhat arbitrary as it does not consider the level of tissue injury40. The latest definition 
of TIA requires the evaluation of the level of injury in a clinic scale40. Most studies have found 
that ischemia with a duration less than 1 h is TIA40. Increased ROS have been found in cerebral 
cortex in the animal model (rat)41, rat hippocampal slices42 and isolated hippocampal and cortical 
neurons in transient ischemia with a duration less than 1h43.   
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The hippocampus, the critical region in brain for developing short term and long term 
memory, is subject to neuronal damage as are other parts of brain during ischemia44. There are two 
ROS related observations corresponding to the hippocampus. One is that neurons are more 
susceptible to ischemia/RP than other cell types such as astrocytes45. The antioxidant, glutathione 
(GSH) is believed to be important for the protection of cells from excessive ROS46. The 
consumption of H2O2 is much faster in astrocytes compared to neurons47, which could be ascribed 
to the fact that the intracellular GSH level is higher in astrocytes than in neurons46. Astrocytes have 
a higher activity of glutathione peroxidase (GPx) which facilitates the reduction of ROS by 
GSH46,47. Accumulating evidence46,48-52 show that astrocytes are endowed with a greater GSH 
system in order to support neurons during ROS insult by maintaining the GSH level of neurons. 
Dringen et al.52 proposed a mechanism by which astrocytes feed neurons with GSH: astrocytes 
release GSH, which is degraded to CysGly by γ-glutamyl-transpeptidase (γGT); then CysGly is 
taken up by neurons and used to synthesize GSH. Griffin et al. 49 observed that astrocytes help 
prevent a significant decrease of GSH concentration in neurons after OGD, supporting Ringen et 
al.’s52 mechanism. The other ROS related observation is that pyramidal cells in hippocampal area 
CA1 are much more prone to death than those in CA3 after ischemia53. Wang et al.54-56 found that 
more superoxide and H2O2 generation are accompanied with more cell death in CA1 compared to 
CA3. They attempted to explain the scenario by comparing the transcriptional levels of several 
ROS related enzymes and proteins in CA1 and CA3. They found that both transcriptional levels 
of pro-oxidants (e.g. superoxide dismutase (SOD) and xanthine oxidase (XO)) and pro-
antioxidants (e.g. nuclear factor E2-related factor 2 (Nrf2) and NAD(P)H quinone oxidoreductase 
1(Nqo1)) are higher in CA1 than in CA355. Compared to CA3, The significantly higher mRNA 
2 
 
levels of SOD, XO, Nrf2 and Nqo1 responds to the higher ROS level in CA155. The oxidative 
stress exerts the differential post-regulation in CA1 and CA3.  
About the ischemia-induced cell injury, we know that 1) the ROS level determines the 
extent of cell/tissue damage; 2) GSH is very important against ROS induced by ischemia-RP; 3) 
there is intrinsic regulation in the expression of pro-oxidant and antioxidant genes initiated by the 
excessive ROS. There are also a lot of things that we don’t know. We note that there is very little 
research aimed at revealing the instantaneous effects of ischemia-RP by monitoring the real-time 
changes of related molecules. Real time profiles of ROS have been reported in neurons during 
ischemia-RP43, but the particular types of ROS such as superoxide and H2O2 have not been studied 
separately.  Moreover, there is no report about the real-time changes of the GSH system in neurons 
to study the ROS induced by ischemia-RP from the perspective of antioxidants. We can obtain a 
better understanding of  ROS management during ischemia-RP if we monitor the concomitant 
changes of superoxide, H2O2, the relative molecules participating in ROS generation and removal 
such as NAD(P)H57, GSH58-61 and thioredoxin (Trx)62-64 by fluorescence imaging. Upon a 
comprehensive view of these molecules during ischemia-RP or other pathological treatments, we 
hope to reveal the key factors causing the differential ROS levels and susceptibility to these ROS 
inducing conditions in different cell types and different hippocampal areas.   
In order to understand why NAD(P)H, GSH and Trx are correlated with ROS, we discuss 
the metabolism of these molecules in the next section. Currently developed fluorescent sensors of 
these molecules are also introduced to help understand our experimental design, operation and data 
analysis in the following sections. 
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1.2 CRITICAL MOLECULES IN REACTIVE OXYGEN SPECIES (ROS) 
MANAGEMENT 
1.2.1 The redox couples, NADH/NAD+ and NADPH/NADP+ 
NADH/NAD+ and NADPH/NADP+ redox couples are critical important in ROS 
generation and removal57. These redox couples both exist in mitochondria and cytosol segregated 
by the inner mitochondrial membrane (IMM)57, but communicate through NADH or NADPH 
shuttle systems.  
 
 
Figure 1-1. The oxidation and reduction of NADH/NAD+ and NADPH/NADP+ couples. 
NADH/NAD+ and NADPH/NADP+ redox couples serve as electron carriers for critical biological processes in 
different cellular compartments. These redox couples in mitochondria (left) and cytosol (right) are not strictly 
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segregated by IMM space (Middle), but communicate through NADH or NADPH shuttle systems. Abbreviations: α-
KG, α-ketoglutarate; BS, biosynthesis; mGSH, mitochondrial glutathione; Trx2, thioredoxin 2; Grx2, glutaredoxin 2;  
cGSH, cytosolic glutathione; Trx1, thioredoxin 1; Grx1, glutaredoxin 1;  NAD(H), nicotinamide adenine dinucleotide; 
NADP(H), nicotinamide adenine dinucleotide phosphate. 
As shown in Fig. 1-1, in cytosol, NADH is generated from NAD+ via glycolysis65 with 
glucose as substrate, and transported into mitochondria via malate-aspartate shuttle66. NADH is 
mainly generated in mitochondria from the citric acid cycle, and participates several important 
pathways67 such as being an electron donor to the electron transfer chain (ETC) and used in 
oxidative phosphorylation for energy generation67. When the ETC is blocked, oxygen molecules 
turn into superoxide by taking over the electron from NADH, then degrade into less energetic 
reactive oxygen species (ROS) such as H2O268. NADH in mitochondria can also act as reducing 
agent to regenerate NADPH via transhydrogenase69. In contrast to NADH, which is used as fuel 
molecule for cellular respiration, NADPH mainly participates in biosynthesis and maintains the 
reducing powers of glutathione and thioredoxin in mitochondria and cytosol70. Pentose phosphate 
pathway is the main pathway to generate NADPH in cytosol, while other possible pathways exist65. 
There is no physiological passage allowing NADP(H) to be transported between mitochondria and 
cytosol, but electron carriers via malate/pyruvate71 or citrate/α-ketoglutarate cycles72 could balance 
the ratio of NADPH/NADP+ from the two sides. Because of the complicated network of the 
metabolism mentioned above, the respective pool of NAD(P)H/NAD(P)+ in mitochondria and 
cytosol are spatially separated, but balanced dynamically in redox potential through their shuttle 
systems. Moreover, we have to emphasize that NAD(P)H/NAD(P)+ is involved in ROS generation 
and antioxidant maintenance and plays an indispensable role to maintain redox homeostasis. 
5 
 
1.2.2 The metabolism of superoxide and H2O2 
There are different types of ROS including superoxide, H2O2, hydroxyl radical (·OH), 
nitric oxide radical (NO·) and peroxynitrite (ONOO-) and hypochlorite (OCl-)35. Here we are going 
to focus on superoxide and H2O2.  
 
 
Figure 1-2. The metabolism of superoxide and H2O2 within intracellular compartments and 
extracellular space. 
The scheme details the generation and removal of superoxide and H2O2 in mitochondrial matrix, inner mitochondrial 
membrane space, cytosol and extracellular space. Abbreviations: MnSOD, manganese superoxide dismutase; 
CuZnSOD, copper, zinc containing superoxide dismutase; EC-SOD, extracellular superoxide dismutase; XO, xanthine 
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oxidase; NOX, NADPH oxidase; DUOX, dual oxidase; QH2, ubiquinol; Q, ubiquinone; see the definitions of mGSH, 
Trx2, cGSH, Trx1, NAD(H),  and NADP(H) in Figure 1-1. 
 
As shown in Fig. 1-2, superoxide and H2O2 are generated in different intracellular 
compartments and the extracellular space (ECS). In mitochondria, the major site of superoxide 
generations are complex I and complex III, which are embedded in the inner mitochondrial 
membrane73. When ETC is inhibited at Complex I, NADH passes an electron to oxygen and 
releases superoxide into the mitochondrial matrix (MM). When inhibition of ETC occurs at 
complex III, the electron from ubiquinol (reduced form of ubiquinone) combines with oxygen and 
releases superoxide into both of MM and IMM space74. The new formed superoxide does not have 
a long lifetime, but is rapidly converted into H2O2 via MnSOD (in MM) and CuZnSOD (in IMM 
space)74,75. The metabolism of cytosolic superoxide and H2O2 generation is different. Superoxide 
in cytosol can be directly generated on XO by using hypoxanthine and oxygen as substrates76 and 
then degraded into H2O2 via CuZnSOD75. NOX and DUO are transmembrane enzymes with 
NADPH binding sites in the intracellular side77. The isoforms 1, 2, 3 and 5 of NOX are the major 
sites for extracellular superoxide generation, whereas isoform 4 of NOX and isoforms 1 and 2 of 
DUO are the major sites for extracellular H2O2 generation. The negative charge on superoxide 
impedes its pass through the cellular membrane, but it can be dismutated by EC-SOD into H2O2, 
which can diffuse through the cell membrane. Mitochondrial and cytosolic H2O2 can be removed 
by Trx278 and mGSH79 (in mitochondria) and Trx178 and cGSH79 (in cytosol), respectively. 
Cytosolic H2O2 can also be removed via catalase80. 
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1.2.3 Antioxidants: glutathione and thioredoxin 
There are two critical types of antioxidants in cells, GSH58-61, a tripeptide, and Trx, a small 
12 kD protein62-64.  
 
 
Figure 1-3. GSH and thioredoxin serve as H2O2 scavengers and their regeneration by NADPH. 
The scheme details the oxidation and reduction of GSH and thioredoxin in mitochondrial matrix and cytosol. 
Abbreviations: GPx, glutathione peroxidase; GR, glutathione reductase; Prx, peroxiredoxin; TrxR, thioredoxin 
reductase. mGSSG, mitochondrial glutathione disulfide; cGSSG, cytoplasmic glutathione disulfide. Subscript: Ox, 
oxidized form; Red, reduced form. See the definitions of mGSH, Trx2, cGSH, Trx1 and NADP(H) in Figure 1-1. 
 
As shown in  Fig. 1-3, GSH and Trx are oxidized while scavenging H2O2 via respective 
enzymes, Gpx81 and Prx82, and are regenerated by NADPH via GR81 and TrxR82, respectively. 
NADPH acts as a reducing agent to maintain the antioxidant capability of GSH and Trx 
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systems81,82. There are mitochondrial or cytoplasmic specific isoforms of Prx, TrxR and Trx, but 
not for GR73,74. Mitochondria and cytoplasm contain the same GPx isoform, GPx1, whereas the 
other GPx isoforms are not selectively localized to any cellular compartments, but have various 
roles in regulating cellular process83. In mitochondria, the Trx system contains Trx2, Prx3/Prx5 
and TrxR2; and in cytosol, the Trx system consists of Trx1, Prx1/Prx2 and TrxR1. The GSH 
system contains GSH, GPx1 and GR, in both mitochondria and cytosol. The reaction between Trx2 
/Trx 1 and H2O2 or GSH and H2O2 is catalyzed by Prx isoforms or GPx1, respectively, while their 
direct reactions are very slower with rate constant, ~ 1 M-1·s-1 without the catalysts84 (Fig. 1-3). 
Cox et al. summarized the kinetic parameters (concentration in µM/second order rate constant in 
reaction with H2O2, μM-1·s-1) of these enzymes in mitochondria (e.g. Prx3, ~ 60/20;  Prx5, 20/0.3; 
GPx1, 2/60) and proposed that Prx3 is responsible for 90% of H2O2 scavenging in mitochondria 
since Prx3 has much higher concentration than GPx1with similar reaction constant with H2O284. 
In cytosol, the second order rate constant85 in reaction with H2O2 for Prx1 and Prx2 is 1 ~ 4 
μM−1·s−1 and their intracellular concentration is relatively high, ~ 250  μM85,86, whereas cytosolic 
GPx1 with concentration (2 μΜ) reacts with H2O2 with a second rate constant84 of 60 μM-1·s-1. 
After doing the math, Prx1/2 have larger pseudo-first order reaction constant than GPx1 in the 
reaction with H2O2 indicating that Prx1 and Prx2 can scavenge H2O2 more rapidly than GPx1 in 
cytosol. Oxidized Prx and GPx will be reduced by Trx and GSH, respectively. The second order 
rate constant86,87 of reaction between Prx3/Prx5 and Trx2 ~1 μM−1·s−1  is much higher than that of 
reaction between GPx1 and GSH88, 0.01 – 0.1 μM−1 · s−1 . The rate constant of reaction between 
Prx1/2 and Trx189 is predicted to be ~ 0.1 μM−1 · s−1. The concentration of mGSH is similar to that 
of cGSH, 1~10 mM23. The concentrations of Trx284 and Trx190 are similar at 10 μM. If we assume 
that all Prx isoforms and GPx1 are oxidized and all GSH and Trx2/Trx1 are reduced, the final 
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reaction rates turn out to be: 600 μM·s-1 (Prx3/Trx2), 200 μM·s-1 (Prx5/Trx2), 250 μM·s-1 
(Prx1,2/Trx1) and 100 ~ 2000 μM·s-1 (GPx1/GSH). There is currently no report about the 
concentration of mitochondrial H2O2. The concentration of cytosolic H2O2 is predicted to be in the 
range of nM and only 18 nM H2O2 can be generated in cytosol when cell is exposed to 100 μΜ 
from model simulations89. If this is true, the reaction rate of physiological H2O2 and Prx or GPx 
will be ~ 1- 10 μM·s-1 or 0.1 - 1 μM·s-1, respectively. The Trx system can scavenge H2O2 ten times 
faster than GSH system both in mitochondria and cytosol. Oxidized GSH and Trx can be 
regenerated by NADPH. Unfortunately, the kinetic parameters of GR and TrxR are not known, so 
this step in the overall process cannot be factored in to this analysis quantitatively. The 
regeneration of Trx could be faster than that of GSH since the second order rate constants for 
Trx/NADPH and GSSG/NADPH are  20 μM-1·s-1 and 3.2 μM-1·s-1, respectively89. 
By comparing the kinetic parameters of the Trx and GSH system, we believe that Trx is 
more important than GSH to remove transient increased H2O2 because Trx is more reactive in 
reaction with H2O2.  
By mapping the metabolism about NAD(P)H, ROS (e.g. superoxide and H2O2) and 
antioxidants (e.g. GSH and Trx), we find that all of them are inter-connected. We need to follow 
the network of their activities during ischemia, and the feasible methods for obtaining their 
transient or real-time profiles are required. 
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1.3 FLUORESCENCE IMAGING FOR MONITORING THE ROS RELATED 
CRITICAL MOLECULES 
Fluorescence imaging allows us to look inside cell at molecular level91. Here we detail 
fluorescent probes used for detecting NAD(P)H, ROS (emphasize on superoxide and H2O2) and 
GSH, Trx and other thiols involved in ROS management. 
1.3.1 Fluorescence imaging of NAD(P)H 
NADH and NADPH exhibit auto-fluorescence and have very similar absorbance and 
emission spectra, thus confocal or two-photon imaging cannot differentiate them92-94. Recently, 
fluorescence lifetime imaging (FLIM) is reported to separate NADH from NADPH by correlating 
the ratio of NADPH/NADH with their fluorescence decay parameters95. However, this technique 
demands extremely high time resolution in nanoseconds, and is only effective in enzyme-bound 
NAD(P)H, not the free ones95.  A NADH/NAD+ redox sensitive sensor, Peredox, is constructed in 
Yellen group96. This sensor responds to [NADH]/[NAD+] and is pH sensitive96. It cannot be used 
in the mitochondria as the mitochondrial [NADH]/[NAD+] is too high and beyond its detection 
range96. The other NADH sensor, Frex, is highly selective for NADH, and has no response to 
NAD+, NADP(H), ATP and other abundant adenine nucleotides. However, The signal of Frex is 
unstable over time upon its binding with NADH97. Frex is also pH sensitive and its application 
needs pH control97. There are more details in Appendix A.1. We will image NAD(P)H directly by 
using two-photon microscope in this manuscript.  
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1.3.2 Fluorescence imaging of superoxide and H2O2 
Both superoxide and H2O2 can be measured in real time by using non-specific ROS dyes. 
2’,7’-Dichlorodihydrofluorescein (DCFH2) is a commonly used in biological research for more 
than 50 years98,99. Its detection for ROS is based on the oxidation of the nonfluorescent DCFH2 to 
yield fluorescent 2’,7’-Dichlorofluorescein (DCF)98. The ester version of DCFH2, 2’,7’-
Dichlorofluorescein diacetate (DCFH2-DA), is designed to increase its membrane permeability 
and cellular retention99.   DCFH2 and its derivative are reported to have pharmacological effects. 
For instance, DCFH2-DA can inhibit the upregulation of oxygenase-1 by arsenite, cadmium and 
hemin100, and DCFH2 can be used as an alternative substrate for xanthine oxidase101. Moreover, 
we cannot ignore interference in the oxidation of DCFH2 and its derivative from ROS related 
enzyme systems, such as iron/H2O2101, hypoxanthine/xanthine oxidase (XO)101, superoxide 
dismutase (SOD)102 and catalase (CAT)102. Moreover, the evaluation of these interferences is 
controversial since the effects on DCFH2 vary depending on cell types and pharmacological 
conditions98. DCFH2 is not suitable for application in pH < 5 as DCF will exist as its lactonic form, 
which is non-fluorescent103. Three ROS-reactive fluorescent protein sensors have been constructed 
since 2001: redox sensitive yellow fluorescent protein (rxYFP), redox sensitive green fluorescent 
protein 1 (roGFP1) and roGFP2. These sensors are developed to sense the redox change in 
intracellular environment upon the oxidation of two spatially adjacent cysteines causing 
consequential configuration change in their chromophores104-106. The benefit for using genetically 
coded protein sensor is that it can reflect the dynamic redox change upon its reversible 
oxidation/reduction, and they can be easily engineered to be selective for cellular compartments 
with appropriate targeting sequences (roGFP1 and roGFP2 have their mitochondrial and cytosolic 
versions105,106). rxYFP is the first genetically coded redox sensor, which responds slowly (~2 min) 
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to the reductant, DTT after been treated with oxidant 4-DPS104. It equilibrates with H2O2, 
GSH/GSSG and other disulfide compounds very slowly107.  A fusion protein sensor with 
incorporated glutaredoxin (Grx), rxYFP-Grx1p, has been designed to make the sensor selective to 
the redox change of GSH/GSSG with a boosted reaction rate, over 3000 ~25000 fold increase 
compared to rxYFP107. However, rxYFP is very pH sensitive and has a small spectroscopic 
dynamic range (the ratio of fluorescence at its fully reduced form over its fully oxidized form) of 
1.2~1.5104, which limits its application in biological research. In contrast to rxYFP, roGFP1 and 
roGFP2 are pH insensitive. roGFPs can provide ratiometric readouts (the ratio of fluorescence 
from excitation at 405 nm over 488 nm, R = F405/F488). The FIs of two excitation channels (405 & 
488 nm) change oppositely: F405 increases and F488 decreases upon oxidation; F405 decreases and 
F488 increases upon reduction. Because ~95% roGFPs remained in their reduced forms in cells, 
roGPFs usually move to a more oxidized status, not a more reduced status in the occurrence of 
most biological events105,106. roGFP1 has stronger F405 than F488, which is different from roGFP2 
with weaker F405 than F488105,106. In practical term, roGPF2 is preferred over roGFP1 because 1) 
when imaging oxidation events, roGFP1 is unfavorable since FIs of its two excitation channels 
change divergently (the weaker F405 becomes weaker and the stronger F488 becomes stronger), 
which makes it difficult to set an appropriate imaging thresholds at the beginning.  What’s more, 
more systematic errors can be found in F405 since it is weak and becomes weaker during 
measurement; 2) roGFP2 has a larger dynamic range (DR; the ratio of R at full oxidation over that 
at full reduction, ROx/RRed;  DR= ~ 4  ) than roGFP1 with DR, ~ 2.7 in cells105,106. However, it’s 
important to note that roGFPs have slow responses (> 15 min) to the different oxidants at 100 μM 
such as menadione, diamide and H2O2106, which requires more improvement on its dynamic 
performance.  
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Any non-specific ROS dye or genetically coded protein sensor has advantages and 
disadvantages. In practical term, DCFH2 and roGFP2 are preferred. 
Dihydroethidium (DHE) and its mitochondrial verison, MitoSox, have been used for 
detecting superoxide since 1980s108,109. The detection of superoxide is based on the measurement 
of the DNA/ethidium complex (Exi/Emi: 510/580 nm). However, it has been reported that DHE 
and MitoSox can also be oxidized by H2O2110 and cytochrome c111.  What’s more, ethidium is not 
the only one oxidized product upon the oxidation of DHE or MitoSox. There are two additional 
products, nonfluorescent dimers and fluorescent 2-hydroxyl-ethidium (Exi/Emi: 396/580 nm, 
proved to be superoxide specific product112) after the oxidation of DHE and MitoSox108. Thus 
selectively imaging of 2-hydroxyl-ethidium with the excitation at 396 nm instead of ethidium with 
the excitation at 510 nm is promising to selectively detect superoxide108,109. However, 
Kalyanaraman and his colleagues pointed out that there are other concerns about 2-hydroxyl-
ethidium113. For instance, 2-hydroxyl-ethidium could be unstable with the presence of peroxidase 
in some biological samples113.  There is still no satisfactory protocol for using DHE and MitoSox 
to selectively detect superoxide. What’s more, DHE and MitoSox are irreversible sensors. They 
cannot be used in long-term imaging since they are consumed by accumulative oxidation over 
time. A genetically coded protein superoxide sensor, mito-cpYFP is reported114 and can be used 
for long term imaging (see more details in Appendix A.2). However, it has been strongly 
questioned to be a superoxide or pH sensor115. We should be cautious to apply these claimed 
superoxide sensors. 
There are several H2O2 selective dyes, which have not been commonly used in biological 
research (see more details in Appendix A.2).  We focused on several novel genetically coded 
protein sensors here. Two different types of genetically coded protein sensor are constructed for 
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sensing H2O2 reversibly: circularly permuted yellow fluorescent protein (cpYFP) and redox 
sensitive green fluorescent protein (roGFP). HyPer is a fusion cpYFP with OxyR regulatory region 
(OxyR-RD)116. The oxidation/reduction of HyPer causes its chromophore to convert between its 
oxidized form (deprotonated/anionic form, Exi: 500 nm) and reduced form (protonated/neutral 
form, Exi: 420 nm)116. R = F500/F420 is used to indicate the H2O2 level. This sensor has fast reaction 
constant, 105 M-1ˑs-1, with t1/2  ≈ 0.7~7 s in reaction with 1 ~ 10 μM H2O2116. However, HyPer is 
pH sensitive because its chromophore can undergo proton exchange with its surrounding 
environment which mimics redox effects116. Two advanced versions of HyPer are constructed: 
HyPer-2117 and HyPer-3118. HyPer-2 has a larger DR (ROx/RRed) = 6~7 compare to HyPer with DR 
= 3 but has slower H2O2 reaction rate117. Hyper-3 has advantages from both HyPer and Hyper-2, 
with high reaction rate and large DR, but neither HyPer-2 nor HyPer-3 can escape the effect of pH 
on its redox sensing117,118. roGFP2-Orp1 is a fusion of roGFP2 with peroxidase Orp1119. The 
oxidation/reduction causes its chromophore to convert between its oxidized form 
(protonated/neutral form, Exi: 400 nm) and reduced form (deprotonated/anionic form, Exi: 490 
nm)120. Though the redox change of roGFP2 is proton exchange related, the final ratiometric 
readout is pH insensitive since pH exerts similar influence on F400 and F490119. In practice, the 
application of roGFP2-Orp1 is easier than HyPers since it doesn’t require internal pH sensitive 
reference. However, roGFP-Orp1 equilibrates with H2O2 (~3.5 min) much slower than HyPers119.    
To sum up, DCFH2, DHE and MitoSox are still the most commonly used dyes for sensing 
ROS. We will use roGFP2-Orp1 to selectively sense H2O2 in this research. 
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1.3.3 Fluorescence imaging of Glutathione and Thioredoxin 
There are many thiol-reactive dyes. First, we choose to not to discuss about the probes that 
could selectively target particular thiols such as cysteine (Cys), homocysteine (Hcy) and 
glutathione (GSH). Second we focused on the dyes based on the Michael addition mechanism. 
More dyes are discussed in Appendix A.3. 
N- (4’- (7-diethylamino-4-methylcoumarin-3-yl) phenyl) maleimide (CPM) is one of the 
first examples of such type of dyes121. CPM is also pH sensitive, and its reaction rate with thiols 
and FI of final thiol derivatives vary with pH122. A complete thiol staining with CPM requires ~ 
60 min122. Corrie et al. reported several maleimide baring probes in 1994: dansyl maleimide 7, 
coumarin maleimide 11a, b and phthalimide maleimide 30123. These probes shows different 
enhancement of FI upon the addiction of thiols: dansyl maleimide 7 (~31 fold), coumarin 
maleimide 11a, b (~ 4.2~4.8 fold) and phthalimide maleimid 30 (~ 7.4 fold)123. We currently do 
not have any information about the kinetic parameters of thiol reaction and the pH sensitivity of 
these probes. Precautions must be taken while using these compounds since they have a half-life 
of 24 hours at pH =7123. Thioglo-1, fabricated in 1991124, is a trademarked product of 
MerckMillipore, Inc. This sensor is excellent for its rapid reaction with thiols (reaction constant = 
2.1 × 104 M-1·s-1, t1/2  ≈ 3.3 s with 10 μΜ thiol, complete thiol staining in few seconds) and pH 
stability of FI from its thiol adducts125. What’s more, no obvious hydrolysis of thioglo-1 has been 
reported123.  Like Thioglo-1, Thioglo-3 and Thioglo-5 are naphthopyranone-maleimide based 
probes and commercially available in Covalent associates Inc. These two probes can react with 
thiols very quickly, usually in 2-5 min126.  Thioglo-3/thiol adduct can be kept for several weeks at 
-80oC without degradation127. It reacts with thiols at pH = 7 and is kept and detected at pH =1. 
what’s more, the hydrolysis of free Thioglo-3 cannot be ignored127. We do not have direct 
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information of pH sensitivity about these two probes so far.  o-Maleimide-BODIPY (BODIPY: 
boron-dipyrromethene) is an novel probe constructed by Matsumoto et al. in 2007128. This probe 
is claimed to be pH insensitive and requires short time (~ 5 min) to completely react with thiols128. 
Thiol Probe IV129 is a coumarin-enone based dye. The addition of thiol to enone causes 
fluorescence129 or spectral shift130. Thiol Probe IV is able to stain thiols very rapidly (rate constant, 
4.8 × 103 M-1·s-1, t1/2  ≈ 14.4 ms with the presence of 10 mΜ thiol)129,  but this sensor is pH sensitive 
and its thiol-adduct shows different FI under different pHs (our unpublished data). Also according 
our experience, the aqueous solution of free Thiol Probe IV at pH = 7 is unstable after 2 hours. In 
practical term, Thioglo-1 and Thiol Prove IV are favored because they can react with thiols rapidly. 
However, both two dyes should be applied with cautious pH control. 
There are several GSH selective dyes, but we will not list them out here (see more details 
in Appendix A.3). Monochlorobimane (mCB) is a highly GSH reactive dye, which has been widely 
used for more than 30 years. The reaction between mCB and GSH is complete in 5 min131. We 
have not found any information regarding pH sensitivity for mCB so far.  
The current available genetically coded protein sensor for monitoring [GSH]2/[GSSG] is 
Grx1-roGFP2, which is a fusion of roGFP2 with glutaredoxin 1 (Grx1)132. The sensor selectively 
responds to the redox change of GSH/GSSG. Isolated Grx1-roGFP2 does not respond to oxidants 
such as H2O2, cystine and hydroxyethyl disulfide and reductants such as dithiothreitol, ascorbate 
and cysteine, but the sensor in cell can responds to oxidant/reductant treatment in the presence of 
intracellular GSH132. Isolated Grx1 has a rapid reaction rate with GSH/GSSG (k = 10 ~13 s-1, t1/2 
=  0.05 ~ 0.07s)133, which indicates that Grx1-roGFP2 is a better candidate for monitoring dynamic 
changes than HyPer or roGFP2-Orp1 (H2O2 protein sensors mentioned above). It is also much 
faster in detecting redox change than roGFP1 or roGFP2 (redox protein sensor mentioned above). 
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Because of the catalysis of Grx1, the sensor can monitor the redox change of GSH/GSSG occurring 
within 1 min132.  Moreover, due to its pH stability, the sensor has been utilized in monitoring 
mitochondrial (pH ≈ 8) and cytosolic (pH ≈ 7) GSH system in neurons in hippocampal slice79. 
There are not feasible Trx selective sensors developed in recent years (see more details in 
Appendix A.3).  
To sum up, Thioglo-1 is a good choice for the measurement of the intracellular thiols with 
pH and fluorescence stability and rapid derivatization. Grx1-roGFP2 is the best developed protein 
sensor for monitoring the real-time redox change of GSH/GSSG couple so far. 
1.4 OBJECTIVE AND MOTIVATION 
This dissertation is aimed at gaining fundamental understanding of the real-time redox 
change of oxidant (mainly H2O2 here) and reductant (mainly GSH here) under biological and 
pathological conditions. Our overall goal is to decipher why pyramidal cells in CA1 and CA3 have 
differential susceptibility to ischemia? In order to finish this goal, specific questions that motivated 
this work include: 1) How do we make an improvement on the control of the oxygen and glucose 
delivery to cell/tissue to closely mimic pathological condition, ischemia/stroke? 2)  How can we 
improve the quantitative measurement of roGFP2 based ratiometric imaging for reporting redox 
change of oxidant and reductant system in real-time? 3) Corresponding to the excessive ROS 
generation, what does the redox change of the GSH system demonstrate and what are the 
differential performances of GSH in different cell types? 4) What is the key factor for the ROS 
management with regard to the critical molecules/systems such as NAD(P)H, GSH and Trx? We 
designed our experiments aiming at resolving these questions.  
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Chapter 2.0 details our efforts at establishing optimized protocol for mimicking ischemia 
in vitro and quantitatively recording the dynamic oxidation/reduction of the GSH sensors under 
ischemia/model. We developed an optimized superfusion system with the capability of rapid and 
reproducible exchange of the solution bathing the OHSCs for introducing oxygen/glucose 
deprivation, an in vitro ischemia model. Measurements of pO2 as a function of tissue depth show 
that in the region containing the transfected cells, the pO2 is well-controlled. We also found that 
the response time of pO2 changes using our optimized superfusion system is in the same time scale 
as changes in intracranial pressure, cerebral blood flow, and pO2 during acute stroke. Single 
pyramidal neurons in the CA1 subfield of organotypic hippocampal slice cultures (OHSCs) were 
transfected with a redox-sensitive Grx1-roGFP2 fusion protein. Since determining redox terms 
such as EGSH from the ratiometric fluorescence signal requires an absolute intensity measurement, 
we use the signal from co-transfected tdTomato as an internal standard improves quantitative 
measurements of roGFP2 oxidation and allows EGSH to be determined.  
In Chapter 3.0, we monitored the OGD-RP induced redox change of GSH system in 
mitochondria and cytoplasm from HeLa cell, pyramidal cell and astrocyte with the protocol 
created in Chapter 2.0 in real-time. This sensor was characterized and verified that its dynamic 
range (DR; the ratio of R at full oxidation over that at full reduction, ROx/RRed) is stable in all the 
six biological models that vary in pH, GSH concentration, and other aspects. By doing so, we are 
confident to apply this sensor for reporting redox information of GSH system. The redox terms, 
R405/488, OxDS, ln
[GSH]2[GSSG] and EGSH demonstrate consistent information about GSH during OGD-RP. 
Larger values in them mean more oxidized GSH system, while smaller values indicate more 
reduced GSH system. We observed that GSH systems differ in mitochondria and cytoplasm as 
well as in various cell types that we tested here.  
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Chapter 4.0 aims to answer whether differential management of ROS level is the key factor 
causing differential susceptibility to ischemia. We monitored ROS generating system (including 
NADH, H2O2) and anti-oxidant systems (including Glutatione (GSH) and thioredoxin (Trx), 
NADPH) in real time during OGD-RP. Without conclusive understanding of the impact of OGD-
RP on relative enzyme systems, it is difficult to make convincing interpretation of the OGD-RP 
data. Thus, we further designed experiments aiming to selectively target certain enzyme involved 
in ROS generating and anti-oxidant systems and monitored the consequence reflected from the 
H2O2 and GSH system.   
With profound understanding of molecular mechanism of ROS generating and antioxidant system, 
we can help to provide points of entry for developing potential therapeutic methods for ischemia. 
Also we can broaden its application to other neuron-degradation associated disease like 
Parkinson’s disease, Alzheimer disease and amyotrophic lateral sclerosis134,135 
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2.0  OPTIMIZE SUPERFUSION SYSTEM AND RATIOMETRIC IMAGING ON 
ROGFP2 BASED SENSOR TO MONITOR THE REDOX CHANGE IN ORGANOTYPIC 
HIPPOCAMPUS SLICE CULTURE DURING OGD-RP 
Parts of this chapter are adapted from a manuscript “Optimized real-time monitoring of 
glutathione redox status in single pyramidal neurons in organotypic hippocampal slices during 
oxygen-glucose deprivation and reperfusion” published in ACS chemical neuroscience. 
Weber, S. G. and Yin, B. conceived the study. Yin, B. performed all the experimental work, and 
wrote the paper under the guidance of Weber, S. G. 
2.1 INTRODUCTION 
Neuronal damage in stroke1-3, trauma4-6, hypoxia7 is in part caused by oxidative stress due 
to excessive production of reactive oxygen species (ROS)23-25. Neurons and glial cells are endowed 
with mechanisms for maintaining ROS homeostasis including the glutathione-glutathione 
disulfide couple (GSH/GSSG) and the thioredoxin system. Hypoxia/ischemia (HI) episodes, such 
as those that occur during stroke, disrupt ROS homeostasis leading to short-term effects in cellular 
function, and longer-term changes that ultimately cause cell death32-34. Several approaches exist 
for measuring ROS in real time including those based on voltammetry136-138 and fluorescence 
microscopy that relies on fluorogenic small molecule probes113,139-141. However, there are no small-
molecule redox-sensitive fluorophores that respond to the GSH system. Thus, it is noteworthy that 
several groups have developed the ability to measure its status in real time. Specifically, different 
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redox protein-based sensors were developed simultaneously by the Winther (rxYFP142) and the 
Tsien and Remington groups (roGFP106,143 ). The sensor response kinetics were relatively slow 
and were oxidized to varying degrees by a variety of oxidizing agents106. Altering the electrostatic 
environment of the active disulfide by engineering amino acid substitutions in the region of the 
modified GFPs increased the rate of reaction of the sensors with GSH/GSSG143,144. Meyer et al.145 
discovered that roGFP’s reaction with GSH/GSSG was catalyzed by endogenous glutaredoxin 
(Grx). Gutscher et al.146 made a chimeric protein, Grx1-roGFP2 that responded rapidly to cytosolic 
changes in GSH/GSSG status. In addition, they determined that the isolated Grx1-roGFP2 was not 
oxidized by cystine, hydroxyethyl disulfide, or H2O2, and was not reduced by ascorbate, cysteine 
or the thioredoxin system (thioredoxin, thioredoxin reductase and NADPH). Thus, this sensor is 
quite selective for the glutathione redox couple.” 
While these sensors have illuminated redox events in a variety of types of cells, they have 
not been used extensively in mammalian central nervous system (CNS) tissue. Using primary 
cultures of hippocampal neurons from rats Funke147 carefully compared the roGFP1’s response 
against a widely used small molecule sensor hydroethidine. These investigators showed a “proof 
of principle” that the sensor would respond to exogenous peroxide application to an organotypic 
hippocampal slice culture (OHSC). However, there was no attempt to infer biological information 
from the observed response. Grosser et al., using roGFP1, studied OHSCs from a Rett syndrome 
mouse model148. They found that cytoplasmic GSH status was more oxidized in the Rett syndrome 
hippocampus than controls. Hasel et al.149 contrasted dendritic and somatic responses of Grx1-
roGFP2 to stressors in cultured neurons, finding the dendritic regions more oxidized under resting 
conditions and changing more dramatically under stress than somatic regions.  More recently, 
Breckwoldt et al.150 created a mouse that expressed Grx1-roGFP2 in neuronal mitochondria. They 
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used this model with multiparametric imaging to investigate redox and size changes in 
mitochondria in explants of neuromuscular junctions and in vivo in lesioned spinal axons. 
Thus far, the few investigations of the GSH system’s status in CNS tissue have employed 
roGFP1 rather than the more rapidly responding Grx1-roGFP2 sensor.  There are no reports that 
we are aware of that use the latter sensor to determine redox events in cortical CNS tissue. Here 
we describe a method for investigating redox events during oxygen-glucose deprivation, 
reperfusion (OGD/RP) in the OHSC151.  OHSCs subjected to OGD/RP is a useful in vitro model 
of HI37-39. We use the rapidly responding Grx1-roGFP2 in single transfected pyramidal neurons in 
the CA1 subfield. We have validated that the transfection occurs within a narrow range of depths 
into the culture and that the pO2 during OGD and RP are reproducible in this range of depths. We 
have also improved the standard superfusion system so that changes in pO2 occur on the same 
timescale as it does in in vivo models of stroke. In addition, calibration of Grx1-roGFP2 is 
improved by cotransfecting with the redox-insensitive tdTomato. Fluorescence from tdTomato is 
used as a reference during calibration when absolute (not ratiometric) intensities from the Grx1-
roGFP2 sensor are needed to report well-defined redox parameters (e.g. degree of oxidation of the 
sensor (OxD), EGSH) as opposed to the measured ratiometric response only147-150. Using this 
optimized approach, we have found that the GSH system changes rapidly and significantly during 
OGD/RP in mitochondria but not in cytoplasm. 
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2.2 EXPERIMENTAL SECTION 
2.2.1 Biosample preparation 
2.2.1.1 Cloning of plasmids 
Plasmids for expressing Mito-Grx1-roGFP2132, Cyto-Grx1-roGFP2132 were obtained from 
Tobias P. Dick as generous gifts.  pCMV-tdTomato (Clontech) and pCS2+ (Addgene) were kindly 
provided by Dr. Zachary P. Wills (University of Pittsburgh). Plasmid Mito-tdTomato was 
constructed for targeting mitochondria with help from Jihe Liu in Dr. Alexander Deiter’s group 
(University of Pittsburgh). The mitochondria-targeting-sequence from ATP synthase protein 9 
(Neurospora crassa) was amplified from Mito-Grx1-roGFP2 using primers 5’-ATT AGG TCT 
CAC ATG GCC TCC ACT CGT GTC CTC GCC TC-3’ and 5’-ATT AGG TCT CAT CAC GGA 
TCC GGA AGA GTA GGC GCG CTT C-3’. pCMV-tdTomato full-length sequence was 
amplified using primers 5’-AGT GGT CTC AGT GAG CAA GGG CGA GGA GGT C-3’ and 5’-
ATT GGT CTC TCA TGG TGG CGA CCG GTG GAT C-3’. Two fragments were assembled to 
construct pMito-tdTomato by using the Golden Gate Cloning method152. All of the plasmids were 
introduced into One Shot TOP10 Chemically Competent E.Coli cells (Invitrogen), selected on 
ampicillin or kanamycin agar plates, amplified in LB media and purified with a QIAGEN Plasmid 
Prep Kit (Qiagen). 
2.2.1.2 Cell preparation and transfection 
HeLa cells were grown in 75 cm2 cell culture flasks (Corning) and cultured in a 5% 
CO2/95% air incubator at 37oC. Culture medium, made of 90% (v/v) DMEM + 10% (v/v) fetal 
bovine serum (FBS) purchased from Invitrogen, was replaced every 3-5 days. Before experiments, 
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the cells were transferred onto 35 mm culture dish (BD bioscience) with 2 mL cell culture medium 
at a seeding density of 1 x 105 cell/ dish. The cells were transfected by using lipofectamine 
(Invitrogen) according to the manufacturer’s suggestions. The optimized amount of lipofectamine/ 
DNA was obtained to minimize the cell death and maximize the transfection efficiency: 1 μg DNA 
and 2 μL lipofactamine were dissolved in 100 μL opti-MEM for 5 min separately, then the two 
solutions were mixed for up for 20 min before adding to the cells. The medium containing 
lipofectamine/DNA was replaced with fresh cell culture medium after 6 hours. Plasmid expression 
was usually checked in 1-2 days. All of the tools and solutions were sterile. 
2.2.1.3 OHSC preparation, transfection 
Organotypic hippocampal slice cultures (OHSC) was prepared according to Gogolla’s 
protocol153. All of the surgical tools were autoclaved. The dissection medium contained 75%(v/v)  
Opti-MEM, 25%(v/v)  HBSS with the addition of 45% D-glucose solution (1.0 mL per 100 mL 
medium). Tissue culture medium was made from 50% (v/v) Opti-MEM, 25% (v/v) HBSS, 25% 
(v/v) horse serum (Invitrogen) with the addition of 45% D-glucose solution (1mL per 100 mL 
medium). 
Our surgery protocol was approved by the Institutional Animal Care and Use Committee 
(IACUC) of the University of Pittsburgh. Surgery was done in sterilized hood. The postnatal 7-
day old Sprague-Dawley rats (Charles River, Pittsburgh) was sacrificed and the hippocampus was 
taken out and sliced on a McIIwain tissue chopper (Mickle laboratory Engieering Company Ltd., 
UK). The slices were suspended  in dissection medium for 30 min – 1h at 4 oC before plating onto 
Millicell organotypic inserts (Millipore Co.) and cultured with tissue culture medium in the 
incubator at 37oC for 3~5 days before transfection. Culture medium was replaced every 3 days. 
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Biolistic transfection or electroporation were applied to transfect cells in OHSCs. Biolistic 
transfection was based on the Woods’s154 protocol. Slice cultures were transfected by using a 
Helios Gene Gun (Bio-Rad Laboratories, Inc. CA, USA). The bullets were made by coating 
gold/DNA particles onto inner wall of Tefzel tubing (Bio-Rad). The optimized recipe for 
gold/DNA complex was 20 μg roGFP2 mitochondrial or cytoplasmic contruct132, 10 μg 
mitochondrial or cytoplasmic tdTomato as internal standard and 20 μg pCS2+ as DNA filler 155 
loading to 14 mg gold particle (Φ = 1.6 μm), which could be used to make 40-50 bullets. The 
gold/DNA particles were blown onto an OHSC under 120 PSI pneumatic pressure with the gene 
gun. Plasmid expression occurs in about two days. 
Single cell electroporation on OHSCs was applied according to Haas’s procedure156. A 1-
second train of 1 ms pulses of -50 V at 200 Hz generated by an isolated pulse stimulator (Model 
2100, A-M Systems, WA, USA) through a pulled borosilicate glass pipette (18 ΜΩ) to deliver 
plasmid into single cells in OHSCs. Borosilicate glass tubing, OD x ID x L, 1.5 mm x 0.86 mm x 
10 cm (Sutter Instrument Co. CA, USA) was pulled on P-97 micropipette puller (Sutter Instrument 
Co. CA, USA) to tip size 1-2 μm. Pulled pipette was filled with 0.3 μg/μL (total plasmid 
concentration) DNA in intracellular solution. The intracellular solution recipe157 contained 145 
mM K-gluconate, 10 mM HEPES, 14 mM phosphocreatine, 4 mM Mg-ATP, 2 mM MgCl2, and 
0.25 mM EGTA, adjusted to pH = 7.30 with KOH. The plasmid was added in a weight ratio of 
2:1:2 (roGFP contruct : tdTomato vector : pCS2+). Pyramidal cells in OHSCs (30-50 μm deep 
inside) were viewed under ZEISS Axioskop FS (Zeiss, Germany). The pipet on holder (Warner 
Instruments, LLC, CT, USA) was controlled manually with X7500 micromanipulator (Siskiyou 
Co. OR, USA). After electroporation, tissue was rinsed with sterilized Hank’s buffer solution and 
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placed back to 37oC incubator for culturing at least 2 days for plasmid expression. Both of the 
methods work well in OHSCs. 
The pO2 was measured within OHSCs while the OHSC was superfused with ACSF 
saturated with 95% O2/5% CO2 or with 95% N2/5% CO2. The pO2 profile was generated to help to 
understand the pO2 dependent OGD-RP experiment and its relevant oxidation status change inside 
OHSC. 
 
2.2.2 Fluorescent imaging 
All imaging experiments were carried out on a Leica TCS SP5II broadband confocal 
microscope (Department of Biological Sciences, University of Pittsburgh). Cells were imaged with 
an HCX PL FLUOTAR 5x objective lens with N.A. = 0.15 and an HCX APO L U-V-I water 
immersion 63x objective lens with N.A. = 0.90. Only images taken with the 63x lens were used 
for quantitative analysis. The redox green fluorescent protein (roGFP) sensor is excited at 405 or 
488 nm, and emission spectra are acquired between 500 – 530 nm. The red fluorescent protein 
(RFP), tdTomato, was excited at 561 nm and emission was acquired between 580 – 600 nm. 
2.2.2.1 Determine the depths of transfected neurons inside OHSCs 
The depth of the transfected cells is measured on a Leica TCS SP5II broadband confocal 
microscope with imaging under bright field and fluorescence mode, by counting the displacement 
of a z-stack scan, which starts from the top of an OHSC surface and steps through the OHSC until 
the equatorial section of the cell soma is found. 
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 2.2.2.2 Real-time imaging on the roGFP2 based sensor 
Sequential scans are applied to cells with GFP and RFP proteins by alternately exciting at 
488, 405 and 561 nm. The Leica confocal microscope was set up to reduce z-direction shifts with 
an autofocus algorithm and the Hyper-dynamic detector. Shifts in the x, y plane were corrected by 
post processing (ImageJ Plugin-Template Matching and Slice Alignment158). Image series were 
acquired every ~8 s. Raw image files were processed by modules in ImageJ 
(http://imagej.nih.gov/ij/). Slices in the time-lapse videos were re-aligned using ImageJ Plugin-
Template Matching and Slice Alignment158 before extracting numerical data for 405,488 and 561 
signals. Cell area changes in the time-lapse video were measured with built in functions in ImageJ 
as folllows: auto-threshold the images to make the cell area distinguishable from its background, 
then apply the function module “analyze particle” to measure the cell area within the specified 
threshold range. Ratiometric images in ‘Fire’ false-color were created by ImageJ146. 
2.2.3 Processing ratiometric images of roGFP2 sensors 
Fluorescence data are processed to obtain the ratio R405/488, the oxidation degree of Grx1-
roGFP2 (OxDroGFP2), the natural logarithm of the ratio, [GSH]2[GSSG]  and the redox potential of 
glutathione (EGSH), according to Eq. 2.1-2.6, which are derived from equations described by 
Meyer and Dick159 and Gutscher et al.146. 
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Redox information is processed from the fluorescence data of Grx1-roGFP2, R405/488 to 
derive of the oxidation degree of Grx1-roGFP2 (OxDroGFP2), the natural logarithm of the ratio, 
[GSH]2[GSSG] and the redox potential of glutathione (EGSH). 
We use tdTomato to correct the signal of 488 from Grx1-roGFP2 for calculation of 
OxDroGFP2. 
 Î405 = I405/I561, Î488 = I488/I561 (Eq. 2.1) 
 R405/488 = I405/I488 (Eq. 2.2) 
 
 OxDroGFP2 = R405/488 − R405/488RedÎ488𝑂𝑂𝑂𝑂Î488𝑅𝑅𝑅𝑅𝑅𝑅 �R405/488Ox − R405/488�+ (R405/488− R405/488Red )    (Eq. 2.3) 
  
Î405, Î488 are Normalized fluorescence intensities excited at 405 and 488 of Grx1-roGFP2 
by I561. R405/488 is the ratio of the emission intensity excited at 405 nm, I405, to that excited at 488 
nm, I488. R405/488 at fully oxidized status is often normalized to 1 without special mention. Î488Ox ,Î488Red 
are Î488 from Grx1-roGFP2 at full oxidation and full reduction, respectively. R405/488Ox  and R405/488Red  
are ratio 405/488 of fully oxidized and reduced Grx1-roGFP2. 
The Nernst term, ln( [GSH]2[GSSG]), can be derived from OxDroGFP2 . 
 In�[GSH]2[GSSG]� = In �1 − OxDroGFP2OxDroGFP2 � + ZFRT �EGSHO − EroGFP2O � (Eq. 2.4) EGSHO = −240 mV;  EroGFP2O = −280 mV;  Z = 2;  F =  96485 C mol−1; R = 8.315 J K−1mol−1; T = 309.15 K 
The redox potential of the GSH/GSSG couple in mitochondria and cytoplasm is calculated 
from the known OxDroGFP2. Different pH values in the two compartments is considered. 
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 EGSHCyto = EGSHpH=7 = EroGFP2pH=7  = EroGFP2O − RTzF In �1 − OxDroGFP2OxDroGFP2 � (Eq. 2.5) 
In this equation, EGSHO 160 and  EroGFP2O 106 are the standard redox potentials of glutathione 
and Grx1-roGFP2 at pH = 7.00 respectively.  z is the number of electrons transferred in the redox 
reaction,. R is the gas constant, F is the Faraday constant, T is the absolute temperature. 
 EGSHMito = EGSHpH=8 = EGSHpH=7 + RTzF In�[𝐻𝐻+]𝑝𝑝𝑝𝑝=82[𝐻𝐻+]𝑝𝑝𝑝𝑝=72 � =  EroGFP2O − RTzF In�1 − OxDroGFP2OxDroGFP2 [𝐻𝐻+]𝑝𝑝𝑝𝑝=72[𝐻𝐻+]𝑝𝑝𝑝𝑝=82 �   (Eq. 2.6) 
In this equation, [𝐻𝐻+]𝑝𝑝𝑝𝑝=8 = 10-8 mol L-1, [𝐻𝐻+]𝑝𝑝𝑝𝑝=7 = 10-7 mol L-1. 
Numerical data are processed in MatLab (version R2012b, MathWorks, Inc.) and OrginPro 
(version 9.0, OriginLab Corp.). Statistical inferences are from SPSS version 20, IBM Corp.) 
2.2.4 Oxygen measurement 
An oxygen microsensor (OX-25, Unisense, Denmark) was used to measure the oxygen 
partial pressure in OHSCs. This Clark-type sensor161 is equipped with three electrodes. +800 mV, 
0 mV and 0 mV are applied on the reference electrode, working electrode and guard electrode 
during O2 measurement respectively. The existing guard electrode removes O2 from the internal 
electrolyte to prevent signal drift ( < 0.5% /30 min  in ACSF saturated with 95% O2/5% CO2 ). 
The small tip size (20-30 um in diameter) of the electrode facilitates the measurement in small 
volumes (e.g. tissue with surface diameter ~ 1 mm, thickness, ~ 180 μm) with useful spatial 
resolution. An LC-4C amperometric detector (BASi, IN, USA) was used as the potentiostat. Data 
were recorded through a digital logger (NI USB-6008, National instruments Co. TX, USA). The 
sensor was polarized at -800 mv (working & guard vs reference) overnight before use. Three-point 
calibration on the oxygen sensor is performed with zero-oxygen solution (0.1 M NaOH + 0.1M 
sodium ascorbate), artificial cerebrospinal fluid162 (ACSF)  saturated with 95% air/5% CO2 and 
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modifed ACSF (MACSF)162 saturated with 95% O2/5% CO2. Oxygen pressure (pO2) in solution 
is calculated with equation 2.7. 
 pO2 = (atmospheric pressure − water pressure) ∗ percentage of pure oxygen (Eq. 2.7) 
O2% in the three standard solutions mentioned above is 0%, 19.95% and 95% respectively. 
Atmospheric pressure is measured with a mercurial barometer. Water pressure at 35oC is used 
here. 
pO2  in OHSCs is measured at different depths while perfusing with ACSF saturated with 
95% or 0% oxygen-containing gas. Each run is calibrated with ACSF saturated with 95% O2/5% 
CO2. The tissue is viewed under IX-71 inverted microscope (Olympus, USA), while the electrode 
is held by a manipulator (MP-285, Sutter Instrument). The electrode was inserted into a culture at 
an angle of 45o and the tip resided at a certain vertical depth. 
2.2.5 Superfusion system 
OHSC or HeLa cells were placed in a homemade stage chamber and superfused at a flow 
rate of 4 mL/min driven with a peristaltic pump (Sci-Q 400DM2, Watson-Marlow, Inc. MA). 
Solution temperature was maintained at 35 oC by an inline solution heater, SH-27B under the 
control of temperature controller, TC-324B (Warner Instruments, LLC. CT, USA). Solution was 
gassed by an OX miniature gas exchange oxygenator (Living Systems Instrumentation, VT, USA) 
or by direct bubbling. Gas flow was set to 1.5 L/min with an OMA-1 gas flowmeter (Dwyer 
Instruments, Inc.). Artificial cerebrospinal fluid162 (ACSF) is composed of 125 mM NaCl, 2.5 mM 
KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 1 mM CaCl2, 4 mM MgCl2, 10 mM  glucose. Modifed 
ACSF (MACSF) substitutes 10 mM glucose with 10 mM sucrose while maintaining the rest as 
same as ACSF. The osmolarity of buffer solutions used through the works described in the paper 
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was adjusted to between 290 and 300 mOsm. ACSF gassed with 95% O2/5% CO2 and MACSF 
gassed with 95% N2/5% CO2 were alternately introduced into the stage chamber during the control 
period, OGD and RP.  
 
 
Figure 2-1. Different Superfusion setups. 
The conical probe represents the oxygen electrode. [control], oxygen is directly measured in a reservoir with solution 
continuously bubbled with gas. In the remaining four panels, pO2 is measured in the slice chamber. The solution is 
driven by a peristaltic pump. Solutions are switched in all cases by pumping from a second reservoir containing the 
new solution. In the scheme labeled “[B]”, solution from a reservoir being bubbled with gas is flowing continuously. 
[B+V] is as [B] but in addition, when the solution is switched to a new solution, existing solution is removed from the 
chamber by vacuum suction. In [O], solution is gassed by an oxygenator. [O+V] is as [O] except that solution is 
removed by suction when the switch is made. 
In the [O+V] setup (Figure 2-1), we aspirate the solution in the stage chamber by vacuum 
at the time that the peristaltic pump begins drawing solution from a new reservoir (e.g. from control 
to OGD). The oxygen partial pressure was monitored (Supporting Information) with an oxygen 
sensor (OX-25, Unisense, Denmark) connected to a potentiostat (LC-4C amperometric detector, 
BASi, IN, USA) with the working and guard electrodes at -800 mV with respect to the OX-25 
built-in reference electrode. The oxygen sensor was calibrated with zero-oxygen solution (0.1 M 
NaOH + 0.1M sodium ascorbate), and ACSF  saturated with 95% air/5% CO2. There is no 
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difference in the pO2 measured in MACSF saturated with 95% O2/5% CO2 vs. that measured in 
ACSF. The electrode tip was placed in an OHSC at a particular depth with the aid of a 
micromanipulator (MP-285, Sutter Instrument). Values of and pO2 in tissue is recorded at different 
depths inside OHSC and in different superfusion setups. 
2.2.6 OGD-RP experiment 
Cells or OHSCs expressing the roGFP2 based sensor are placed in the superfusion setup 
and imaged under a confocal microscope as shown in Figure 2-2. They are treated with control 
solution for 10 min, oxygen glucose deprivation (OGD) for 20 min, and reperfusion (RP), 30 min. 
ACSF gassed with 95% O2/5% CO2 is used for the control solution and RP, and MACSF gassed 
with 95% N2/5% CO2 is used in OGD. The use of aspiration by vacuum is preferred during solution 
switching to assist in the solution exchange in the stage chamber. We run the OGD-RP experiment 
on pyramidal cells in OHSCs, followed by treating with H2O2 and DTT. 
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 Figure 2-2. Sketch of optimized superfusion system. 
(a) An OHSC is placed in the stage chamber of a Leica SP5 upright microscope and imaged with a water immersion 
objective while being superfused with gassed buffer solution. Solution is driven through the chamber by a two channel 
peristaltic pump, gassed with an oxygenator and heated with an inline heater placed near the inlet of the chamber. 
Vacuum is applied to remove solution in the chamber when the reservoir feeding the pump is changed. (b) OHSCs 
are cultured on a porous membrane insert (Millipore Co.), 30 mm diameter. The OHSC is about 3 mm in the longest 
dimension. (c) An OHSC (gray) is placed on the porous membrane insert shown (red broken line) held by a plastic 
frame (purple), and superfused with a buffer solution. The OHSC is positioned 0.6 mm from the base of the stage 
chamber. The depth and volume of solutions in the chamber above OHSC is 4.2 mm and 2.97 mL. 
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2.3 RESULTS AND DISCUSSION 
2.3.1 Calibration Oxygen sensor 
The sensor has a rapid response to oxygen pressure changes ~ 10s as shown in Fig. 2-3a. 
The current signal acquired with the sensor has a linear relationship with oxygen partial pressure 
(Fig. 2-3b). The values of pO2 measured in different solution with variable oxygen level have a 
very small deviation, which verify that the oxygen sensor is reliable for pO2 measurement. 
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 Figure 2-3. Calibrate oxygen sensor (Ox-25) in standard solutions. 
a) The sensor is dipped alternately into solutions 1 and 2, which are zero-oxygen solution (0.1 M NaOH + 0.1M 
sodium ascorbate) and ACSF buffer saturated with 95%O2/5%CO2, respectively. b) Three point calibration measured 
in zero-oxygen solution, 95% air/5%CO2 saturated ACSF buffer , and 95%O2/5%CO2-saturated ACSF buffer. c) pO2 
is measured in four different solutions based on the calibration (n=5). 
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2.3.2 Optimize superfusion system 
The conventional method of slice oxygenation relies on bubbling the superfusion solution, 
ACSF containing 10 mM D-glucose, with 95% O2 ⁄ 5% CO2 and delivering it to the slice chamber 
with a peristaltic pump ([B], Fig 2-1). OGD is initiated by changing the superfusion solution to 
ACSF containing 10 mM sucrose (modified ACSF, MACSF) in place of the glucose with 95% 
N2/5% CO2 (see section 2.2.5 for the details of the solution compositions). We measured changes 
in pO2 within in the cell dish with no slice culture using four different superfusion systems (Fig. 
2-1). In all cases, the tube leading to the pump is manually switched from one reservoir to another 
to change conditions and the temperature of the incoming fluid is controlled online. In [B] the 
solution flows continuously while it is bubbled with gas in its reservoir. [B+V] adds a step - the 
fluid in the slice chamber is removed by vacuum at the time the solutions are switched. In [O] and 
[O+V] the solution is gassed by an online oxygenator placed near the chamber. The oxygenator 
uses microfluidic channels with a thin, gas-permeable membrane to introduce oxygen to the 
solution as it passes through the device. In [O+V] the solution in the chamber is removed by 
vacuum when the gas supply and the source reservoir are switched. We investigated the four 
superfusion setups and compared them to the [control] (Fig. 2-4). Clearly setup [O+V] (highlighted 
in blue box, Fig. 2-1) maintains the desired oxygen level in the stage chamber (Fig. 2-4b). 
Furthermore, the transition time for complete solution exchange also is dramatically shortened to 
less than 30 s using the setup [O+V]. In contrast, the other three superfusion systems show 
significant differences from the control (Fig. 2-4c). The optimized superfusion setup [O+V] will 
be used in the following experiments without special mention. 
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 Figure 2-4. Control of pO2 in different superfusion setups. 
Control and the four different setups ([B]. [B+V], [O] and [O+V]) have been described in Figure 2-1. (a) Continuous 
measurement of pO2 in the slice chamber during superfusion with the four arrangements described in (Figure 2-1). 
Note the break and the change in the time scale. The solution is switched from 95% O2/5% CO2 to 95% N2 /5% CO2 
(indicated by the green arrow point). τ is the time from the solution switch to the onset of a new steady state pO2. (b) 
Steady-state pO2 are measured in control and the four superfusion setups.  Arrows indicate control and setup [O+V]. 
(c) τ from the 5 setups. One-way ANOVA with post-hoc test (***, p< 0.001, n=6) 
2.3.3 Determine the pO2 and gas exchange efficiency in the depth where transfected 
neurons located in OHSC placing in our optimized superfusion setup 
By controlling the transfection conditions (see section 2.2.1.3), we were able to target 
pyramidal cells localized within a relatively narrow range of distances below the surface of the 
OHSC. Half of the transfected cells are confined to 33-40 µm below the surface shown in Fig 2-
5. When we treat the tissue with OGD-RP, we need to know if the pO2 experienced by the neurons 
expressing roGFP redox sensor is consistent through experiments. Thus, we need to measured pO2 
at various depths within OHSC in our optimized superfusion setup [O+V]. 
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 Figure 2-5. The transfected neurons located in a narrow range of depth in OHSCs. 
(a)  Scan deep into OHSC, the equatorial section of the neuron expressing tdTomato (red fluorescent protein) is found 
at 21 μm depth. (b) Transfected cells are mostly located 30-45 μm below the surface of the culture (n=121 
cultures). 
 
Figure 2-6. pO2 varies with depth inside OHSC in optimized superfusion setup 
(a-f) Measurements made in OHSCs with [O+V], the optimized setup described in Figure 2-1. (a) The image of OHSC 
with an oxygen sensor placed. (b) The sketch of OHSC placed in superfusion setup [O+V] and interstitial pO2 is 
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measured.  (c) pO2 profile in different depths inside OHSC. Superfusate is switched from 95% O2/5% CO2 to N2/5% 
CO2. Gray arrow indicates the switching time. The second arrow (labelled with the same color as relative trace) 
indicates point where τ is measured to. (d, e) pO2 in OHSC vs depth in OHSCs for  95% O2/5% CO2 and N2/5% CO2. 
Red symbols are in the range of depths where we transfect cells and make measurements. (f) τ measured at different 
depths inside the OHSC. Error bars from 6 individual tests in (d) to (f). 
 
As shown in Figure 2-6, we measure pO2 in depths from 0-180 μm in superfusion setup 
[O+V]. The condition that ACSF saturated with 95% O2/5% CO2 is used in the first 10 min of Fig. 
2-6c, 2-6d, and will be used in “control” and “RP” for OGD-RP experiment. The condition that 
MACSF saturated with 95% N2/5% CO2 is used in the later 10 min of Fig. 2-6c, 2-6e, and will be 
used in “OGD” for OGD-RP experiment. As noted in Fig. 2-6c, the changes in pO2 in the OHSC 
at depths less than about 50 µm occurs rapidly. In addition, we have determined the steady-state 
pO2 during superfusion with ACSF saturated with 95% O2/5% CO2 (Fig. 2d). pO2 within the OHSC 
ranges from 691 ± 6 mmHg at the top surface to a minimum of 358 ± 10 mmHg in the middle, and 
520 ± 17 mmHg at the bottom surface. This is consistent with two facts. One is that oxygen takes 
time to diffuse into the OHSC and that is consumed on the way163. The other is that the culture is 
maintained with the interface method, so the lower surface of the culture is exposed to the medium 
underneath which is in equilibrium with air. The pO2 distribution during superfusion with MACSF 
saturated with 95% N2/5% CO2 and transition times (τ) show similar trends (Fig. 2e,f) indicating 
that the depth is a significant factor in controlling tissue oxygenation. 
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2.3.4 The oxidation status of mitochondrial GSH changes in a concert with pO2 that 
OHSC experiences 
It is very important to control pO2, especially in OGD-RP experiment because the redox 
status of the mitochondrial GSH is sensitive to the oxygen level, and it can be tracked with the 
Grx1-roGFP2 sensor that we used here. As discussed in section 2.3.3, OHSC experienced different 
pO2 conditions by using different superfusion setups (Figure 2-6). We expressed mito-Grx1-
roGFP2 in OHSCs, and observe its response during an OGD-RP protocol (described in section 
2.2.6) under 4 different superfusion systems (Fig. 2-1). Fig. 2-7 shows that Grx1-roGFP2 signal 
changes on the same timescale as that of pO2 in the four superfusion setups. 
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 Figure 2-7. mito-Grx1-roGFP2 signal tracks the pO2 change during OGD/RP. 
Each of the four quadrants represents a superfusion method: a: [B], b: [B+V], c: [O], d: [O+V]. In each quadrant there 
are traces of pO2 (top) and the mito-Grx1-roGFP2 ratiometric signal, R405/488 (bottom) measured simultaneously in 
OHSCs versus time. “Control”, “OGD”, “RP” correspond to superfusion with ACSF saturated with 95% O2/5% CO2, 
95% N2/5% CO2 and 95% O2/5% CO2, respectively. Each trace is representative of three separate experiments. R405/488 
(t) reflects the redox status of the GSH system, which changes with extracellular pO2.  The [O+V] configuration 
significantly improved gas exchange within the OHSC thereby decreasing the response time of the Grx1-roGFP2. 
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2.3.5 tdTomato corrects signal from Grx1-roGFP2 
In OHSCs that have not been subjected to OGD/RP, there are very small or no changes in 
cell size during exposure to the calibrants (Fig. 2-8a). However, after OGD/RP there are significant 
changes in cell size (Fig. 2-8b, Fig A-3b in Supporting Information). roGFP2 is ratiometric, so cell 
size does not change the measured ratio. However, to determine the degree of oxidation of the 
sensor and redox potentials of the sensor and the GSH/GSSG system we must measure the absolute 
intensities of Grx1-roGFP2 excited at 488 nm in its fully oxidized form,  I488Ox , and in its fully 
reduced form, I488Red. These intensities are influenced by changes in cell size (Fig. 2-8d). We have 
found that the fluorescence emission intensity of tdTomato164 is not sensitive to H2O2 or DTT (Fig. 
2-8a,c and Fig. B-3a,c). In the following discussion, it will be helpful to define some terms. We 
excite tdTomato at 561 nm, thus we refer to the intensity of the emission from that excitation as I561. We then define ratios of  I488Ox  and I488Red to I561 as  Î488Ox  and  Î488Red respectively. More generally, 
the ratio of the intensity from exciting roGFP2 at 488 nm to the intensity from 561 nm excitation 
of tdTomato is Î488. See SI for more discussion of these terms and their relationships. Notably, Fig. 
2-8b and Fig B-3b show that I561 is inversely correlated with the relative changes in cell size. The 
changes in cell size (ΔS/S) also influence the fluorescence arising from roGFP2 as can be seen in 
the upper panel of Fig. 2-8d and Fig B-3d. When I488Ox  and I488Red (measured during calibration) are 
divided by I561 at each time point, clear steady state values of the ratios Î488Ox   and  Î488Red are obtained 
making calibration possible. 
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 Figure 2-8. tdTomato corrects for changes in cell morphology allowing for stable signal during 
calibration. 
Fluorescence emission of tdTomato (excited at 561 nm) and Grx1-roGFP2 (excited at 405 and 488 nm) recorded from 
cytoplasm of a CA1 pyramidal cell in an OHSC. (a) Top: With no OGD/RP, the cell area does not change during 
exposure to calibrants H2O2 and DTT. Bottom: tdTomato fluorescence emission is not sensitive to H2O2 and DTT. (b) 
With OGD/RP, Top: ΔS/S, cell size, changes dramatically, does not reach a steady state, and oscillates. Bottom: 
Fluorescence signal from tdTomato is inversely correlated with changes in cell size. (c) The absolute intensities (Top) 
and ratios (bottom) from the three channels are obtained when exposed to ACSF, H2O2 and DTT with no OGD/RP. 
The Grx1-roGFP2 fluorescence shows dramatic changes. No difference in trend are observed when comparing 
absolute intensities (top panel of c) and ratios (bottom panel; I405 vs. Î405, I488 vs. Î488). (d) tdTomato calibration is 
necessary on single channel 405 nm or 488 nm (see the difference in I405 vs. Î405, I488 vs. Î488 when exposed to DTT) 
after OHSCs are continuously superfused for ~1.5 h during an OGD/RP experiment with the superfusion setup [O+V] 
as described in Figure 2-1. Fluorescence traces prior to OGD/RP (control) and during calibration post-OGD/RP with 
H2O2 and DTT are shown (note the break in the time axis). The value of Î488Red (bottom panel of d) is significantly more 
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stable than the I488Red fluorescent signal in (top). The confounding effects of OGD-induced cell size changes on I488 are 
corrected by I561. Î488Ox  and Î488Redare used to calculate the degree of oxidation of Grx1-roGFP2, OxDroGFP2 (see section 
2.2.3 for more details). The curves shown here are representative examples from five sets of measurements on five 
different OHSCs. 
Fekete et al. 165 saw significant swelling/volume changes in acute hippocampus slices 
during OGD. In an attempt to determine the fluorescence signal from the ROS-reactive dye, 
dihydrodichlorofluorescein, they used calcein AM (ROS insensitive) to correct for the changing 
volume. In our case, it was more appropriate to use co-transfection in order to make measurements 
on single pyramidal neurons in the CA1 region. While the sensor responds rapidly and 
reproducibly for neuronal mitochondria and cytoplasm in CA1 during the OGD/RP procedure, it 
was difficult to infer thermodynamically meaningful parameters from the data due to signal 
instability during the calibration steps following OGD/RP. In other sorts of investigations that do 
not involve such stressful conditions, changes in cell morphology may not be a problem and the 
internal standard may not be necessary. Of course, it is often sufficient to just report R405/488 as 
ratiometric measurement which is immune to the volume changes. But introducing tdTomato as 
an internal standard to correct the fluorescent signal during calibration of mito-Grx1-roGFP2 
allowed us to quantify the degree of oxidation of the sensor over time, OxDS(t), from the 
ratiometric signal I405/I488(t). With assumptions about the local pH, this in turn can be used to 
infer EGSH. We can applied this method to the determination of changes in OxDGSH in the cytoplasm 
and mitochondria of pyramidal neurons in OHSCs. 
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2.3.6 Quantitative analysis of redox changes in the GSH system in mitochondria and 
cytoplasm 
Fig. 2-9 shows the time-dependent changes in the GSH system in cytoplasm and 
mitochondria of single pyramidal neurons in the CA1 subfield of OHSCs during OGD/RP. Steady-
state values of the Grx1-roGFP2 signal and derived quantities are averages of the last five minutes 
of each period. The data for pyramidal cells in CA1 (Fig. 2-9) show that the sensor in mitochondria 
is more oxidized than that in cytoplasm under normal conditions. (OxDroGFP2: Mito/Cyto, 0.297 ± 
0.029/0.126 ± 0.023), but EGSH in mitochondria is more negative than that in cytoplasm (Mito/Cyto 
, -351 ± 2/-305 ± 3 mV) because of the different pHs in mitochondria and cytoplasm (Eq. 2.5-2.6, 
section 2.2.3). Mitochondrial GSH is notably reduced during OGD, then oxidized to a larger extent 
in RP than control (OxDroGFP2: Control/OGD/RP, 0.297 ± 0.029/0.101 ± 0.024/0.447 ± 0.002), 
whereas no significant change is observed in cytoplasmic GSH (OxDroGFP2: Control/OGD/RP, 
0.126 ± 0.023/0.156 ± 0.037/0.160 ± 0.026). 
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 Figure 2-9. Quantitative analysis of GSH redox changes during OGD/RP. 
Superfusion setup [O+V] described in Figure 2-1 is used. (a) Ratiometric images of Grx1-roGFP2 in mitochondria 
(Mito) and cytoplasm (Cyto) at different points in the OGD/RP procedure. (b) Mitochondria (data shown in black) 
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show a different response during OGD/RP than cytoplasm (data shown in red). Real time data traces are represented. 
The data in the last 5-minutes of each condition (indicated by the gray bar) from the traces are averaged and plotted 
with error bars. The data are statistically analyzed and compared to the control data (n.s. (no significant difference), p 
> 0.05; ***, p < 0.001, n=30 data points, ANOVA test). All of terms used are defined in Eq. 2.1-2.6 in section 2.2.3. 
The curves shown here are representative examples from five sets of measurements on five different OHSCs. 
Our observation shows that the mitochondrial GSH system becomes more reducing during 
OGD, and more oxidizing during RP in comparison to the pre-OGD control conditions (Figure 2-
9). On the other hand, the cytoplasmic GSH system did not respond to OGD-RP. Abramov et al. 
recently did a careful investigation of ROS generation during OGD/RP in hippocampal neuron/glia 
primary co-cultures43.  They found three sources of ROS occurring in series based on MitoSOX 
and ethidium fluorescence following application of hydroethidine, HEt. In the first 10-20 min of 
OGD, ROS production is mitochondrial and correlated with the presence of inner mitochondrial 
membrane (IMM) depolarization. After about 25 min (longer than our OGD period), Abramov et 
al. found that there is a phase during which ROS is produced in the cytoplasm by the 
xanthine/xanthine oxidase system43. During RP, ROS generation occurs in the cytoplasm from the 
NAD(P)H oxidase system. We observed that the mitochondrial GSH system becomes more 
reducing quite rapidly at the onset of OGD and that this more reducing status is maintained during 
OGD. A negative shift in EroGFP2 could be caused by a number of factors, e.g., import of GSH from 
cytoplasm166, reduction of mitochondrial GSSG, or indeed by an increase in local pH. We note 
that Abramov et al. in primary cultures and others on OHSCs167-169 have seen rapid IMM 
depolarization during OGD. This would decrease the local pH in the matrix. Thus, we can be 
reasonably sure that the response of mito-Grx1-roGFP2 during OGD represents an increase in the 
ratio [GSH]2/[GSSG]. That is, the GSH system becomes more reduced.  Recall that in primary 
cultures Abramov et al.43 see a significant increase ROS during OGD which seems in a sense 
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inconsistent with our observations on GSH.  Funke et al.147 compared the responses of roGFP1 
(i.e., the cytoplasm-resident redox responsive GFP with no Grx1) and HEt in primary cultures of 
hippocampal neurons/glia under various treatments. Indeed, while several treatments led to 
qualitatively equivalent responses from each sensor, i.e., both indicating more oxidizing conditions 
or more reducing conditions, exposure to glutamate and (separately) uncoupling with FCCP 
showed opposite responses – more ethidium fluorescence but a more reduced roGFP. In this same 
work, a five-min exposure to anoxia led to the same gross changes in roGFP response as we 
observed though on a much slower timescale. Thus, we are in qualitative agreement with Funke et 
al.147 who used the slower, less selective, cytoplasm-resident roGFP1. We conclude that the 
difference in the ethidium response seen by Abramov et al. and what we have detected during 
OGD is not likely due a technical issue. While certainly more work is required to understand the 
contrasting observations, the response of Grx1-roGFP2 may be dominated by increased reducing 
power during brief OGD rather than by the more oxidizing environment due to excess ROS. There 
are two contributions to increased reducing power. One is that the pH change from about 8 to about 
7 as a result of IMM depolarization increases the difference in redox potentials of the 
NADP+/NADPH and the GSH systems making the reduction of GSSG by NADPH more 
thermodynamically favorable (see Appendix A). In addition, the abundance of NADH from the 
absence of oxidative phosphorylation can lead to more NADPH production by transhydrogenase 
73,170 and more GSH from GSSG. 
During RP, we find a sharp change in the mitochondrial sensor to more oxidizing 
potentials. Abramov et al. see an increase in HEt fluorescence as well. This is consistent with the 
discussion above: the supply of reducing equivalents ultimately derived from fuel and then 
becoming NADH is a significant factor in mitochondrial GSH status. In the early stages of OGD, 
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without oxygen present, the mitochondrial matrix concentration of NADH should be relatively 
high, and during RP with the re-introduction of oxygen it should drop. Thus, the supply of NADPH 
for acting to reduce GSSG to GSH via glutathione reductase may dictate, at least qualitatively, the 
GSH system’s status. 
It is surprising not to find changes in cytoplasmic GSH during OGD/RP. Perhaps 
cytoplasmic GSH, which has a much larger antioxidant capacity than the mitochondrial GSH 
system43,171, can maintain homeostasis when facing increases in ROS generation in the 
mitochondria and/or the cytoplasm43. It might be also reasonable to attribute the lack of response 
in the cytoplasmic GSH system during OGD/RP to the absence of cytoplasmic ROS. According 
to Abramov et al.172, the cytoplasmic sources do not emerge until 25 min of OGD while our OGD 
time frame is only 20 min. On the other hand, during RP we would expect to see changes in the 
GSH system if indeed superoxide is being formed from NAD(P)H oxidase172. In summary, the 
time-dependence of the redox status of the GSH system provides new, and perhaps complementary 
information to that obtained by more classical fluorescence-based techniques. We find that during 
non-lethal OGD/RP, single CA1 pyramidal neurons show rapid changes in the GSH system in 
mitochondria during OGD/RP. The mitochondria become more reducing during OGD and more 
oxidizing during RP. The status of the GSH system is of course a steady state. It is possible that 
changes in the supply of reducing equivalents, not the supply of oxidizing equivalents, i.e., ROS, 
is the dominant factor determining the redox status of the GSH system during OGD/RP. 
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2.4 CONCLUSION 
We are not aware of ways to determine the redox status of the GSH system in real time 
other than by using protein-based sensors159. Herein, we choose to use Grx1-roGFP2, which is 
highly selective and sensitive to GSH system to monitor the redox change in OHSC during OGD-
RP. In order to report OxDroGFP2 and EGSH in tissue cultures during OGD-RP, we try to optimize 
our protocol in following aspects: 1) Due to the requirement on well control on pO2 via superfusion 
in OGD-RP experiment, we try to optimize the superfusion setup to obtain high gas delivery and 
exchange efficiency. 2) With a proper transfection protocol, we are able to have a narrow 
distribution of neurons expressing roGFP2 sensor in depth in OHSC, which enable us to exert 
consistent experimental conditions on our objects, since we have observed that pO2 level and 
transition time varies in different depths. 3) Deriving OxDroGFP2 and EGSH requires correction on 
the fluorescent signal of Grx1-roGFP2, we, for the first time, introduce tdTomato, a redox 
insensitive fluorescent protein, for the aid to exclude the effect from cell morphology change, 
vibration, or other non-redox factor. 
Our reliable report on OxDroGFP2 and EGSH, showing that mitochondrial and cytoplasmic 
GSH system responds different to OGD-RP in hippocampal neurons, could be broadly applied to 
study on the systematic pharmacological experiments, like the inhibition assays on GSH related 
enzymes (e.g. glutathione peroxidase46, glutathione reductase46, γ-glutamylcysteine Synthetase52, 
GSH synthase50 and γ-glutamyltranspeptidase52), which will influence the GSH system. 
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3.0  GSH SYSTEM RESPONDS DIFFERENTLY WITHIN DIFFERENT CELL TYPES 
DURING OGD-RP 
3.1 INTRODUCTION 
ROS induced by antimycin-A severely inhibited the proliferation of HeLa cells via 
initiating apoptosis173. Imbalanced production of ROS23-25 has been found to be the main cause of 
neuronal damage in stroke1-3. A proper amount of ROS plays a critical role in cell signaling such 
as signal transduction and neuronal transmitter releasing26-31, but excess ROS will leading to short-
term effects in cellular function, and longer-term changes that ultimately cause neuronal death32-
34. Hypoxia/ischemia (HI) episodes, such as those that occur during stroke, disrupt ROS 
homeostasis in neurons and glial cells.  In order to counter against the harmful oxidative stress 
cuased by ROS, the cells are endowed with mechanisms for maintaining ROS homeostasis. 
Glutathione (GSH) is an important antioxidant in both abnormal and normal cells for removing 
ROS generated during oxidative metabolism52,81,174-179. HeLa cells are found to have more ROS 
resistance by enhancing the expression of glucose-6-phosphate dehydrogenase (G6PD) which 
facilitates the restoration of GSH levels inside180.  Many anti-tumor drugs are found to cause 
excessive ROS in HeLa cells that leads to the final cell death181.  Overexpression of γ-glutamyl-
transpeptidase (γGT), which utilizes GSH to create Cys-Gly, helps the survival of HeLa cells under 
the existence of platinum anti-tumor reagent, cisplatin, the function of which is inhibited by Cys-
Gly182. Applying exogenous GSH helps to rescue the neurons from the ischemia insult by reducing 
the ROS generated183. Depletion of GSH in the mitochondria of rat cerebellar granule neurons 
causes neuronal death in 2 hours, but no such phenomenon is found by cytoplasmic GSH 
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depletion184. A more sustained activity of GSH in neurons is the promotion of cell survival by 
participating in beneficial enzymatically catalyzed reactions185,186 like those of glutathione 
peroxidases (GPxs), glutathione S-transferases (GSTs). 
The GSH system varies in different cell types. There are very few reports that we are aware 
of comparing the GSH system of HeLa cells and neuronal cells. HeLa cells show a more robust 
GSH synthesis system to replenish GSH back to normal levels than rat spleen lymphocytes by 
utilizing different sulfur amino acid sources, methionine, cysteine and cystine (the oxidized form 
of cysteine)187. The capacity of total GSH in HeLa cells is about 35 fold of that in rat spleen 
lymphocytes, and the activities of GSH-related enzymes are different in the two types of cells187. 
Astrocytes are found to be more resistant to OGD-induced ROS than pyramidal cells in primary 
cell cultures45. The consumption of H2O2 is much faster in astrocytes compared to neurons47, which 
could be ascribed to the fact that the intracellular GSH level is higher in astrocytes than in 
neurons46. Astrocytes have a higher activity of glutathione peroxidase (GPx) which facilitates the 
reduction of ROS by GSH46,47. Accumulating evidence46,48-52 shows that the primary function of 
astrocytes is to support neurons during ROS insult by maintaining the GSH level in neurons. 
Ringen et al.52 proposed a mechanism about how astrocytes feed neuron with GSH: astrocytes 
release GSH, which is degraded to CysGly by γ-glutamyl-transpeptidase (γGT); then CysGly is 
uptaken by neurons and used to synthesize GSH inside. Griffin et al. 49 observed that astrocyte 
cells promote the survivability of neurons after OGD, in which primary cell cultures (neurons or 
astrocytes) were used. The intracellular GSH level was not affected in astrocytes only cell culture 
in the 24 h after OGD, but the GSH concentration dropped dramatically in astrocytes when they 
were co-cultured with neurons, especially with OGD-treated neurons49. Meanwhile, the GSH was 
observed to keep releasing into the culture medium in the 24 h after OGD in the co-culture of 
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neurons and astrocytes49.  All of this evidence provided by Griffin et al.49 directly supports Ringen 
et al.’s52 mechanism.  
Because oxidation of intracellular GSH leads to the disulfide GSSG and the GSH/GSSG 
couple is in a dynamic redox status, the redox state of the GSH/GSSH couple is an indicator of 
oxidative stress. ROS in real time could be measured by voltammetry136-138,188 and fluorescence 
imaging with fluorogenic small molecule dyes113,139-141. The ROS management inside cells could 
be investigated through the prospective of its antioxidant pool, GSH system. However, there are 
not many practical ways to study the GSH/GSSG couples. The concentration of GSH or GSSG 
could be measured by 5,5′-dithio-bis-2-nitrobenzoic acid (DTNB) assay using spectroscopy or 
high-performance liquid chromatography (HPLC) with or without the existence of NADPH and 
glutathione reductase, but it is not practical or efficient for real-time measurement189. It is a 
breakthrough that  roGFP1147 and roGFP2145 have been used to detect ROS in real-time, even 
though it is in a relative slow time scope. Real time GSH/GSSG redox status has not been 
monitored until that Meyer et al.145 applied exogenous glutaredoxin (Grx) and roGFP2. Gutscher 
et al.146 made a chimeric protein (Grx1-roGFP2) to facilitate the measurement of intracellular 
GSH/GSSG redox status.  By now, there are rare reports investigating the GSH system in central 
neuron system (CNS) tissue.  We applies the selective sensors, mito-Grx1-roGFP2146 and cyto-
Grx1-roGFP2146, in which their advantages over other chemical ROS detecting dyes113,139-141, and 
rxYFP142 or roGFP based protein sensors (roGFP1147, roGFP2145) has been discussed in Chapter 
2. HeLa cells are a ubiquitous biological model used in research190. We used HeLa cells to test the 
Grx1-roGFP2 sensor and to help transfection optimizition, fluorescence imaging and calibration 
for calculation of redox information of GSH system in Chapter 2. In this chapter, HeLa cells were 
used as an abnormal-cell model, and expected to have different GSH system mediating ROS 
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homeostasis from normal neuronal cells (pyramidal cells and astrocytes) in OHSC during OGD-
RP. The GSH system in mitochondria and cytosol were studied individually since their differences 
in mediating ROS have been found in rat cerebellar granule neurons184.  
We follow the protocol in Chapter 2 to treat Cells or OHSCs with OGD-RP in optimized 
superfusion system.  Well-defined redox parameters (R405/488, OxDroGFP2, ln([GSH]2/[GSSG]) and 
EGSH) are reported with Grx1-roGFP2’s fluorescence intensity referenced by signal from 
tdTomato, and compared in six different biological models (two cell compartments × three cell 
types) as mentioned above. 
3.2 EXPERIMENTAL SECTION 
3.2.1 Cell and tissue preparation 
HeLa cells were cultured and transfected with the plasmids for expressing tdTomato and 
Grx1-roGFP2 sensor (see Section 2.2.1.2 for more details). Organotypic hippocampal slice 
cultures (OHSC) were prepared by following Gogolla’s protocol153 from the postnatal 7-day old 
Sprague-Dawley rats (Charles River, Pittsburgh) with approval by the Institutional Animal Care 
and Use Committee (IACUC) of the University of Pittsburgh. tdTomato and Grx1-roGFP2 sensor 
were introduced into OHSC by biolistic transfection or single cell electroporation (see Section 
2.2.1.3 for more details). Pyramidal cells (A.K.A. neurons) and astrocytes with tdTomato and 
Grx1-roGFP2 were found in the treated OHSC. 
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3.2.2 Ratiometric imaging and characterization of Grx1-roGFP2 in different cell types 
Cells were imaged with an HCX PL FLUOTAR 5x objective lens with N.A. = 0.15 and an 
HCX APO L U-V-I water immersion 63x objective lens with N.A. = 0.90 on a Leica TCS SP5II 
broadband confocal microscope (Department of Biological Sciences, University of Pittsburgh). 
Grx1-roGFP2 was excited at 405 or 488 nm and its emission intensity was acquired in a 
range of 500 – 530 nm. In Grx1-roGFP2, roGFP2 is the functional fluorescent subunit responding 
to redox change of GSH/GSSH couple, due to the change of the chromophore from its neutral form 
to anionic form105,106. The part of Grx1132 is incorporated to accelerate the reaction between 
roGFP2 and GSH/GSSG couple when countering redox change and it dramatically boosts the 
response rate. The spectroscopic changes in roGFP at 405 and 488 nm excitation are quantitatively 
related, which allows them to be used to calculate OxDroGFP2 and EGSH 105,106,120. 
We examined the response of Grx1-roGFP2 in three different cell types (pyramidal cells, 
astrocytes in OHSCs and HeLa cells) and two different cell compartments (mitochondria and 
cytoplasm) in each cell type. I405 and I488 from Grx1-roGFP2 are firstly divided by I561 from 
tdTomato (normalized I405 and I488 are represented as Î405 and Î488, respectively). The ratios  
Î405𝑚𝑚𝑚𝑚𝑚𝑚Î405𝑚𝑚𝑚𝑚𝑚𝑚  
and Î488𝑚𝑚𝑚𝑚𝑚𝑚Î488𝑚𝑚𝑚𝑚𝑚𝑚  are the dynamic range of channels of Grx1-roGFP2 excited at 405 and 488 nm 
respectively. R405/488, 
Î405Î488, is commonly used to represent the redox change of roGFP2 based sensor 
105,106,119,132,191,192. The ratio R405
max
R408
min  represents the dynamic range of the Grx1-roGFP2 sensor 
responding to the extreme oxidizing and reducing environment. Î405 and R405/488 increase with 
oxidation and decrease with reduction, but Î488 changes in opposite to them. Thus we can find the 
maximum value of Î405 and R405/488 and minimum value of Î488 from fully oxidized Grx1-roGFP2 
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sensor, but the minimum value of Î405 and R405/488 and maximum value of Î488 from fully reduced 
Grx1-roGFP2 (Eq. 3.2, 3.4). The dynamic range of each single channel of Grx1-roGFP2, excited 
at 405 nm (Î405𝑚𝑚𝑚𝑚𝑚𝑚Î405𝑚𝑚𝑚𝑚𝑚𝑚 ), 488 nm (Î488𝑚𝑚𝑚𝑚𝑚𝑚Î488𝑚𝑚𝑚𝑚𝑚𝑚 ) and dynamic range of R, (R405maxR408min), are statistically analyzed among 
the six biological models, mitochondria and cytoplasm in HeLa cells, pyramidal cells and 
astrocytes in OHSC (Fig. 3-4). The calculations are shown in Equation 3.1-3.6. 
 Î405 = I405/I561, Î488 = I488/I561 (Eq. 3.1) 
 Î405Ox =  Î405max, Î405Red =  Î405min, Î488Ox =  Î488min, Î488Red =  Î488max (Eq. 3.2) 
 R405/488 = I405/I488 (Eq. 3.3) 
 R405/488max =  R405/488Ox ;  R405/488min =  R405/488Red  (Eq. 3.4) 
 
 
DR405 = Î405maxÎ405min = Î405OxÎ405Red ;  DR488 = Î488maxÎ488min = Î488RedÎ488Ox  (Eq. 3.5) 
 DRR = R405/488maxR405/488min =  DR405 ×  DR488 (Eq. 3.6) 
In which, I405, I488 and I561 are fluorescence intensity excited at 405 and 488 nm of Grx1-roGFP2 and 
excited at 561 nm of tdTomato, respectively. Î405 and Î488 are Normalized I405 and I488 by I561. R405/488 is the 
ratio of Î405 to Î488. Î𝑋𝑋𝑂𝑂𝑂𝑂,Î𝑋𝑋𝑅𝑅𝑅𝑅𝑅𝑅, Î𝑋𝑋𝑚𝑚𝑚𝑚𝑂𝑂, Î𝑋𝑋𝑚𝑚𝑚𝑚𝑚𝑚 are fully oxidized, reduced, maximum and minimum normalized 
fluorescence intensity at excitation X nm (405 or 488 nm), respectively. 𝑅𝑅405/488𝑂𝑂𝑂𝑂 , 𝑅𝑅405/488𝑅𝑅𝑅𝑅𝑅𝑅 , 𝑅𝑅405/488𝑚𝑚𝑚𝑚𝑂𝑂  and  
𝑅𝑅405/488𝑚𝑚𝑚𝑚𝑚𝑚  are fully oxidized, reduced, maximum and minimum R405/488. DR405, DR488 and DRR are the 
dynamic range of channels 405, 488 and R405/488 of Grx1-roGFP2. 
The parameters, DR405, DR488 and DRR are compared among six biological models with 
one way ANOVA test (no significant difference, p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, 
n=12).  
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In this work, numerical data were processed in MatLab (version R2012b, MathWorks, Inc.) 
and OrginPro (version 9.0, OriginLab Corp.). Statistical analysis was processed in R (www.r-
project.org) and MatLab (version R2012b, MathWorks, Inc.)  
 
3.2.3 Derivation of redox information from Grx1-roGFP2. 
The fluorescent intensities of roGFP2 that excited at 405 nm and 488 nm are quantitatively 
related with its oxidized and reduced form, which allows the calculation of oxidation degree of the 
sensor, Grx1-roGFP2 (OxDS) and the redox potential of glutathione (EGSH)105,106,120. 
Redox information of OxDS, the natural logarithm of the ratio, 
[GSH]2[GSSG] and EGSH is derived 
from R405/488, Î405Ox  and Î405Red as shown below (Eq. 3.7-3.11). 
.  
 OxDS = R405/488 − R405/488RedÎ488𝑂𝑂𝑂𝑂Î488𝑅𝑅𝑅𝑅𝑅𝑅 �R405/488Ox − R405/488� + (R405/488− R405/488Red )   (Eq. 3.7) 
In which, Î405, Î488, OxDS,R405/488, 𝑅𝑅405/488𝑂𝑂𝑂𝑂  and 𝑅𝑅405/488𝑅𝑅𝑅𝑅𝑅𝑅  have been defined above. The necessity to obtain Î405𝑂𝑂𝑂𝑂  and Î405𝑅𝑅𝑅𝑅𝑅𝑅 by correcting I405 and I488 from Grx1-roGFP2 with I561 from tdTomato has been explicitly 
discussed in Chapter 2.079. 
The Eq. 3.6 can be transformed into Eq. 3.7 as R405/488Ox  is normalized to 1 and R405/488 is 
normalized to R405/488Ox . 
 OxDS = R405/488 − 1DRR1DR488 �1 − R405/488� + (R405/488 − 1DRR) (Eq. 3.8) 
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In which, DR488, DRR, R405/488 and OxDS have been defined above.  
The Nernst term, ln( [GSH]2[GSSG]), can be derived from OxDS . 
 In�[GSH]2[GSSG]� = In �1 − OxDSOxDS � + ZFRT �EGSHO − EroGFP2O � (Eq. 3.9) 
In which, 𝐸𝐸𝐺𝐺𝐺𝐺𝑝𝑝𝑂𝑂  160 and  𝐸𝐸𝑟𝑟𝑟𝑟𝐺𝐺𝑟𝑟𝑟𝑟2𝑂𝑂  106 are the standard redox potentials of glutathione and Grx1-roGFP2 at 
pH = 7.00 respectively;  Z is the number of electrons transferred in the redox reaction; R is the gas 
constant; F is the Faraday constant; T is the absolute temperature. 𝐸𝐸𝐺𝐺𝐺𝐺𝑝𝑝𝑂𝑂 = −240 𝑚𝑚𝑚𝑚;   𝐸𝐸𝑟𝑟𝑟𝑟𝐺𝐺𝑟𝑟𝑟𝑟2𝑂𝑂 =
−280 𝑚𝑚𝑚𝑚; Z = 2; F= 96485 C/mol; R = 8.315 JˑK-1ˑmol-1; T = 309.15 K. 
The redox potential of the GSH/GSSG couple in mitochondria and cytoplasm is calculated 
from the known OxDS. Different pH values in the two compartments are considered. 
 EGSHCyto = EGSHpH=7 = EroGFP2pH=7  = EroGFP2O − RTZF In �1 − OxDSOxDS � (Eq. 3.10) 
 EGSHMito = EGSHpH=8 = EGSHpH=7 + RTzF In �[𝑝𝑝+]𝑝𝑝𝑝𝑝=82[𝑝𝑝+]𝑝𝑝𝑝𝑝=72 � =  EGSHCyto − 61.3 (mV)    (Eq. 3.11) 
In this equation, the same values of 𝐸𝐸𝐺𝐺𝐺𝐺𝑝𝑝𝑂𝑂 , 𝐸𝐸𝑟𝑟𝑟𝑟𝐺𝐺𝑟𝑟𝑟𝑟2𝑂𝑂 , Z, F, R and T are used here; [𝐻𝐻+]𝑝𝑝𝑝𝑝=8 = 10-8 mol L-1, [𝐻𝐻+]𝑝𝑝𝑝𝑝=7 = 10-7 mol L-1.  
 
3.2.4 OGD-RP experiment 
HeLa cell cultures and OHSC were treated with OGD-RP (see Section 2.2.6 for more 
details), in which optimized superfusion system [O+V] (see Section 2.2.5 for more details) was 
applied. The purpose of these experiments is to investigate whether the GSH system responds 
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differently to OGD-RP in these six different biological models (two cellular compartments × three 
cell types:  mitochondria and cytoplasm × HeLa cells, pyramidal cells and astrocytes). 
3.3 RESULTS AND DISCUSSION 
3.3.1 Expressing tdTomato and Grx1-roGFP2 sensor in HeLa cell culture and OHSC.  
As shown in Fig. 3-1, 3-2 and 3-3, Grx1-roGFP2 and tdTomato are introduced into the HeLa cell 
culture and OHSC successfully. To transfect the HeLa cell culture, lipofectamine (Invitrogen) with 
plasmids were mixed to form a subtle positively charged complex, which could better fuse with negativly 
charged cell membrane, sequentially increasing the transfection efficiency193. Our recipe was modified 
based on the manufacture’s protocol to minimize the toxicity to the HeLa cell culture. However, the 
lipofectamine aided transfection does not work on OHSCs according to our experience. The poor case could 
be due to the extremely low permeability of intense microglial194 cell layer covering OHSC impeding the 
delivery of the lipofectamine/plasmid complex. We had to circumvent the microglia cell layer by using 
gene gun195. As shown in Fig. 3-2b, the gold particles fired with gene gun firstly penetrate through the glia 
cell layer, then get trapped somewhere beneath (~ 30 – 45 μm below79 the very top of OHSC), and leave 
the loaded plasmid to its target, pyramidal cell or astrocyte. In order to study the GSH system in 
mitochondria and cytoplasm individually, mitochondrial targeting sequence132 was tagged into the normal 
tdTomato79 and Grx1-roGFP2132 that was used for expression in cytoplasm to create their mitochondrial 
types. The distributions of tdTomato and Grx1-roGFP2 in mitochondria and cytoplasm are observable in 
Fig. 3-1 and 3-3.  
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 Figure 3-1. Transfection in HeLa cells. 
Grx1-roGFP2 and tdTomato co-expressed in mitochondria or cytoplasm of HeLa cells. Images of merge (merge of 
bright field image and fluorescent image of tdTomato), tdTomato, 405 nm excitation of Grx1-roGFP2 and 488 nm 
excitation of Grx1-roGFP2 are shown from left to right. 
 
 
 
Figure 3-2. Transfection inside OHSC. 
Plasmid coding for tdTomato is transfected into cells in OHSCs by gene gun. (a) Images are taken with a 5x objective 
lens to give bright field (BF), fluorescence (FL) and merged images from left to right. The dotted line indicates 
approximately the Cornu Ammonis (CA). Gene gun-enabled transfection in 10~15 cells per OHSC. Pyramidal cells 
or astrocytes expressing tdTomato are distributed randomly in OHSC. Cell highlighted by a white arrow in (a) is 
b a 
62 
 
imaged under 63x objective lens to show enlarged details in (b). (b) Pyramidal cells show a different pattern of 
alignment and cell shape than astrocytes. Gold particles (indicated by blue arrows) are found left in OHSC after using 
gene gun. 
 
 
Figure 3-3. Co-expression of tdTomato and Grx1-roGFP2 in mitochondrial or cytoplasmic pyramidal 
cells and astrocytes and in OHSCs. 
Grx1-roGFP2 and tdTomato co-expressed in mitochondria or cytoplasm in pyramidal cells or astrocytes in OHSCs. 
Images of merge, tdTomato, 405 nm excitation of Grx1-roGFP2 and 488 nm excitation of Grx1-roGFP2 are shown 
from left to right. 
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3.3.2 Characterization of Grx1-roGFP2 in six different biological models. 
Before applying Grx1-roGFP2 to investigate the GSH system in six different biological 
models (two cell compartments × three cell types: mitochondria, cytoplasm × HeLa cells, 
pyramidal cells and astrocytes), we characterized the sensor to see whether its spectroscopic 
change would vary depending on the biological environment.  
 
 
Figure 3-4. Characterization of Grx1-roGFP2 in different cell compartments and cell types. 
Grx1-roGFP2 is expressed selectively in 6 biological models (2 cell compartments × 3 cell types; mitochondria or 
cytoplasm × HeLa cells, pyramidal cells or astrocytes in OHSCs). (a) A representative data set from Grx1-roGFP2 
expressed in the cytoplasm of pyramidal cell. Cell or OHSC were treated with ACSF in control (CT), then calibrated 
with oxidant, H2O2 and reductant, DTT to reach full oxidation and full reduction. Î405, Î488 are fluorescence intensity 
from Grx1-roGFP2, exited at 405 nm and 488 nm and normalized by I561, fluorescence intensity from tdTomato, 
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excited at 561 nm. R405/488 is the ratio of Î405 and Î488. (b) DR405 and DR488 are the respective dynamic range of excitation 
channels, 405 and 488 nm, of Grx1-roGFP2, which are approximately 2.2 (p>0.05, n=12 for each case). There is no 
significant difference found between the two excitation channels (c) The ratios of DR405/DR488 are ~ 1 (p>0.05, n=12 
for each case). There is no difference among the 6 biological models. (d) DRR (referred to as dynamic range of R405/488) 
is ~5 (p>0.05, n=12 for each case) and similar in the 6 different biological models. Data are shown in mean ± SEM 
and statistically analyzed by student’s t test or one-way ANOVA test. There is no special mentions or labels when 
there is no significant difference found. All of the terms shown in the figure are defined in Eq. S1 – S6 in Supporting 
Information. 
As represented in Fig. 3-4a, cell culture or OHSC was treated with ACSF, then calibrated 
sequentially with H2O2 and DTT. I405 and I488 of Grx1-roGFP2 was calibrated by I561 from 
tdTomato, and represented as Î405 and Î488, respectively (Eq. 3.1). It is necessary to make this 
correction since several confounding factors distort I405 and I488, such as the vibration introduced 
by continuous superfusion during OGD-RP and the noticeable cell-volume changes during H2O2 
and DTT calibration after OGD-RP experiment (fully discussed in Chapter 2.079). Î405 and Î488 
change oppositely, and R405/488 changes in the same trend as Î405. Î405max , R405/488max  and Î488min  are 
acquired with H2O2 treatment, and Î405min, R405/488min  and Î488max are acquired with DTT treatment. We 
compared the dynamic range of channel 405, 488 and R405/488 of Grx1-roGFP2 (DR405, DR488 and 
DRR) in the six different biological system and found that all of the terms are not significant 
different in the tested models (Fig. 3-4b, d). The GSH system varies in different cell types. HeLa 
cells have stronger capability in synthesizing GSH by utilizing different sulfur amino acid sources 
(e.g. methionine, cysteine and cysteine) and maintaining much higher GSH level than normal cells 
such as rat spleen lymphocytes187. Astrocytes contain higher intracellular GSH level than 
neurons46. Apparently, the dynamic change of spectrum of Grx1-roGFP2 will not vary with the 
different GSH levels in HeLa cells, pyramidal cells and astrocytes according to our observation. 
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The concentration of mitochondrial GSH (mGSH) is similar to that of cytoplasmic GSH (cGSH)23, 
but pH is different in mitochondria and cytoplasm196. R405/488 of Grx-roGFP2 is not sensitive to 
pH120. We also observed that neither DR405, DR488 nor DRR influenced by pH. All of the data in 
Fig. 3-4 convinces us that the same equation (Eq. 3.8) could be used to derive OxDS from R405/488 
in all six tested biological models because the rest of terms, DR488 and DRR in Eq. 3.8 are measured 
to be constant. Grx1-roGFP2 is verified to be a proper sensor for the redox change of GSH system, 
which is not influenced by the complex cellular environments differing in many factors such as 
GSH level and pH. 
3.3.3 HeLa cells, pyramidal cells and astrocytes in OHSCs respond differently to OGD-
RP.  
As shown in Fig. 3-5, the redox terms, OxDS, ln
[GSH]2[GSSG] and EGSH derived from R405/488 are 
obtained from mitochondria and cytoplasm of HeLa cells, pyramidal cells and astrocytes. All of 
the terms change in a similar trend during OGD-RP, and the values of the redox terms show the 
similar relationship among HeLa cells, pyramidal cells and astrocytes. In general, larger redox 
terms represent more oxidized GSH system, and smaller redox terms indicate more reduced GSH 
system.  We found that mitochondrial or cytoplasmic OxDS are not significant different among 
HeLa cells, pyramidal cells and astrocytes, but the sensor in the mitochondria is more oxidized 
than that in the cytoplasm under normal condition (mito: HeLa/Pyra/astro, 0.238 ± 0.046/0.205 ± 
0.064/0.229 ± 0.061; cyto: HeLa/Pyra/astro, 0.103 ± 0.006/0.074 ± 0.030/0.065 ± 0.028; mean ± 
SEM, n=6; CT). Basically, we found larger R405/488 and ln
[GSH]2[GSSG] in mitochondria under normal 
conditions. In contrast, EGSH in mitochondria is more negative than that in cytoplasm under normal 
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conditions (Fig. 3-4, Table. C-1) because the pH difference will shift EGSH by -61.3 mV from 
cytoplasm to mitochondria even with the same OxDS (Eq. 3.11). Our data is consistent with the 
OxDS and EGSH in HeLa cells reported via rxYFP 197 (OxDS: mito/cyto, ~ 0.22/~ 0.05; EGSH: 
mito/cyto, ~ -345mV/~ -345 mV ). We did not report the degree of oxidation of the GSH/GSSG 
couple (OxDGSH = 2[GSSG]/(2[GSSG]+ [GSH])) in this work because that we do not know the 
accurate concentration of mGSH and cGSH in different cell types. However, with reasonable 
assumption about mGSH = cGSH ≈ 10 mM23, our values of these redox terms correspond to a very 
small degree of oxidation of the GSH/GSSG couple (OxDGSH: mito/cyto, ~5×10-4/~1×10-4) 
indicating that the majority of GSH (> 99%) exist as its reduced form in different cell types under 
normal conditions159.   
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 Figure 3-5. GSH systems in variable biological models respond differently to OGD-RP. 
Cells or OHSCs were sequentially treated with 10 min control/20 min OGD/30 min RP followed with H2O2 and DTT 
calibration (Data portion for H2O2 and DTT calibration are not shown here). Superfusion setup [O+V] described in 
Figure 2-1 is used. Fluorescence signals from mitochondrial or cytosolic Grx1-roGPF2 and tdTomato were measured. 
R405/488, OxDroGFP2, ln([GSH]2/[GSSG]) and EGSH were calculated from 405 nm, 488 nm and 561 nm signals. R405/488 
at the fully oxidized period is normalized to 1. OxDroGFP2, ln([GSH]2/[GSSG]), EGSH were calculated from fluorescence 
signal at excitation 405 and 488 nm of Grx1-roGFP2 with calibration of I561 of tdTomato (see Section 2.2.3 for more 
details). Mean ± SEM for six separate experiments are shown in each subplot. Statistical analysis was applied to 
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compare among the different cell types at each period during OGD-RP (indicated by blue vertical line with relative 
blue result symbol), or compare among the different periods of OGD-RP in each biological model (indicated by 
horizontal line with relative result symbol) with ANOVA analysis (n.s., no significant difference, p > 0.05, *p < 0.05, 
**p < 0.01, ***p<0.001). Data traces, symbols, labels, and lines for HeLa cells, pyramidal cells and astrocytes are 
colored by black, red and green, respectively. 
 
 
 
 
 
Figure 3-6. GSH systems respond differently in mitochondria and cytoplasm. 
Mitochondrial and cytoplasmic GSH systems have a different redox status and response to OGD-RP in three cell 
types, HeLa cells, pyramidal cells and astrocytes. Steady state values of R405/488, OxDroGFP2, ln([GSH]2/[GSSG]) and 
EGSH in control, OGD and RP are represented as mean ± SEM in the plots (n=6). Their full data traces in OGD-RP 
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are shown in Figure 3-5. A one way ANOVA was applied to compare mitochondria and cytoplasm (*p<0.05, 
**p<0.01, ***p<0.001, n=6). There is no special mentions or labels when there is no significant difference found. 
 
There is no change to the time-dependent redox terms from the cytoplasm during OGD-
RP, and the cGSH system performs similarly in HeLa cells, pyramidal cells and astrocytes (Fig. 
3-5 (Right)). In contrast, mGSH system changes dramatically in pyramidal cells and astrocytes 
even though no obvious change is found in the mitochondria of HeLa cells. All of the redox terms 
differ between mitochondria and cytoplasm in our six biological models under various 
pathological conditions (Fig. 3-6) indicating the presence of intrinsic differences in their GSH 
system. In theory, OxDS, ln
[GSH]2[GSSG] and EGSH are balanced by internal ROS generation and reducing 
power by NADPH81. Three sources of ROS were discovered in the investigation of ROS 
generation in hippocampal neurons during 40 min OGD- 20 min RP conducted by Abramov et 
al.43. According to his observation, the first ROS production occurred at 10-20 min of OGD origins 
from the mitochondria membrane depolarization, and the additional ROS produced by cytoplasmic 
xanthine/xanthine oxidase system did not happen until 25 min from the onset of OGD. ROS 
produced in RP with participation of NAD(P)H oxidase were found both in the mitochondria and 
the cytoplasm43. As pointed out by Abramov et al.43, the absence of cytoplasmic ROS during 20 
min OGD could result in the lack of response of cGSH in our time frame of OGD. To our surprise, 
we also observed no change of cGSH during RP. A reasonable explanation for this could be that 
cGSH has enough antioxidant capacity to maintain its oxidation status when facing ROS generated 
in RP. In contrast to cGSH, mGSH systems in OHSCs (pyramidal cells/astrocytes) respond to the 
ROS generated in OGD and RP in different ways. mGSH becomes more reduced in OGD, but 
more oxidized in RP compare to CT. One rational explanation for our observation is that the redox 
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status of mGSH is regulated mainly by the increased reducing power of NADPH in OGD, but 
mainly by increased ROS in RP. NADPH is abundant during OGD since it is well maintained (via 
transhydrogense73,170) by NADH, the consumption of which is inhibited due to the absence of 
oxygen198. During RP, the consumption of NADH is resumed, and NADPH is continuously being 
utilized to replenish reduced GSH81 and other thiols82. The reduction of GSSG by NADPH to 
produce more mGSH is favored and un-favored in OGD and RP, respectively. In theory, increased 
proton concentration in mitochondria, [H+]mito, facilitates this reduction (Eq. A1-A6, see Appendix 
A for more details).  The presence of rapid mitochondria membrane (MM) depolarization166,168,169 
evoked during OGD brings up the [H+]mito, while the MM hyperpolarization199 after RP brings 
down the [H+]mito. mGSH in RP gets more oxidized due to the increase ROS production and 
compromised reducing power of NADPH in mitochondria, while opposites changes of mGSH, 
ROS and NADPH occur in OGD43,73. 
We believe that the different behaviors of mGSH in HeLa cells, pyramidal cells and 
astrocytes are attributed to the presence of differences in their mitochondria from various aspects. 
In rat cortical slice, unlike neurons, astrocytes do not exhibit MM depolarization after launching 
the spreading depression (a spreading MM depolarization), which often occurs in stroke 200.  
Campanella et al.201 observed that inhibitor factor 1 (IF1) is a critical protein for determining the 
tendency of MM depolarization (more IF1, easier depolarization). The mechanism behind it is 
complicated. In brief, [H+]mito is maintained lower than [H+] outside mitochondria ([H+]OM). The 
proton gradient (AKA, MM potential) is built up by the continuously outward flow of [H+]mito 
powered by electron transfer flow from NADH. The protein gradient can be dissipated by the 
inward flow of  [H+]mito, which powers the ATP generation at F1F0 ATP synthase in mitochondrial 
respiration201. When the respiration halts, the original outward flow of [H+]mito is no longer been 
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powered, and the original inward flow of  [H+]mito is inverted since F1F0 ATP synthase converts 
into F0F1 ATPase to consume ATP and pump [H+]mito out of mitochondria 201. IF1, the F0F1 ATPase 
inhibitor, stops the inversion of the original inward flow of [H+]mito and allows the proton gradient 
to dissipate201. Campanella et al.201 treated different cell types with 1 mM NaCN (an efficient 
inhibitor of cellular respiration) and monitored their MM potential. In their experiment, FCCP, an 
uncoupler, was used to induce 100% MM depolarization. Mitochondria in pyramidal cells 
depolarized up to 90% in 15 min, but astrocytes showed much smaller MM depolarization (~ 40%) 
in 15 min, due to higher IF1 in neurons (vs. astrocytes). Incredibly, HeLa cells showed more stable 
MM potential in that their mitochondria only depolarized by ~13 % in 15 min with low 
concentrated IF1 compare to pyramidal cells and astrocytes201.  As mentioned above, increased 
[H+]mito in MM depolarization during OGD favors the reduction of mGSH by NADPH. The 
tendency towards MM depolarization (pyramidal cells > Astrocytes > HeLa cells) is responsible 
for our observation of the reduction extent of mGSH in the same order (pyramidal cells > 
Astrocytes ≈ HeLa cells) during OGD (Fig. 3-5 (left)).  
HeLa cells have a much lower oxygen consumptions rate in mitochondria (mOCR) 
compared to cortical primary neuron under normal condition202.  Upon the MM potential dissipated 
by FCCP, mOCR increases and ATP generation decreases dramatically in neurons, but mOCR and 
ATP generation are not affected in HeLa cells202. This demonstrates that oxygen dependent ROS 
generation in compromised mitochondria is higher in neurons compare to HeLa cells. Pyramidal 
cells in mice are reported to have earlier and more rapid generation of mROS compared to 
astrocytes after the insult of transient forebrain ischemia203. Considering the larger heterogeneity 
between HeLa cell and rat hippocampal cells than that between different hippocampal cell types 
(pyramidal cells, astrocytes), we believe that mROS generation ranks in an order (pyramidal cells 
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> Astrocytes > HeLa cells), which is similar to the order of the oxidation status of mGSH (larger 
→ smaller) during RP (Fig. 3-5 (left)).  
The various concentrations of total GSH also corresponds to the variation of redox status 
of mGSH. HeLa cells have much higher GSH than normal cells (various cell types other than 
hippocampal cells)187,204. After comparing their data of hippocampal neurons with Dooley et 
al.’s106 data of HeLa cells, Funke et al.147 concluded that ROS generation is much easier and more 
rapid in hippocampal neurons because of their less capable anti-oxidant system. Astrocytes are 
higher in GSH than pyramidal cells46. It is reasonable to rank the GSH concentration in the 
sequence, HeLa cells > astrocytes > pyramidal cells. Their relative GSH pool size contributes to 
their relative redox response (smallest in HeLa cells, modest in astrocytes, largest in pyramidal 
cells) both in OGD (reduction in mGSH) and RP (oxidation in mGSH).  
3.4 CONCLUSION 
In summary, unobservable OGD-RP induced change in cGSH in any cell type was due to 
the absence of ROS in cytoplasm during 20 min OGD. cGSH remained well-maintained when 
facing RP-induced ROS. mGSH showed opposite redox changes in OGD and RP because 1) the 
reduction of GSH by NADPH is favored in MM depolarization in OGD, but disfavored in MM 
hyperpolarization in RP; and 2) the oxidizing power by ROS cannot beat the reducing power in 
OGD, but dominates in RP. The different tendency of MM depolarization (pyramidal cells > 
astrocytes > HeLa cells) dictate the different mGSH reduction degrees (pyramidal cells > 
astrocytes > HeLa cells) in OGD. In theory, ROS production and GSH pool size exert opposite 
impacts on the redox status of GSH. It is very impressive that the opposite tendency in ROS 
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production (pyramidal cells > astrocytes > HeLa cells) and order in GSH pool size (pyramidal cells 
< astrocytes < HeLa cells) enhance their overall influence on mGSH oxidation in RP (pyramidal 
cells > astrocytes > HeLa cells). 
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4.0  THE DIFFERENTIAL SUSCEPTIBILITY BETWEEN CA1 AND CA3 
PYRAMICAL CELLS TO OGD-RP DUE TO THEIR DIFFERENCE IN ROS 
MANAGEMENT 
4.1 INTRODUCTION 
Observations on the brains of patients suffering from transient global ischemia in the 1980s 
demonstrated that the hippocampus was more vulnerable than other regions so that cell death was 
high in that region.205,206  The phenomenon that pyramidal cells in CA1 have much higher cell 
death after ischemia than in CA3 in organotypic hippocampal slice cultures (OHSC) was observed 
decades ago53,207, and has not yet been fully understood. As early as 1962, a 43 year-old woman 
suffered from transient ischemia induced by anesthetic during surgery and she died 23 months 
later208. Her hippocampus was found to have more cell loss in CA1 than other CA areas208. A 
famous ischemia case about a patient (R.B.) was reported in 1986207. Histological examination 
after his death showed that the hippocampal lesion was found in CA1, not in CA3207. Selective 
vulnerability to transient global cerebral ischemia had been found in animal experiments. More 
damage in CA1 than CA3 was found in rat209,210 and gerbils211. A latest study reported in 2015 by 
using magnetic resonance imaging shows that the selective neuronal damage in hippocampal CA1 
after the global ischemia is consistently found in 50 patient cases212. 
Different concerns including Ca2+ mediated mechanisms213,214 and oxidative stress exerted 
by reactive oxygen species (ROS)54 are ascribed to the regionally selective vulnerability in OHSC 
to ischemia. The intracellular Ca2+ concentration is regulated by Ca2+ permeable N-methyl-D-
aspartate (NMDA) receptor and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
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receptor. Both receptors are therapeutic targets to relieve ischemia induced cell damage214. 
Hippocampal lesions after ischemia also can be alleviated when excessive ROS are depressed215. 
The excessive generation of ROS is concomitant with the elevation of Ca2+ 213,216. Both increases 
of Ca2+ and ROS are found to be larger in CA1 than in CA3 under the insults such as ischemia217-
219 and glutamate/NMDA213,214,216.  
Excessive generation of ROS is a critical threat to cellular redox homeostasis during 
ischemia215. Mitochondria with excessive ROS levels undergo membrane depolarization and 
structural damage213, accompanied by the release of cytochrome c220, which triggers a cascade of 
events with caspase 9 and caspase 3 involved220, leading to necrosis. In cerebral ischemia, ROS 
also target the DNA repair enzymes215, and activate nuclear factor-κB (NF-κB)221 inducing the 
expression of pro-oxidant enzymes and functional proteins, such as cyclooxygenase-2 (COX-2, 
EC 1.14.99.1)222, metalloproteinase (EC 3.4.24.77)223 and cytokines224, which provoke an 
inflammatory response and propagate the formation of additional ROS leading to neuronal 
death221.  
There are two particular types of ROS, superoxide and H2O235. Superoxide in mitochondria 
is produced by transferring an electron from NADH to oxygen molecule at NADH:ubiquinone 
oxidoreductase (complex I, EC 1.6.5.3)225. H2O2 in mitochondria is converted from superoxide via 
manganese superoxide dismutase (MnSOD, EC 1.15.1.1)75. The mechanism for the generation of 
superoxide and H2O2 is different in cytosol, in which superoxide is formed at xanthine oxidase 
(EC 1.17.3.2)76 , and then degraded into H2O2 via copper, zinc, superoxide dismutase (CuZnSOD, 
EC 1.15.1.1)75.  
It is promising to address the importance of the antioxidant systems against ROS to 
interpret the differential cell death between CA1 and CA3 after ischemia. There are two critical 
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types of antioxidants in cells, glutathione (GSH)58-61, a tripeptide, and thioredoxin (Trx), a small 
12 kD protein62-64 (Trx2 is the special type of Trx in mitochondria226). GSH and Trx are oxidized 
while scavenging H2O2 via the enzymes, glutathione peroxidase (Gpx, EC 1.11.1.9) 81 and 
peroxiredoxin (Prx, EC 1.11.1.15)82, respectively, and are regenerated by NADPH via glutathione 
reductase (GR, EC 1.8.1.7)81 and thioredoxin reductase (TrxR, EC 1.8.1.9)82, respectively. There 
are other antioxidants that are not enzymes such as ascorbate, vitamin E, carotenoid, flavonoids 
and selenium227. SOD and catalase are claimed to be enzymatic antioxidants to remove superoxide 
and H2O2 (cytosol only), respectively227. Of course, SOD is also a ROS generator since it generates 
H2O2 from superoxide75. There are is disagreement about the estimate of the relative contributions 
of the GSH and Trx systems to depress pathological ROS. Mitozi et al.228 claim that the glutathione 
system is superior in decomposing hydrogen peroxide with their assays in which separate 
inhibition of glutathione reductase and thioredoxin reductase were tested in acute hippocampal 
slices. Meanwhile, Kudin et al.229 observed a completely different result indicating that the Trx 
system outperforms the GSH system in H2O2 removal. 
Wang et al.54-56 attempted to decipher the mechanism leading to differential vulnerabilities 
to oxidative stress in CA1 and CA3 by collecting mRNA profiles from several oxidative stress-
related enzymes and proteins. They found that both ROS generating proteins (e.g. superoxide 
dismutase (SOD, EC 1.15.1.1) 230, xanthine oxidase (EC 1.17.3.2)231) and ROS depressing proteins 
(e.g. Gpx, Nuclear factor E2-related factor 2 (Nrf2)232, NAD(P)H: quinone oxidoreductase 1 
(Nqo1, EC 1.6.5.2)233) present higher mRNA levels in CA1 than CA3, but mRNA levels for Trx 
and TrxR (which are anti-oxidants) were found not to be significantly different between CA1 and 
CA3 under normal conditions55.   The mRNA levels of Nqo1 are consistently higher in CA1 after 
different exposure times to duroquinone (a superoxide generator)56. Wang et al. did not clarify the 
77 
 
rationale of the co-existence of higher ROS generation and higher expression of antioxidant genes 
in CA1. Instead, they stated that the higher mRNA levels of antioxidant genes (e.g. Nrf2 and Nqo1) 
correspond to the demand of scavenging higher ROS concentrations54-56. It is clear that more work 
is required to understand the ROS generating and antioxidant systems, and not just at their 
transcriptional level. It is more promising to address the real-time activities of critical metabolites 
and proteins (oxidants and antioxidants) that participate in ROS management in order to find the 
reasons for different responses to the ischemia in CA1 and CA3. 
Here, we focus on the NAD(P)H, superoxide, H2O2, GSH and Trx systems to investigate 
their respective contributions to the marked difference in ROS management between pyramidal 
cells in areas CA1 and CA3 in oxygen-glucose deprivation/reperfusion (OGD-RP, an in vitro 
ischemia model234,235). NAD(P)H was directly monitored with two photon imaging94, and H2O2 
and the GSH system were assessed by using  roGFP2-based redox sensors119,132 with confocal 
fluorescent imaging during OGD-RP,. There are no reliable protocols to monitor either superoxide 
or Trx by fluorescence imaging, but we designed particular experiments to indirectly monitor their 
activity by using the H2O2 and GSH sensors.  ROS generation and removal were studied with a 
combination of stimulation and inhibition assays. Related protein levels in CA1 and CA3 were 
compared by Western blots (WB) and immunofluorescence (IF). Our data demonstrate that during 
the fifty minute OGD-RP, H2O2 and GSH changes are confined to the mitochondria. Compared to 
CA1, pyramidal cells in CA3 have a greater reducing capability because of having a larger pool of 
Trx2. This is the main reason that CA3 is more resistant to OGD-RP than CA1.  
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4.2 EXPERIMENTAL SECTION 
4.2.1 Chemicals and reagents 
All chemicals are purchased from Sigma Aldrich and used as received. Tryptone and yeast 
extract are from BD bioscience.  
Various redox sensors based on roGFP2 construct including Mito-Grx1-roGFP2132, Cyto-
Grx1-roGFP2132, Mito-roGFP2-Orp1119, Cyto-roGFP2-Orp1119 were obtained from Tobias P. 
Dick as generous gifts, pCMV-tdTomato236 (Clontech) and pCS2+155 (Addgene) were kindly 
provided by the Wills lab (University of Pittsburgh). pMito-tdTomato was constructed in the 
Deiter lab (University of Pittsburgh): the full-length sequence of tdTomato was amplified from 
pCMV-tdTomato using primers 5’-AGT GGT CTC AGT GAG CAA GGG CGA GGA GGT C-
3’ and 5’-ATT GGT CTC TCA TGG TGG CGA CCG GTG GAT C-3’. The mitochondria-
targeting-sequence from ATP synthase protein 9 was amplified from Mito-Grx1-roGFP2132 using 
primers 5’-ATT AGG TCT CAC ATG GCC TCC ACT CGT GTC CTC GCC TC-3’ and 5’-ATT 
AGG TCT CAT CAC GGA TCC GGA AGA GTA GGC GCG CTT C-3’. Two fragments were 
assembled to construct pMito-tdTomato by using the Golden Gate Cloning method152. One Shot 
TOP10 Chemically Competent E.Colis (Invitrogen) was used to amplify plasmids. The final 
plasmid solution was purified with QIAGEN Plasmid Prep Kit (Qiagen), dissolved in 10 mM 
Tris·HCl + 1 mM EDTA solution (pH = 8.0). 
Opti-MEM and HBSS were purchased from Invitrogen. The tissue dissection media 
contained 75%(v/v)  Opti-MEM, 25%(v/v)  HBSS with the addition of 45% D-glucose solution 
(1mL per 100 mL medium). The tissue culture media was made from 50% (v/v) Opti-MEM, 25% 
(v/v) HBSS, 25% (v/v) horse serum (Invitrogen) with the addition of 45% D-glucose solution 
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(1mL per 100 mL medium). Intracellular solution (IS) consists of 145 mM K-gluconate, 10 mM 
HEPES, 14 mM phosphocreatine, 4 mM Mg-ATP, 2 mM MgCl2, and 0.25 mM EGTA, adjust to 
pH = 7.3 with KOH. Artificial cerebrospinal fluid162 (ACSF) was composed of 125 mM NaCl, 2.5 
mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 10 glucose, 1 mM CaCl2, 4 mM MgCl2, 10 mM  
glucose. Modifed ACSF (MACSF) substituted 10 mM glucose with 10 mM sucrose.  
1.6 µm gold nanoparticles and other accessories used for biolistic transfection154 were 
purchased from Bio-Rad Laboratories, Inc. Thiol probe IV129 was obtained from Invitrogen, 
dissolved in anhydrous DMSO at 5 mM, stored at -80oC and protected from light. Menadione stock 
solution was made in anhydrous DMSO at 25 mM, and stored in a dark place at -80oC.  Auranofin 
DMSO stock solution was made by dissolving 10 mg of gold salt into 2 mL DMSO, and was 
protected from light and store at -80oC. MnSOD mimic (MnSODm), MnTnBuOE-2-PyP5+237, was 
obtained from Ines Batinic-Haberle (Duke University Medical Center) in 5.31 mM aqueous 
solution, stored at 4 oC, and protected from light.  All of the stock solutions were diluted in ACSF 
solution to the desired working concentrations. 
 
4.2.2 OHSC preparation and transfection 
Organotypic hippocampus slice culture (OHSC) were prepared by following the 
modification of Gogolla’s protocol153. The surgery protocol was approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University of Pittsburgh. Surgery was performed 
in a sterilized hood. The postnatal 7-day old Sprague-Dawley rats (Charles River, Pittsburgh) were 
decapitated and the hippocampus was harvested and chopped into slices on a McIlwain  tissue 
chopper (Mickle laboratory Engieering Company Ltd., UK). The slices were first healed in tissue 
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dissection medium at 4 oC for at least 30 min, and then plated onto Millicell organotypic inserts 
(Millipore Co.). Tissue culture medium was used to nourish the tissue and was replaced every 2- 
3days. Tissue was used after incubating for 5 days.  
Either biolistic transfection154 or single-cell electroporation156 can be applied to transfect 
cells in OHSCs. A Helios Gene Gun (Bio-Rad Laboratories, Inc. CA, USA) was used following 
the Woods154 protocol. 20 μg roGFP sensor119,132 + 10 μg tdTomato + 20 μg pCS2+ as DNA 
filler155 was loaded onto 14 mg of gold particles (Φ = 1.6 μm) for 40-50 bullets, which were fired 
toward the OHSC at 120 PSI.  
Single cell electroporation on OHSCs was performed based on Haas’s156 procedure. 0.3 
μg/μL (total plasmid concentration) plasmid dissolved in IS was used here. The plasmid was added 
in a weight ratio of 2:1:2, roGFP contruct vs. tdTomato vector vs. pCS2+. Pyramidal cells in OHSC 
were electroporated with a train of pulses (1 ms pulse width, -50 V voltage, 200 Hz frequency, last 
for 1s) through a pulled borosilicate glass pipette (18 ΜΩ after filled plasmid solution, tip size, 1-
2 μm). Borosilicate glass tubing, OD x ID x L, 1.5 mm x 0.86 mm x 10 cm (Sutter Instrument Co. 
CA, USA) was pulled on P-97 micropipette puller (Sutter Instrument Co. CA, USA). 
Electroporation on OHSCs was performsed under a ZEISS Axioskop FS microscope (Zeiss, 
Germany) with X7500 micromanipulator (Siskiyou Co. OR, USA). It took 2-3 days to observe the 
expression of fluorescent protein in OHSC. 
4.2.3 OGD-RP experiment in superfusion system 
OHSCs were placed in a homemade stage chamber, and perfused with buffer solution at a 
flow rate of 4 mL/min driven by a peristaltic pump (Sci-Q 400DM2, Watson-Marlow, Inc. MA). 
One input tube and one output tube were used to fill the stage chamber with ~3 mL flowing buffer 
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solution, and one vacuum pump (KNF Neuberger. Inc.) was used to rapidly remove solution if 
needed. The solution flow rate was set to 4 mL /min. A TC-324B temperature controller and a SH-
27B inline solution heater (Warner Instruments, LLC.) were used to maintain the solution 
temperature at 35oC. The solution was gassed by an OX miniature gas exchange oxygenator 
(Living Systems Instrumentation, VT). The gas flow was adjusted to 1.5 L/min with an OMA-1 
gas flowmeter (Dwyer Instruments, Inc.). Isotonic buffer solution (290 - 300 mOsm) was used for 
perfusion. For the OGD-RP experiment, OHSCs were treated with 10 min control (CT), 20 min 
oxygen glucose deprivation (OGD) and 30 min re-perfusion (RP), in which ACSF gassed with 
95% O2/5% CO2 is used in CT and RP, and MACSF gassed with 95% N2/5% CO2 is used in OGD. 
Then OHSC was treated with 3 mM H2O2 and 3 mM DTT for 5 min each for calibration.  
4.2.4 Fluorescence imaging 
All fluorescent images were acquired on a Leica TCS SP5II broadband confocal 
microscope (Department of Biological Science, University of Pittsburgh). Live tissues were 
imaged with a 63x water immersion objective lens (model: HCX APO L U-V-I, N.A. = 0.90). 
Formaldehyde fixed tissues were imaged with a 63x oil immersion objective lens (model: HCX 
PL APO, N.A. = 1.40-0.60 with variable iris). Images of the whole OHSC were taken with a 5x 
objective lens (model: HCX PL PLUOTAR, N.A. = 0.15). Quantitative analysis of images was 
performed in ImageJ (http://imagej.nih.gov/ij/), then the numerical data was processed in MatLab 
(version R2014b, The MathWorks, Inc.) and OrginPro (version 9.0, OriginLab Corp.). Statistical 
data was analyzed in SPSS Statistics (version 20, IBM Corp.) 
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4.2.4.1 Cell death assay: propidium iodide stain and imaging 
OHSCs treated with various conditions were stained with 7 μM propidium iodide (PI) 
overnight. PI  can enter dead cells through the compromised cell membranes, bind to DNA and 
converts to fluorescent complex238. PI stained OHSCs were imaged with 561 nm excitation and 
600-640 nm emission (Fig. 4-7). The cell death percentage in a particular area of OHSC was 
calculated by following Eq. 4.1: 
 
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷ℎ% =  (𝐼𝐼𝑠𝑠𝑚𝑚𝑚𝑚𝑝𝑝𝑠𝑠𝑅𝑅 − 𝐼𝐼𝑚𝑚𝑅𝑅𝑛𝑛𝑚𝑚𝑛𝑛𝑚𝑚𝑛𝑛𝑅𝑅)(𝐼𝐼𝑝𝑝𝑟𝑟𝑠𝑠𝑚𝑚𝑛𝑛𝑚𝑚𝑛𝑛𝑅𝑅 − 𝐼𝐼𝑚𝑚𝑅𝑅𝑛𝑛𝑚𝑚𝑛𝑛𝑚𝑚𝑛𝑛𝑅𝑅)  × 100% (Eq. 4.1) 
Isample, Ipositive and Inegative are fluorescence intensity from tested OHSC, positive control and 
negative control, respectively. 100% methanol treated OHSCs were used as the positive control 
(assuming 100% cell death) and healthy OHSCs were used as the negative control (assuming 0% 
cell death).  
4.2.4.2 Two-photon imaging of NAD(P)H 
 
NAD(P)H239 images of pyramidal cell layer in OHSC were acquired with Mai Tai 
Ti:Sapphire laser (Spectra-Physics. CA), which excites NAD(P)H at 740 nm with a power output 
of 2.175 W.  NAD(P)H images were detected by a non-descanned detector (NDD), which was 
equipped with a dichromatic mirror (cut off, 580 nm). Multiple scans (line average and frame 
accumulation) are applied to capture a NAD(P)H image with a better signal to noise ratio (S/N), 
but requires a relatively long time to collect one image (~20 s).  In order to maintain focus on one 
pyramidal cell layer in the OHSC, “autofocus (AF)” (a built-in function of Leica confocal 
microscope) was applied to a pyramidal cell expressing tdTomato 236 to prevent out-of-focus (Fig. 
D-3). tdTomato (Exi: 561 nm, Emi: 580 – 600 nm) and bright field (BF) image (lighten by 561 
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nm) were simultaneously recorded with a hyper dynamic detector (Leica-Microsystems). 
Sequential scan of (tdTomato+BF) and NAD(P)H was operated on one area of OHSC. In order to 
acquire information from CA1 and CA3 within the same OHSC at the same time frame, the 
function “Mark & Find and Tile Scan” in the Leica microscope platform was applied to shuttle 
scans between the area CA1 and CA3 (Fig. D-3). 
4.2.4.3 GSH stain and imaging 
Glutathione (GSH) can rapidly react with thiol probe IV129, which is non-fluorescent and 
cell permeable, and shows strong fluorescence after derivatization (Exi: 405 nm, Emi: 440-480 
nm).  OHSCs were incubated with 100 μΜ thiol probe IV and the staining process was monitored 
over time. Sequential scan of (tdTomato + BF) and GSH stain, was performed.  The AF function 
was applied to the single cell labelled with tdTomato in order to maintain focus during imaging 
(Fig. D-3). The function “Mark & Find and Tile Scan” was applied to scan between CA1 and CA3 
sequentially (Fig. D-3). 
4.2.4.4 Ratiometric image of roGFP2 sensor and calculation of oxidation degree 
The roGFP2 sensor119,132 was excited at 405 or 488 nm, and emission spectra are acquired 
between 500 – 530 nm. tdTomato236 was excited at 561 nm, acquired between 580 – 600 nm.  
Sequential scan was operated by exciting fluorescent proteins at 488, 405, and 561 nm in order. 
The AF function was applied to the 488 nm excitation channel. Image series were acquired every 
~8 s. The ImageJ Plugin “Template Matching and Slice Alignment”158 was used to align slices in 
time lapse video for removing the location shift in x, y axis. Fluorescence intensities excited at 
405, 488 and 561 nm were extracted after the re-alignment.  Ratiometric images were represented 
in ‘Fire’ false-colored mode by ImageJ132 (see Fig. D-1, S2). 
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 The ratio 405/488 (R405/488) and oxidation degree of roGFP2 sensor (OxDroGFP2) are 
calculated according to Eq.  4.2-4.3120,132. 
 R405/488 = I405I488   (Eq. 4.2) 
I405, I488 are fluorescence intensities excited at 405 and 488 nm from roGFP2 sensor. 
R405/488, when it is fully oxidized by H2O2, is often normalized to 1 in this paper. 
We used tdTomato to correct the signal of 488 nm from roGFP2 sensor for calculation of 
OxDroGFP2 according to the equation shown below. The necessity to apply tdTomato has been fully 
described in Chapter 2.079.  
 OxDroGFP2 = R405/488 − R405/488RedI488𝑟𝑟𝑂𝑂I488𝑅𝑅𝑅𝑅𝑅𝑅 �R405/488ox − R405/488� + (R405/488− R405/488Red ) (Eq. 4.3) R405/488ox  and R405/488Red  are R405/488 of fully oxidized and reduced roGFP2 sensor. I488𝑟𝑟𝑂𝑂  and I488𝑅𝑅𝑅𝑅𝑅𝑅 are fluorescence intensity excited at 488 nm of roGFP2 sensor when it is fully oxidized and 
reduced. The value of I488
𝑜𝑜𝑚𝑚
I488
𝑅𝑅𝑅𝑅𝑅𝑅 is corrected by  
I488
𝑜𝑜𝑚𝑚 /I561𝑜𝑜𝑚𝑚
I488
𝑅𝑅𝑅𝑅𝑅𝑅/I561𝑅𝑅𝑅𝑅𝑅𝑅 , where I561𝑟𝑟𝑂𝑂  and I561𝑅𝑅𝑅𝑅𝑅𝑅 are fluorescence intensity 
of tdTomato excited at 561 nm, which are simultaneously recorded with I488𝑟𝑟𝑂𝑂  and I488𝑅𝑅𝑅𝑅𝑅𝑅 , 
respectively.  
 
The signal of the roGFP2 sensor was calibrated by treating with H2O2 (full oxidation) and 
DTT (full reduction).  
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4.2.4.5 Quantitative analysis of the protein content in OHSCs by immunofluorescence. 
We follow Gogolla’s240 protocol to stain OHSCs. NADH dehydrogenase subunit 4L 
(ND4L) is a part of complex 1241. Anti- (anti-ND4L) produced in rabbit (sc-20665, Santa Cruz 
Biotechnology, Inc.), anti-SOD2 produced in rabbit (ab13533, Abcam Inc.) and anti-thioredoxin 
2 produced in rabbit (ab185544, Abcam Inc.) were used to stain complex I, SOD2 and thioredoxin 
2, respectively. Then, they were fluorescent labelled with the secondary antibody, CFTM568 
conjugated goat anti-rabbit pre-absorbed antibody with low cross reaction (Cat# 20103-1, Biotium, 
CA, USA). α-tubulin, used as the internal control, is firstly immune-stained with anti-α-tubulin 
(DM1A) mouse monoclonal antibody (Cell Signaling Techonology, USA), then labelled by goat 
anti-mouse with CF™488A antibody (SAB4600387, Sigma-Aldrich, USA). OHSC was first fixed 
with 4% paraformaldehyde solution for 5 min then permeabilized with 1% Triton X-100 PBS 
solution at 4oC for 18 h, blocked with 20% BSA for 3 h at room temperature (RT), and then 
incubated with the primary antibody at 4oC overnight, followed by incubation with the secondary 
antibody at RT for 4 h. Washing with 5% BSA PBS was needed between the treatments.   
Well prepared OHSC on glass slide were imaged with a 63x oil immersion objective lens. 
Images from CA1 and CA3 within one OHSC were acquired with the same imaging parameters 
and processed by imageJ with incorporated multi-plugins.  Fluorescence ratio, FR, was used to 
quantify the protein content corresponding to the internal standard, α-tubulin (details shown in Fig. 
D-7). It is calculated using equation shown below. 
 FR =  FproteinFα−tubulin (Eq. 4.4) 
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4.2.5 Western blot after laser capture microdissection (LCM) 
The protein content between subfield CA1 and CA3 from OHSC with Western blot242,243. 
To prepare frozen tissue sections, we collected hippocampuses from postnatal 7-day old Sprague-
Dawley rats (Charles River, Pittsburgh), froze them in a cryopreservative solution (OCT)244 matrix 
and sliced them into frozen sections at 100 μm thickness. Every three frozen sections were 
transferred to a normal glass slide, then treated with the hematoxylin and eosin stain244 (but without 
treating with xylene) to reveal the anatomy of OHSC. The pyramidal cells in the area CA1 or CA3 
of OHSC (Fig. 4-6a) were cut out by LCM244, operated on an Arcturus PixCell IIe LCM device 
(Molecular Devices, LLC.). In order to collect enough samples, pyramidal cells of CA1 or CA3 
were collected from ~ 50 frozen sections to ensure ~ 10 μg of total protein that could be extracted. 
The harvested sample was lyzed in 10 μL RIPA buffer with phenylmethanesulfonyl fluoride 
(PMSF) from Cell Signaling Technology, sonicated on ice with 10 rounds of cycles (15 s pulse on 
and 1 min pulse off) at 15% power with a Fisher Scientific 550 sonic dismembrator, and then 
loaded to a 12% polyacrylamide gel for separation. In order to detect complex I, SOD2, thioredoxin 
2 and α-tubulin (used as internal control), anti-NADH dehydrogenase subunit 4L(Anti-ND4L) 
rabbit antibody (sc-20665) from Santa Cruz Biotechnology, Inc., anti-SOD2 rabbit 
anbody(ab13533), anti-Thioredoxin 2 rabbit antibody (ab185544) from Abcam Inc., and anti-α-
tubulin mouse monoclonal antibody (DM1A) from Cell Signaling Technology, USA) were used 
as primary antibodies.  Anti-mouse IgG/HRP-linked antibody (#7076) and anti-rabbit IgG/HRP-
linked antibody (#7074) from Cell Signaling Technology were used as secondary antibodies. 
Chem-illuminescence was detected by using SignalFire™ Elite ECL Reagent (#12757, Cell 
Signaling Technology). 
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4.2.6 Assays to trigger superoxide generation, dismutation and Trx system inhibition 
Menadione (MD) was used to trigger the generation of superoxide by acting on complex I 
on the mitochondrial inner membrane.  Exogenous MnSOD mimic (MnSODm) was used to 
complement the catalytic power of endogenous superoxide dismutase.  Auranofin acts an inhibitor 
of the Trx system. All chemicals were tested on OHSCs by monitoring the H2O2 (OxDHS) and 
GSH (OxDGS) systems with ratiometric imaging. ACSF buffer, oxygenated with 95% O2/5% CO2 
and maintained at 35 oC was used for control (CT) or wash out (WO) to recover OHSC from 
chemical treatment. The proper maximum working concentration of MnSODm was found by 
testing at 10, 20, 30 μM MnSODm by co-adding 10 μM MD (Fig. D-5). The effect of MnSODm 
only was tested by treating OHSC with 5 min CT/ 15 min 20 μM MnSODm/15 min WO in order 
(Fig. D-4). To manage the superoxide generation and dismutation, a serial assay was applied (Fig. 
4-4): OHSC was first stabilized for 5 min in CT, then stimulated with 10 μM or 20 μM MD for 15 
min following by 15 min WO; After the redox status of OHSC was recovered, OHSC was treated 
with 15 min with 10 μM or 20 μM MD + 20 μM MnSODm following by 15 min WO. In the assay 
of Trx system inhibition (Fig. 4-5), OHSC was pre-incubated with 1 μM auranofin (AF) for 1h, 
then imaged with 5 min CT, 15 min 10 μM MD + 20 μM MnSODm. All of the assays mentioned 
above were calibrated with H2O2 (full oxidation) and DTT (full reduction).  
4.2.7 Fitting and Statistical analysis of curves 
4.2.7.1 Peak analysis 
The peaks in Fig. 4-3 were analyzed in an open source statistical software, R (www.r-
project.org), in four aspects: peak altitude, ascending slope, descending slope and the emerging 
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time of the peak from the onset of OGD. All of the peak parameters from different peaks were 
compared with a t-test with bootstrap (no significant difference, n.s., p > 0.05, *p < 0.05, **p < 
0.01, ***p < 0.001).  
4.2.7.2 Linear fitting 
Linear data segments were analyzed in the statistical software, R, to extract parameters, 
mean and slope of the lines with linear regression. In Fig. 4-1g, h, the traces were divided into 
several portions with a singular linear trend. The linear parameters, mean and slope, were 
compared according to two subcategories, OGD-RP time period (CT vs. OGD vs. RP; one way 
ANOVA) and tissue subfield (CA1 vs. CA3; t-test with bootstrap). In Fig. 4-4b, d, the data in I to 
III with linear trend were fitted and linear parameters were compared according to two 
subcategories, treat period (CT vs. 10 μM MD vs. WO; one way ANOVA) and tissue subfield 
(CA1 vs. CA3; t-test with bootstrap). The same criteria (no significant difference, n.s., p > 0.05, 
*p < 0.05, **p < 0.01, ***p < 0.001) were used to present the analysis results.  
4.2.7.3 Nonlinear fitting to the first order exponential equation 
The theory of pseudo-first order mechanism is shown in Fig. 4-1c, the enzymatic subunit 
of the H2O2 sensor, Orp1 (left), and of GSH sensor, Grx1 (right), catalyze the coupling the sensors 
with their relative redox couples. The rate equations of OxDHS and OxDGS are derived as below 
according to Fig. 4-1c:  
H2O2 sensor 
 
[𝑂𝑂𝑂𝑂𝑂𝑂1]𝑇𝑇 𝑑𝑑𝑂𝑂𝑂𝑂𝐷𝐷𝑝𝑝𝐺𝐺𝑑𝑑𝐷𝐷 = 𝑑𝑑[𝑂𝑂𝑂𝑂𝑂𝑂1]𝑂𝑂𝑂𝑂𝑑𝑑𝐷𝐷 =  𝑘𝑘1[𝐻𝐻2𝑂𝑂2][𝑂𝑂𝑂𝑂𝑂𝑂1]𝑅𝑅𝑅𝑅𝑅𝑅 −  𝑘𝑘2[𝑇𝑇𝑂𝑂𝑂𝑂]𝑅𝑅𝑅𝑅𝑅𝑅[𝑂𝑂𝑂𝑂𝑂𝑂1]𝑂𝑂𝑂𝑂 (Eq. 4.5) 
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 [𝑂𝑂𝑂𝑂𝑂𝑂1]𝑇𝑇 = [𝑂𝑂𝑂𝑂𝑂𝑂1]𝑅𝑅𝑅𝑅𝑅𝑅 + [𝑂𝑂𝑂𝑂𝑂𝑂1]𝑂𝑂𝑂𝑂 (Eq. 4.6) 
 
𝑂𝑂𝑂𝑂𝐷𝐷𝑝𝑝𝐺𝐺 =  [𝑂𝑂𝑂𝑂𝑂𝑂1]𝑂𝑂𝑂𝑂[𝑂𝑂𝑂𝑂𝑂𝑂1]𝑇𝑇  (Eq. 4.7) 
 𝑑𝑑𝑂𝑂𝑂𝑂𝐷𝐷𝑝𝑝𝐺𝐺
𝑑𝑑𝐷𝐷
=  𝑘𝑘1[𝐻𝐻2𝑂𝑂2] − ( 𝑘𝑘1[𝐻𝐻2𝑂𝑂2] + 𝑘𝑘2[𝑇𝑇𝑂𝑂𝑂𝑂]𝑅𝑅𝑅𝑅𝑅𝑅)𝑂𝑂𝑂𝑂𝐷𝐷𝑝𝑝𝐺𝐺 (Eq. 4.8) 
In which [𝑂𝑂𝑂𝑂𝑂𝑂1]𝑇𝑇, [𝑂𝑂𝑂𝑂𝑂𝑂1]𝑂𝑂𝑂𝑂 and [𝑂𝑂𝑂𝑂𝑂𝑂1]𝑅𝑅𝑅𝑅𝑅𝑅 are the concentration of total form, oxidized 
form and reduced form of roGFP2-Orp1, respectively. [𝐻𝐻2𝑂𝑂2]  is the concentration of H2O2. [𝑇𝑇𝑂𝑂𝑂𝑂]𝑅𝑅𝑅𝑅𝑅𝑅 is the concentration of reduced form of Trx. H2O2 and Trxred are all first order in the their 
reactions with Orp1 at different redox forms in our H2O2 sensor, roGFP2-Orp1245,246.  
GSH sensor 
 
[𝐺𝐺𝑂𝑂𝑂𝑂1]𝑇𝑇 𝑑𝑑𝑂𝑂𝑂𝑂𝐷𝐷𝐺𝐺𝐺𝐺𝑑𝑑𝐷𝐷 = 𝑑𝑑[𝐺𝐺𝑂𝑂𝑂𝑂1]𝑂𝑂𝑂𝑂𝑑𝑑𝐷𝐷 =  𝑘𝑘1′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺][𝐺𝐺𝑂𝑂𝑂𝑂1]𝑅𝑅𝑅𝑅𝑅𝑅 −  𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻][𝐺𝐺𝑂𝑂𝑂𝑂1]𝑂𝑂𝑂𝑂 (Eq. 4.9) 
 [𝐺𝐺𝑂𝑂𝑂𝑂1]𝑇𝑇 = [𝐺𝐺𝑂𝑂𝑂𝑂1]𝑅𝑅𝑅𝑅𝑅𝑅 + [𝐺𝐺𝑂𝑂𝑂𝑂1]𝑂𝑂𝑂𝑂 (Eq. 4.10) 
 
𝑂𝑂𝑂𝑂𝐷𝐷𝐺𝐺𝐺𝐺 =  [𝐺𝐺𝑂𝑂𝑂𝑂1]𝑂𝑂𝑂𝑂[𝐺𝐺𝑂𝑂𝑂𝑂1]𝑇𝑇  (Eq. 4.11) 
 𝑑𝑑𝑂𝑂𝑂𝑂𝐷𝐷𝐺𝐺𝐺𝐺
𝑑𝑑𝐷𝐷
=  𝑘𝑘1′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] − ( 𝑘𝑘1′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] + 𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻])𝑂𝑂𝑂𝑂𝐷𝐷𝐺𝐺𝐺𝐺 (Eq. 4.12) 
In which [𝐺𝐺𝑂𝑂𝑂𝑂1]𝑇𝑇, [𝐺𝐺𝑂𝑂𝑂𝑂1]𝑂𝑂𝑂𝑂 and [𝐺𝐺𝑂𝑂𝑂𝑂1]𝑅𝑅𝑅𝑅𝑅𝑅 are the concentration of total forms, oxidized 
form and reduced form of Grx1-roGFP2, respectively. [𝐺𝐺𝐺𝐺𝐻𝐻] and [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] are the concentration of 
GSH and GSSG, respectively. GSH and GSSG are all first order in their reactions with Grx1 at 
different redox status in our GSH sensor, Grx1-roGFP2247. 
Fitting OxDHS and OxDGS to the pseudo first order reaction model 
 𝑑𝑑𝑂𝑂
𝑑𝑑𝐷𝐷
=  𝐴𝐴 − 𝑘𝑘𝑂𝑂 (Eq. 4.13) 
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𝑂𝑂 = 𝐴𝐴
𝑘𝑘
− (𝐴𝐴
𝑘𝑘
− 𝑂𝑂0)𝐷𝐷−𝑘𝑘𝑛𝑛 (Eq. 4.14) 
 
In which A is a constant, k is a reaction rate constant for this pseudo first order reaction, 
and x is the independent variable.  
If we organize Eq. 4.8 for H2O2 sensor and Eq. 4.12 for GSH sensor into the form of Eq. 
4.13 and 4.14. We get the table below. 
 
Table 4-1. Parameters of the equations of OxDHS and OxDGS in terms of x, A, k, x0 in Eq. 4.13, 
4.14. 
sensor x A k x0 
H2O2 𝑂𝑂𝑂𝑂𝐷𝐷𝑝𝑝𝐺𝐺 𝑘𝑘1[𝐻𝐻2𝑂𝑂2] 𝑘𝑘1[𝐻𝐻2𝑂𝑂2] + 𝑘𝑘2[𝑇𝑇𝑂𝑂𝑂𝑂]𝑅𝑅𝑅𝑅𝑅𝑅 𝑂𝑂𝑂𝑂𝐷𝐷0𝑝𝑝𝐺𝐺 
GSH 𝑂𝑂𝑂𝑂𝐷𝐷𝐺𝐺𝐺𝐺 𝑘𝑘1′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] 𝑘𝑘1′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] + 𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻] 𝑂𝑂𝑂𝑂𝐷𝐷0𝐺𝐺𝐺𝐺 
 
𝑂𝑂𝑂𝑂𝐷𝐷𝑝𝑝𝐺𝐺 would change exponentially in first order (Eq. 4.14) when 𝑘𝑘1[𝐻𝐻2𝑂𝑂2]  and 
𝑘𝑘2[𝑇𝑇𝑂𝑂𝑂𝑂]𝑅𝑅𝑅𝑅𝑅𝑅  are stable, and 𝑂𝑂𝑂𝑂𝐷𝐷𝐺𝐺𝐺𝐺  would change exponentially in first order (Eq. 4.14) when 
𝑘𝑘1
′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] and 𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻] are stable. 
The nonlinear regression was coded and operated in MatLab (version R2014b, The 
MathWorks, Inc.). The curve segments of OxD in Fig. 4-4b (IV), 4-4c (II), 4-4c (IV), 4-4d (IV), 
4-4e (II), 4-4e (IV), the curves of OxD in Fig. 4-5b, c during “10 μM MD + 20 μM MnSODm” and 
the curves of OxD in Fig. D-5 during “MD + MnSODm” were fitted to the first order exponential 
equation (Eq. 4.14). T-test with bootstrap and one way ANOVA were operated in open source 
statistical software, R (www.r-project.org) and MatLab (version R2014b, The MathWorks, Inc.) 
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(no significant difference, n.s., p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001) on these fitted 
parameters (Table 4-1). 
 
 
4.3 RESULTS AND DISCUSSION 
4.3.1 Real-time redox change of the H2O2 and GSH systems during OGD-RP 
We monitored the real time redox change of H2O2 and GSH/GSSG couple in mitochondria 
or cytosol of pyramidal cells by using roGFP2 based H2O2119 and GSH132 sensors, respectively 
(Fig. 4-1a, b,  Fig. D-1, S2).  
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 Figure 4-1. Mitochondrial OxDHS and OxDGS show significant differences during OGD-RP in 
pyramidal cells (stratum pyramidale). OxDGS but not OxDHS is higher during reperfusion in CA1 than CA3.  
(a) Grx1-roGFP2 is expressed in mitochondria or cytoplasm in pyramidal cells, imaged with excitation at 405 nm and 
488 nm. roGFP2-Orp1 has the similar fluorescence parameters as Grx1-roGFP2. (b) Four chimeric protein sensors are 
expressed in CA1 and CA3 (Fig. D-1, D-2): Mito-Grx1-roGFP2, Cyto-Grx1-roGFP2 (GSH sensor targeting 
mitochondria or cytoplasm) and Mito-roGFP2-Orp1, Cyto-roGFP2-Orp1(H2O2 sensor targeting mitochondria or 
cytoplasm). (c) Orp1 in H2O2 sensor and Grx1 in GSH sensor regulate the oxidation and reduction of their functional 
 0 ≤ OxDS =  [OS][OS] + [RS]  ≤ 1 
H2O2 sensor GSH sensor 
e 
d 
a b 
h 
c 
g 
f 
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fluorescent subunit, roGFP2. Orp1 is coupled with H2O2/H2O and TrxOx/TrxRed and Grx1 is coupled with GSH/GSSG, 
labelled with k1, k2, k1’ and k2’ as the reaction constant in the rate determining step for the respective forwarding 
reactions. (d) OxDS is the percentage of oxidized form out of the total sensor molecules, changes in a range of 0 - 1. 
(e) and (f) OxDHS and OxDGS represent the OxDS of H2O2 and GSH sensor, respectively. The sensors are calibrated 
with oxidant (H2O2) and reductant (DTT). Each trace is representative of 40 individual tests (mean ± SEM). (g) and 
(h) Data of OxDHS in (g) and OxDGS in (h) in pyramidal cells in OHSC during OGD-RP are presented in mean ± SEM 
(n=6 for each trace). Data from mitochondria and cytoplasm are shown in the top and bottom, respectively. Statistical 
analysis was applied with t test with bootstrap and one way ANOVA test (no significant difference, n.s., p > 0.05, *p 
< 0.05, ***p < 0.001, n=6, see Section 4.2 for more details). The horizontal lines with symbols showing the ANOVA 
test result indicate the comparison among different periods in OGD-RP in pyramidal cell in CA subfield, CA1 (black) 
or CA3 (red). The vertical lines with symbols showing the t test result indicate the comparison between CA1 and CA3 
at the corresponding period in OGD-RP.  While there is little change in the cytoplasmic sensors (n.s., p > 0.05, n=6), 
the mitochondrial sensors change significantly (*p < 0.05, ***p < 0.001, n=6) during OGD-RP.  In (g), there is no 
significant difference (n.s., p > 0.05, n=6) between CA1 and CA3 in mitochondrial OxDHS in OGD-RP except during 
the later period of RP, R2 (*p < 0.05, n=6). Noticeable differences are found in mitochondrial OxDGS between CA1 
and CA3 during RP (***p < 0.001, n = 6).  
The H2O2 sensor, roGFP2-Orp1, is oxidized by H2O2/H2O and reduced by thioredoxin 
(Trx)119,246 with rates that are first-order in H2O2 and Trx, respectively245,246. The GSH sensor, 
Grx1-roGFP2, is oxidized by GSSG and reduced by GSH132 (Fig. 4-1c) with rates that are first 
order in GSH and GSSG, respectively247. We observe the degree of oxidation, OxD, of each sensor. 
OxD is the ratio of the oxidized sensor concentration to the total sensor concentration (0 ≤  OxDs 
≤ 1). We report OxD of the H2O2 sensor (OxDHS) and of GSH sensor (OxDGS) (see Eq. 4.2, 4.3 in 
Section 4.2 for more details). In the OGD-RP experiment248-252, OHSCs were treated with 10 min 
control (CT), then with 20 min OGD/30 min RP and followed by the calibration of the H2O2 or 
GSH sensor with 5 min H2O2 (the oxidant) and 5 min DTT (the reductant) sequentially (see Section 
4.2 for more details). OxDHS and OxDGS reach ~ 1 when fully oxidized, and less than ~ 0.01 when 
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fully reduced both in mitochondria and cytoplasm (Fig. 4-1e, f). Neither OxDHS nor OxDGS in 
cytoplasm changes during OGD-RP in CA1 and CA3 neurons. In mitochondria, both OxDHS and 
OxDGS change significantly through the three periods of OGD-RP in CA1 or CA3 neurons (top, 
Fig. 4-1g, h). The different behaviors of mitochondria and cytoplasm have been fully discussed in 
Chapter 2.0234. In brief, the lack of response of OxDHS and OxDGS  in cytoplasm is due to the 
absence of the cytoplasmic ROS in 20 min of OGD43, and much more abundant antioxidants23,253 
in cytoplasm (vs. mitochondria) against ROS produced in RP. In mitochondria, lower OxDHS and 
OxDGS in OGD (vs. CT), but higher OxDHS and OxDGS in RP (vs. CT) indicate a less oxidizing 
cellular environment in OGD and a more oxidizing cellular environment in RP. Mitochondrial 
OxDHS and OxDGS are very similar between CA1 and CA3 neurons during the control period and 
OGD, but not during RP. In the last 15 min of RP, mitochondrial OxDHS increases slightly more 
in CA1 than in CA3, and is maintained at a high level (top, Fig. 4-1g, Table D-1). During RP, 
mitochondrial OxDGS in CA1 increases sharply in the first 8 min, then stabilizes at a much higher 
level than in CA3 (top, Fig. 4-1h, Table D-1). While the difference between mitochondrial H2O2 
(mH2O2) system in CA1 and CA3 (top, Fig. 4-1g) during RP is significant but small, the difference 
of the mitochondrial GSH (mGSH) system in the two CA subfields during RP is striking (top, Fig. 
4-1h), indicating that CA1 and CA3 manage ROS differently and that the which GSH system is 
involved in that difference.  
4.3.2 Reduced thiol concentrations are not different in CA1 and CA3 before OGD-RP, 
but they are different after OGD-RP measured with thiol stain after OGD treatment 
Since GSH is the largest antioxidant pool in cells175, we examined whether the 
concentration of GSH corresponds to the different vulnerability to OGD-RP in CA1 and CA3.  
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 Figure 4-2. Thiol depletion in CA1 is larger than that in CA3 in OHSC after OGD-RP. 
(a) Representative images from CA1 (top) and CA3 (bottom) are displayed: (left) Bright field (BF) image, (middle) 
fluorescence image (exi. 405 nm, emi: 440-480 nm) and (right) threshold image with area of interest (gray), area above 
threshold (green), and area below threshold (blue). Imaging protocol is optimized as shown in Fig. D-3. (b) Non-
fluorescent thiols turn fluorescent after reacting with 100 μΜ thiol probe IV. The cells in CA1 and CA3 of OHSC 
spend similar time (~ 8 min) to reach a stable staining with similar fluorescent intensity (see the traces). (c) The 
absolute contents of reduced thiols are similar between CA1 and CA3 in OHSC (unpaired t-test, no significant 
difference, p > 0.05, n = 17) according to the fluorescent intensity of thiols stain. (d) Significant depletion of reduced 
thiols in OHSCs is found in post OGD and post RP.  CA1 shows much larger loss percentage of reduced thiols than 
CA3 (unpaired t-test, *p< 0.05, ***p<0.001, n = 17).   
The total reduced thiol pool can be determined quantitatively via fluorescence imaging 
after derivatization with thiol probe IV129 (Fig. 4-2b, Section 4.2). The concentration of total thiols 
is similar in CA1 and CA3 neurons (Fig. 4-2c). However, the change in total thiol concentration 
after OGD and RP significantly differs between neurons in those two subfields. Thiol-based 
a b 
c d 
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fluorescence decreases by 42.5 ± 2.9 % (n=6) post-OGD, 51.9 ± 3.6 % (n=6) post-RP in CA1. The 
decreases are 30.1 ± 2.5 % (OGD, n=6) in post-OGD, 43.1 ± 2.3 % (RP, n=6) in CA3. The total 
thiols can represent the content of intracellular GSH since GSH is the most abundant non-protein 
thiols inside the cell181. This suggests that the GSH system is less effectively maintained in CA1 
compared to CA3.   
4.3.3 Real-time imaging of NAD(P)H during OGD-RP 
Though NADH and NADPH are not distinguishable in two-photon spectra, the analysis of 
them is simplified since they often respond concurrently to glucose94 and they are in a dynamic 
balance either in mitochondria or in cytoplasm through mutual conversions via 
transhydrogenase69,94.  
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 Figure 4- 3. A larger change in NAD(P)H is found in CA1 vs. CA3.  
(a) Bright field image (left), two photon image (exi: 740 nm, emi : 580-630 nm) from the pyramidale layer in OHSC 
(middle) and threshold image (right). The threshold is set with an upper and lower boundary of fluorescence intensity. 
The area of interest is shown in gray (above in green, below in blue). Several cells are outlined with red closed lines 
and nuclei are encircled by white closed lines. Nuclei have much lower NAD(P)H content than the rest part of the 
cells according to the fluorescence intensity. The pyramidal cells are larger in size in CA3 (bottom) than in CA1 (top). 
Imaging protocol is optimized as shown in Fig. D-3. (b) The normalized fluorescence intensity of NAD(P)H (mean ± 
SEM, n= 6) changes through OGD-RP (Section 4.2). Fluorescence intensity (FI) is normalized to the stable value 
during “Control”. CA3 shows a different pattern in NAD(P)H change from CA1: During “OGD”, two sequential peaks 
are found in CA1, but only one in CA3. The first peak (labelled 1) in CA1 is not different from the peak (labeled 3) 
in CA3 after statistical analysis (see Section 4.2 for more details). During “RP”, NAD(P)H in CA1 oscillates around 
a notable higher level than the general level in CA3,  and NAD(P)H keeps dropping during RP in CA3.   
a 
b 
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We measured the content of NAD(P)H by two-photon imaging (Section 4.2, Fig. D-3) over 
time during OGD-RP. We measured NAD(P)H from mitochondria and cytoplasm of the pyramidal 
cell (the nucleus is clearly low in NAD(P)H, and excluded from image processing in Fig. 4-3a). 
NAD(P)H responds differently in CA1 and CA3(Fig. 4-3b). NAD(P)H reaches a steady state after 
10 min both in CA1 and CA3 as the OHSC adapts to the pO2 transition from 19% O2 during tissue 
culturing to 95% O2 in CT.  During OGD, one peak emerges between 6-7 min both in CA1 and 
CA3 (not significantly different (n.s.), see Table D-4, Section 4.2 for more details).  An additional 
peak emerges after 12 min OGD in CA1, but not in CA3. During RP, NAD(P)H slowly decays in 
CA3 while in CA1, NAD(P)H oscillates around a level that is much higher than in CA3. 
4.3.4 Controlled generation of superoxide and H2O2 in mitochondria 
To address differences in the response of mH2O2 and mGSH between CA1 and CA3, we 
decided to investigate three steps, namely superoxide generation, dismutation to form H2O2, and 
H2O2 removal (Fig. 4-4a).  
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 Figure 4-4. Difference between pyramidal cells in CA1 and CA3 in the pathways of ROS management 
is evidenced by artificially stimulating the generation and removal of superoxide and ROS. 
 (a) (1) superoxide is generated by inhibiting complex I with menadione; (2) superoxide is dismutated into H2O2 via 
endogenous SOD2 with the absence of ADM. MnSODm (a type of ADM) is added to speed up the conversion; 
MnSODm cannot affect complex I, but only affects the dismutation of superoxide (see Fig. D-4 for more details). 20 
μM is found to be a proper concentration of MnSODm to fully convert superoxide into H2O2 (see Fig. D-5 for more 
details). (3) H2O2 is removed by GSH system or Trx system. In (b-e), there are five periods (labelled with I to V) in 
the treatment. Each trace is represented in mean ± SEM, n= 6. (b) OxDHS of the H2O2 sensor is monitored in CA1 and 
a 
b c 
d e 
f g 
100 
 
CA3 during the treatment of 5 min, CT/15 min, 10 μM MD/15 min, wash out (WO) followed by 15 min, 10 μM MD 
+ 20 μM MnSODm/15 min, wash out (WO). ACSF is used in CT and WO. One way ANOVA test (n.s., p > 0.05, n = 
6) is applied for period I to III in CA1 and CA3 (indicated by black and red horizontal lines, respectively). T test (n.s., 
p > 0.05, n = 6) is applied to CA1 vs CA3 in period I to IV, indicated by vertical lines. (c) OxDHS is monitored in CA1 
and CA3 during the treatment of 5 min, CT/15 min, 20 μM MD/15 min, wash out (WO) followed by 15 min, 20 μM 
MD + 20 μM MnSODm/15 min, wash out (WO). ACSF is used in CT and WO. CA1 and CA3 are compared in period 
I, II and IV with t test (n.s., p > 0.05, ***p < 0.001, n = 6), indicated by vertical lines. (d) OxDGS of GSH sensor is 
monitored in CA1 and CA3 when OHSC is treated in the same condition as in (d). Horizontal lines (black for CA1, 
red for CA3) show the statistical analysis among period I to III with one way ANOVA test (n.s., p > 0.05, n = 6). CA1 
vs CA3 is compared in period I to IV with t test (n.s., p > 0.05, *p < 0.05, n = 6), indicated by vertical lines. (e) OxDGS 
is monitored in CA1 and CA3 treated in the same conditions as in (e). CA1 vs CA3 is compared in period I, II and IV 
with t test (n.s., p > 0.05, ***p < 0.001, n = 6), indicated by vertical lines. (f) k1[H2O2] and k2[Trx]Red were obtained 
by fitting the data trace in b(IV), c(II) and c(IV). (g) 𝒌𝒌𝟐𝟐′ [𝑮𝑮𝑮𝑮𝑮𝑮]/𝒌𝒌𝟏𝟏′ [𝑮𝑮𝑮𝑮𝑮𝑮𝑮𝑮] was obtained by fitting the data trace in 
d(IV), e(II) and e(IV). In (f) and (g), one way ANOVA test (***p < 0.001, n=6) was applied in CA1 (black) or 
CA3(red) to compare among different treatment conditions. A t-test (n.s., p > 0.05, **p < 0.01, ***p < 0.001, n=6) 
was applied under each treatment condition to compare between CA1 and CA3. Curve fitting and statistical analysis 
are described in Section 4.2. The toxicities of MD, MnSODm and MD + MnSODm corresponding to the cell death of 
OHSCs are measured with PI assay (Fig. D-6). 
We applied 10 or 20μM menadione (MD)254 to stimulate superoxide generation at complex 
I 255,256 in OHSCs. As shown in Fig. 4-4a (I), once superoxide forms in mitochondria (step 1), it 
can be converted enzymatically into H2O2 via endogenous superoxide dismutase (SOD), SOD2 230 
(step 2). The rate of the natural dismutation process is limited by the rates of the uncatalyzed and 
catalyzed dismutation rates, and the latter is controlled by the amount of endogenous SOD2. Thus, 
the peroxide sensor’s response depends both on the generation rate of superoxide and the rate of 
its conversion to peroxide. Thus, we obtained a well-designed and effective artificial manganese 
superoxide dismutase mimic, (MnSODm, MnTnBuOE-2-PyP5+), from the Batinic-Haberle237 lab. 
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Its introduction into mitochondria at a sufficiently high concentration would make the peroxide 
sensor sensitive to the rate of generation of superoxide in the mitochondria. We characterized 
MnSODm and confirmed that it did not stimulate superoxide generation as MD did (Fig. D-4). But 
MnSODm efficiently dismutates superoxide since OxDHS reaches a higher steady state with the 
treatment of MD + MnSODm than that of MD only (see Fig. 4-4b (II) vs. 4-4b (IV) and Fig. 4-4c 
(II) vs. 4-4c (IV)). We tested different concentrations of MnSODm with 10 μΜ MD to find a 
[MnSODm]max at which MnSODm is enough to maximize the dismutation of superoxide. As shown 
in Fig. D-5, The steady state values of OxDHS and OxDGS increase from 10 μΜ MnSODm to 20 
μΜ MnSODm, but no significant changes when increasing [MnSODm] from 20 μΜ to 30 μΜ. We 
decided to use [MnSODm]max = 20 μΜ in the following experiments, and assume that the 
generation rate of superoxide will equal that of H2O2 at [MnSODm]max (Ro2·− =  RH2O2, Fig. 4-4a 
(II)).  
We ran a serial experiment, 5 min CT/15 min MD/15 min wash out (WO)/15 min MD + 
MnSODm/15 min WO (see more details in Section 4.2) in Fig. 4-4 (b-e) to explore how the mH2O2 
and mGSH systems in pyramidal cells in CA1 and CA3 would respond when the generation and 
dismutation of superoxide is regulated. As shown in Fig. 4-4b, c, OHSCs are treated with ACSF 
in CT, and OxDHS and OxDGS are acquired as baselines. WO helps to restore OxDHS and OxDGS 
back to baseline by removing the agents. 
MD at 10 μΜ does not cause a noticeable increase in OxDHS (Fig. 4-4b (II)) or OxDGS (Fig. 
4-4d (II)) in either CA1 or CA3 (see Table D-3 for more details). But when MnSODm is also 
applied, a sharp increase in OxDHS (Fig. 4-4b (IV)) and OxDGS (Fig. 4-4d (IV)) are found both in 
CA1 and CA3. Fig. 4-4c clearly shows that 20 μΜ MD alone is capable of influencing OxDHS 
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(Fig. 4-4c (II)) and OxDGS (Fig. 4-4e (II)), while 20 μΜ MD + 20 μΜ MnSODm shifts OxDHS (Fig. 
4-4c (IV)) and OxDGS (Fig. 4-4e (IV)) close to their fully oxidized status in 15 min.  
Note that the traces of OxDHS and OxDGS in Fig. 4-4b (IV), 4-4c (II), 4-4c (IV), 4-4d (IV), 
4-4e (II) and 4-4e (IV) all appear to follow a first order exponential rise in OxD (Eq. 4.14). We 
have thus derived the equation for the change in OxD with time based on first order reactions for 
the oxidation and reduction of each sensor (Eq. 4.5 – 4.12, see Section 4.2 for more details). Four 
quantities can be determined from the curves: for the peroxide sensor, we determined the rate 
parameters of sensor oxidation, 𝑘𝑘1[𝐻𝐻2𝑂𝑂2] and reduction, 𝑘𝑘2[𝑇𝑇𝑂𝑂𝑂𝑂]𝑅𝑅𝑅𝑅𝑅𝑅)  and for GSH we found the 
analogous rate parameters, 𝑘𝑘1′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺]  and 𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻]. Their values are summarized in Tables D-5, 
D-6, and statistically analyzed and plotted in Fig. 4-4f, g.  
We compared OxDHS, OxDGS and the aforementioned rate parameters between CA1 and 
CA3 to find the difference in each step of the ROS pathway (Fig. 4-4a). 1. Superoxide generation. 
OxDHS and 𝑘𝑘1[𝐻𝐻2𝑂𝑂2] with treatment of 10 μM MD + 20  μM MnSODm (Fig. 4-4b, f) or 20 μM 
MD + 20  μM MnSODm (Fig. 4-4c, f) are not significantly different between CA1 and CA3. As 
we discuss above, the H2O2 sensor can be used as a superoxide sensor since Rateo2·− =  RateH2O2 
at [MnSODm]max (Fig. 4-4a (II)). This demonstrates that superoxide generation is similar in CA1 
and CA3 with the same concentration of MD. This implies that CA1 has a similar content of 
complex I as CA3.  2. Dismutation. With 20 μM MD only, OxDHS and 𝑘𝑘1[𝐻𝐻2𝑂𝑂2]  are much higher 
in CA1 than CA3 (Fig. 4-4c (II), f). The difference could be due to different SOD2 activities, 
meaning that less H2O2 is formed in CA3 than CA1. Or it could be caused by a greater rate of 
removal of H2O2 in CA3 than CA1. eration. The latter conclusion is consistent with the observation 
that the concentration of SOD2 is higher in CA3 in adult male Sprague-Dawley rats257. More work 
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will be described below to permit an understanding of these contrasting observations. 3. Removal 
of H2O2. When OHSCs are treated with 20 μM MD or 20 μM MD + 20 μM MnSODm, there is no 
significant difference in any of the measured parameters between CA1 and CA3 (Fig. 4-4f and g). 
In addition combined observations of the two sensors indicate a highly oxidizing environment: 
H2O2 concentration is high (4f, left); Trx2 is oxidized (4f, right) and the GSH system is oxidized 
(4g). However, the same correlation between H2O2 and GSH is absent under the treatment of 10 
μM MD + 20 μM MnSODm.  In this case, the parameters related to the H2O2 sensor are not 
significantly different in CA1 and CA3 (Fig. 4-4b (IV), 4-4f) but OxDGS and 𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻]/𝑘𝑘1′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] 
are dramatically different (Fig. 4-4d (IV), 4-4g). Broadly, then, under highy oxidizing conditions, 
20 µM MD and MnSODm, CA1 and CA3 are similarly stressed. With a high superoxide production 
rate and endogenous SOD2 CA3 maintains a lower concentration of H2O2 and a more reduced 
GSH system than CA1. With a more modest superoxide production rate (10 µM MD) and the same 
effective dismutation rate (20 mM MnSODm) we find, remarkably, statistically indistinguishable 
peroxide sensor response but very different GSH system response with CA3 once again being 
more reduced. We thus wondered whether the other antioxidant system (Trx) contributes to this 
scenario. An efficacious way to study the Trx2 system but with the H2O2 and GSH redox sensors 
would be to inhibit TrxR from participating in the regeneration of Trx2, and to monitor the 
consequential influence on OxDHS and OxDGS.  
4.3.5 Inhibition of the Trx system in mitochondria 
We decided to study the Trx system to determine its contribution to H2O2 removal. The 
redox changes of the H2O2 and GSH systems were monitored with the treatment of 10 μM MD + 
20  μM MnSODm while 1 μM auranofin (AF)228 was applied to inhibit the Trx system as shown in 
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Fig. 4-5a. First order exponential equations for OxDHS (Fig. 4-5b) and OxDGS (Fig. 4-5c) curves 
were fitted to the data (Eq. 4.14, see Section 4.2 for more details), and the fitted parameters are 
listed in Table D-7, D-8. The GSH (via Gpx) and Trx2 systems (via Prx) are consistently more 
oxidized when the Trx system is inhibited: OxDHS and OxDGS become higher after adding AF (Fig. 
4-5b, c). The higher 𝑘𝑘1[𝐻𝐻2𝑂𝑂2] is accompanied by a smaller 𝑘𝑘2[𝑇𝑇𝑂𝑂𝑂𝑂]𝑅𝑅𝑅𝑅𝑅𝑅 and 𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻]/𝑘𝑘1′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] 
(Fig. 4-5d, e). Fig. 4-5b, c shows changes in OxDs due to auranofin: ΔOxDHSCA1 in CA1 (0.241 ± 
0.039) is significantly lower than in CA3 . (0.324 ± 0.019). and the changes in the GSH system 
are very high (ΔOxDGSCA1 vs. ΔOxDGSCA3, 0.056 ± 0.034 vs. 0.404 ± 0.067) These data support the 
idea that CA3 is affected to a much larger extent by Trx inhibition than is CA1. This demonstrates 
that GSH system in CA3 is maintained at a more reduced status due to its Trx system since the 
H2O2 generated is not significantly different in CA1 and CA3 under normal conditions (no AF 
here). No difference in GSH system is found between CA1 and CA3 once the Trx system is 
inhibited (OxDGS: CA1 ≈ CA3 (AF); 𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻]/𝑘𝑘1′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺]: CA1 ≈ CA3 (AF); Fig. 4-5c, e). 
105 
 
 a 
b 
c 
d e 
106 
 
Figure 4-5.The H2O2 and GSH systems experience larger redox shifts in CA3 than in CA1 when the 
Trx system is inhibited by auranofin (AF).  
The tissue is pre-treated with or without 1 μM auranofin 1h before imaging. Tissue is superfused with ASCF in control 
(CT) for ~ 8 min, then with 10 μM menadione + 20 μM MnSOD mimics (10 μM MD+20 μM MnSODm) for 15 min 
during image data acquisition. (a) H2O2 is consumed by the GSH and Trx systems via several redox enzymes, 
glutathione peroxidase (Gpx), peroxiredoxin (Prx) and oxidant receptor protein (Orp). roGFP2-Orp1, the H2O2 sensor 
used here, has the subunit, Orp (underlined in a), which is directly coupled with Trx. AF can inhibit the Trx system 
by deactivating thioredoxin reductase (TrxR). (b) H2O2 in CA1 (left) and in CA3 (right) shifts to a more oxidized 
status when pre-treated with AF. A larger change in OxDHS during 10 μM MD+20 μM MnSODm is found in CA3 than 
in CA1. (c) (left) OxDGS changes subtly during 10 μM MD+20 μM MnSODm in CA1 between “with” and “without” 
AF pre-treatment. (right) OxDGS in CA3 changes noticeably under the conditions from “without” to “with” AF pre-
treatment during 10 μM MD+20 μM MnSODm. In (b) and (c), each trace is represented as mean ± SEM (n=6). 
Comparison between CA1 and CA3 (indicated by vertical lines) (n.s., p > 0.05, ***p < 0.001, t test; n=6). ΔOxD is 
the difference between the steady state values of OxD (AF) and OxD (no AF).  (d) k1[H2O2] and k2[Trx]Red were 
obtained by fitting the data trace in (b). (e) 𝐤𝐤𝟐𝟐′ [𝐆𝐆𝐆𝐆𝐆𝐆]/𝐤𝐤𝟏𝟏′ [𝐆𝐆𝐆𝐆𝐆𝐆𝐆𝐆] was obtained by fitting the data trace in (c). In (d) 
and (e), a t test (***p < 0.001, n=6) was applied in CA1 (cyan) or CA3 (purple) to compare between no AF and AF 
treatment conditions. A t test (n.s., p > 0.05, **p < 0.01, ***p < 0.001, n=6) was applied under each treatment condition 
to compare between CA1 and CA3. Curve fitting and statistical analysis are described in Section 4.2.  
4.3.6 Compare protein content between the pyramidal cells in CA1 and CA3 
To compare the relative content of complex 1, SOD2 and Trx2 between CA1 and CA3, 
We made measurements by Western blot (WB) and immunofluorescence (IF) to OHSCs (see 
Section 4.2 for more details).  
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 Figure 4-6. The expression of Trx2 and SOD2 is much higher in CA3 pyramidal cells than in CA1, but 
not for ND4L. 
(a) top, The pyramidal cell layers of CA1 and CA3 from the H&E stained OHSC are collected separately by LCM; 
bottom, Western blot bands of ND4L, SOD2 and Trx2 from CA1 and CA3 subfields of OHSCs are optically read and 
analyzed. (b) Expression of each protein from CA1 and CA3 is compared quantitatively (***p<0.001, n=3). Band 
intensity ratio (BIR) is used to refer the targeting protein to internal standard, α-tubulin. (c) and (d) Representative 
fluorescence images from subfields of CA1 and CA3 from triple stained OHSCs are displayed in three subplots. From 
left to right in each subplot, ND4L and SOD2 in (c) and Trx2 in (d) are immuno-stained, shown in red; α-tubulin is 
immuno-stained, shown in green; nuclei are counterstained with DAPI, shown in blue; the final image is the overlay 
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of the former three. (e) Fluorescence ratio (FR) of the targeting protein to α-tubulin, is quantitatively analyzed and 
compared between CA1 and CA3 (***p<0.001, n=10, see Fig S7 and Section 4.2 for more details). 
To restrict the measurement to (mostly) pyramidal cells, we used laser capture 
microdissection (LCM)244 to capture the pyramidal cell layers from CA1 or CA3 for Western blots 
(Fig. 4-6a). Only pyramidal cell layers from CA1 and CA3 in OHSCs were imaged in IF (Fig. 4-
6c,d). NADH dehydrogenase subunit 4L (ND4L, a subunit of complex I)241, SOD2 and Trx2 were 
targeted with their specific antibodies. The band intensity (Fig. 4-6a, WB) and fluorescence (Fig. 
4-6c,d, D-7, IF) of each protein was referred to that of the internal standard, α-tubulin. The values 
obtained from CA3 were normalized to that from CA1 (see Section 4.2 for more details). We 
obtained consistent information from WB and IF (Fig. 4-6):  pyramidal cells in CA1 and CA3 have 
similar amounts of complex I, which explains why similar amount of superoxide is generated in 
CA1 and CA3 with a given menadione concentration (Fig. 4-4b (IV), 4-4c (IV)). The amount of 
SOD2 in CA3 is about 1.5 times that in CA1, which indicates that H2O2 generation from 
superoxide is much more efficient in CA3. We found that Trx2 in CA3 is about 2.3 times that in 
CA1 in supporting the idea that the GSH system is more reduced in CA3 with similar H2O2 levels 
(Fig. 4-4b (IV), 4-4d (IV), 4-1h(top, RP)) due to the contribution of reducing capacity from Trx2. 
Considering that CA3 has greater endogenous capabilities to both generate and remove H2O2, it 
would be rational to conclude that maintenance of a lower H2O2 level is governed by the greater 
reducing capacity of CA3, not a lower production rate of ROS (Trx2, CA1 < CA3; GSH, CA1 ≈ 
CA3) (Fig. 4-4c (II), 4-1g(top, RP)).  
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4.3.7 Trx2 is critical important for the prevention of the neuronal death. 
After we found that CA3 has a higher Trx2 content which contributes to its relatively lower 
H2O2 level and less oxidized GSH system, we also found that Trx2 is critically important to protect 
the tissue from neuronal damage following OGD-RP as shown in Fig. 4-7. We measured 
fluorescence from following incubation with propidium iodide (PI) following OGD-RP or 
exogenous stimulation of ROS production with and without AF. PI intensities were compared to 
“live” (0%) and “dead” (100%) controls. We used 1 μM AF, which is not toxic, causing less than 
10% cell death in CA1 and CA3 (Fig. 4-7). CA1 has more cell death than CA3 with the treatment 
of OGD-RP or 10 μM MD + 20 μM MnSODm. When OHSCs were pre-treated with AF, then 
treated with OGD-RP or 10 μM MD + 20 μM MnSODm, the cell death increased both in CA1 and 
CA3, and the difference of cell death disappeared between the two CA areas.  
110 
 
 Figure 4-7. Inhibition of the Trx system by AF increases the cell death percentage and remove the 
difference in cell death between CA1 and CA3. 
 (a) Fluorescence images of OHSCs after different treatments. (b) Data of cell death under different treatments are 
represented and compared in CA1 and CA3 (One-Way ANOVA test, ***p < 0.001, n = 10; no special sign is added 
if there is no significant difference). The cell death percentage is tested with PI stain (Section 4.2). 
a 
b 
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4.4 CONCLUSION 
Our overall goal is to decipher a decades-old observation that pyramidal neurons of the 
CA1 region of the hippocampus are less resilient under hypoxia/ischemia than those of the CA3 
region207. As described earlier, ROS are implicated in this difference, but there is at present no 
clear evidence of why this is the case. We want to determine the mechanism behind this scenario, 
and try to correlate the ROS management with the survivability of cells in different CA regions.  
In the OGD-RP experiment, H2O2, GSH and NAD(P)H were monitored as a function of 
time. The redox changes of the mitochondrial and cytoplasmic sensors for H2O2 and GSH were 
determined readily by fluorescence microscopy. We found no significant changes in the 
cytoplasmic responses, but there were significant changes in the mitochondrial matrix-directed 
sensors during OGD-RP. These changes were different in CA1 and CA3. It is worth mentioning 
that these sensors have several significant advantages over other widely used fluorogenic 
reagents113,119,132,258. We regulated each step in one branch of the ROS pathway (Fig. 4-4a) by 
using MD, MnSODm and AF, Superoxide is generated at complex I and complex III259 with certain 
exogenous reagents. However, superoxide from complex I goes to the mitochondrial matrix, while 
complex III releases superoxide towards the cytosol259. Neuronal production of superoxide mostly 
occurs at complex I255..  Thus, we used MD which targets complex I254,256 to evoke superoxide 
production in mitochondria256. 100 μM MD is toxic to astrocytes, while MD at 10 μM, is non-
toxic260. We applied 10 or 20 μM MD to create a relatively mild insult to OHSCs. NAD(P)H 
responds to the chemical insults in seconds92,261,262. We found that the fluorescence intensity of 
NAD(P)H quickly dropped below the detection limit of the confocal microscope during a 15 min 
exposure to MD or MD + MnSODm, thus no useful information of NAD(P)H can be acquired (data 
not shown). As shown in Fig. 4-4b, c, when only MD is applied, superoxide was only partially 
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converted into H2O2. When MD + MnSODm at [MnSODm]max was introduced, superoxide was 
maximally converted into H2O2. In Fig. 4-4, that the relative values of OxDGS (CA1 vs. CA3) are 
correlated with that of OxDHS (CA1 vs. CA3) when treating with 20 μM MD or 20 μM MD + 20  
μM MnSODm, but this relationship does not exist when treating with 10 μM MD + 20  μM 
MnSODm. However, it is consistent under all MD and MD + MnSODm conditions that the relative 
values of the Trx related term, 𝑘𝑘2[𝑇𝑇𝑂𝑂𝑂𝑂]𝑅𝑅𝑅𝑅𝑅𝑅, are quite correlated with that of H2O2 related terms 
(see Fig. 4-4f). These findings indicate the Trx system may remove H2O2 in a different efficiency 
compared to the GSH system.  Several researchers address the relative contribution and importance 
of the Trx and GSH systems to relieve the oxidative stress. The two antioxidants, the Trx and GSH 
systems, are relatively independent, and can only be coupled through redox reactions via indirect 
electron transfer263. Greetham et al. claim that only the oxidation of mitochondrial Trx leads to 
ROS dependent cell death, while the GSH system is not as influential as Trx264. Similar statements 
claim that Trx system, not the GSH system, is required for cell viability of yeast 265. Kudin et al.229 
demonstrate that Trx2 contributes to remove H2O2 to a larger extent than GSH in mitochondria. In 
the term of kinetics, the Trx system is much more efficient at removing H2O2 than the GSH system, 
and could be more rapidly reduced by NADPH. The rate constants of the reaction of the Trx system 
with H2O2 via Prx89,266,267 are approximately twice that of the reaction of the GSH system with 
H2O2 via Gpx89,268. The rate constant for Trx reduction89,269 by NADPH is about six times that of 
NADPH-dependent GSH reduction89,270. Based on all the evidence, we hypothesized that 1) The 
Trx system is preferred to handle the modest amounts of H2O2 generated (e.g. with 10 μM MD + 
20 μM MnSODm,) with low participation of the GSH system, but it will need high participation of 
the GSH system against large amounts of H2O2 that overwhelm the whole antioxidant systems 
(e.g. with 20 μM MD + 20  μM MnSODm). Inhibiting Trx would force GSH to become the main 
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reducing agent against H2O2; 2) Compared to CA1, Pyramidal cells in CA3 have more Trx in 
mitochondria to maintain their mGSH at relative reduced status.  
AF was applied to inhibit the Trx system, and we found a dramatic influence on the H2O2 
and GSH systems in CA3. H2O2 was generated by adding 10 μM MD + 20  μM MnSODm. We 
observed similar OxDHS in CA1 and CA3 (no AF), but larger OxDHS in CA3 (AF). But we should 
be cautious to believe that larger OxDHS in CA3 indicates a higher H2O2 level in CA3 when AF is 
added. OxD of the H2O2 sensor, roGFP2-Orp1, is not only dependent on H2O2, but also influenced 
by Trx (the sensor is coupled with both H2O2/H2O and TrxOx/TrxRed, Fig. 4-5a)119,246. The increase 
of OxDHS is not purely caused by the increased H2O2 level when Trx is inhibited here. The data of 
OxDGS strongly supports our assumption (1) mentioned above. Similar OxDGS (CA1 vs. CA3) 
with AF matches with similar OxDHS (CA1 vs. CA3) indicating that the GSH system no longer 
partially reacts with H2O2 once the Trx system is inhibited.  
We attempted to find the relative content of complex 1, SOD2 and Trx2 (CA1 vs. CA3) by 
running WB and IF (Fig. 4-6). There is some evidence about these three proteins measured from 
similar animal models. It is reported that the concentration of complex I can vary widely among 
different tissue types255,271. The mRNA level for transcription of  Complex I is higher in CA3 than 
CA1 in mouse93. Research in adult male rats shows that SOD2 (protein level) is higher in CA3 
than CA1257, but mRNA level for SOD2 is higher in CA1 in 7-day cultured OHSCs collected from 
postnatal 10 day old Sprague Dawley rats (p10 SD rats)55,56, and Trx2 (mRNA in p10 SD rat27,28 
or protein level in the adult male rats63) is not different between CA1 and CA3. No reports are 
found to study 7-day cultured OHSCs collected from p7 SD rats so far except our observations 
reported here. We measured the relative contents of proteins via WB and IF. Pyramidal cell layer 
in OHSC was selectively collected by using LCM for WB, and selectively imaged for IF. WB and 
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IF provide consistent information of these proteins (CA1 vs. CA3) in Fig. 4-6. The results match 
with our deduction about these proteins from OxDHS and OxDGS data in Fig. 4-4, 4-5. We 
summarized the conclusions about the differences in managing ROS pathway (CA1 vs. CA3) in 
Fig. 4-8b. In brief, similar protein content of complex I (CA1 vs. CA3) supports that similar 
amounts of superoxide are generated in CA1 and CA3 when OHSC treated with MD + MnSODm 
(Fig. 4-4b (IV), 4-4c (IV)); CA3 has higher protein content both in SOD2 and Trx2. The extra 
reducing capacity from more Trx2 allows CA3 to maintain the GSH system at a more reduced 
state (Fig. 4-4d (IV)) when facing similar amounts of H2O2 generated in CA1 and CA3 (Fig. 4-4b 
(IV)). Compared to CA1, CA3 regulates H2O2 at a lower level by its larger Trx2 pool with the 
similar amounts of superoxide generated and higher efficiency to generate H2O2 via its more 
endogenous SOD2 (Fig. 4-4c (II)).   
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 b 
Step in ROS pathway Key factor CA1 vs. CA3 Evidence 
1.Superoxide generation Complex 1 content CA1 ≈ CA3 Fig. 4-4 - 4-6 
capacity CA1 ≈ CA3 Fig. 4-4b (IV) vs. 4-4c (IV) 
2.convert from superoxide to 
H2O2 
SOD2 
system 
content CA1 < CA3 Fig. 4-4 – 4-6 
capacity CA1 < CA3 Fig. 4-4 – 4-5 
3. removal of H2O2 
GSH system 
content CA1 ≈ CA3 Figure 4-2d 
capacity CA1 ≈ CA3 Fig. 4-4c (IV) vs. 4-4e (IV) and Fig. 4-5c 
Trx system content CA1 < CA3 Fig. 4-4 – 4-6 capacity CA1 < CA3 Figure 4-5 
 
Figure 4- 8. Summary of comparison on ROS management between CA1 and CA3. 
(a) ROS management in mitochondria. (b) Analysis of the differences in ROS pathway between CA1 and CA3 based 
on our data. The conclusions with their relative evidences and the deduction process are explicitly discussed in the 
main text. 
Back to the discussion of the OGD-RP data, we by examining the actions of superoxide, 
H2O2, GSH, Trx and NAD(P)H in the ROS pathway in mitochondriawe note that all of them are 
a 
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redox coupled and connected in a closed loop (Fig. 4-8a). NADH acts as an electron donor to 
generate superoxide, finally leading to the formation of H2O2225,230. NADPH, the phosphorylated 
form of NADH, restores GSH81 and Trx272 to their reduced forms, maintaining the reducing 
capacity of cellular system, while its function in generating ROS is not a main concern in 
mitochondria273; in addition, NADH/NAD+ and NADPH/NADP+ are balanced via 
transhydrogenase69,94.  H2O2 is in the middle of the ROS pathway, in which NADH/NAD+ and 
GSH/GSSG & TrxRed/TrxOx systems located at two opposite terminals for the generation and 
removal of H2O2, respectively.   
We find that the OxDHS and OxDGS from OHSCs treated with 15 min 10 μM MD + 20  μM 
MnSODm (Fig. 4-4b (IV), 4-4d (IV)) resemble that in the earlier 15 min of RP (Fig. 4-1g(top), Fig. 
4-1h(top)): the H2O2 system performs similarly between CA1 and CA3, but the GSH system is 
less oxidized in CA3. The H2O2 levels during RP should be of a similar magnitude as during 10 
μM MD + 20 μM MnSODm. The smaller OxDGS in CA3 during RP can be ascribed to the larger 
reducing capacity provided by Trx2 in CA3. However, the changes of OxDHS and OxDGS in the 
neurons during OGD-RP are not first order exponential as during the treatment of MD + MnSODm. 
Only complex 1 and SOD2 were regulated in the MD + MnSODm treatment. However, more 
enzymes such as Gpx, GR, Prx and TrxR besides complex 1 and SOD2 could be influenced during 
OGD-RP. The enzyme activity of SOD2 and Gpx was found to be depressed in neonatal rat 
hippocampal neurons after 2 h OGD- 24 h RP274. In in vivo hypoxic exposure (pressure atmosphere 
= 282 mmHg) assays on adult SD rats, the activity of Gpx in the hippocampus is enhanced, but 
SOD2 and GR from the hippocampus show lower activity after the experiment275. Expression of 
Prx in mice hippocampus is cut off by ~50% after 1h OGD and 24 h RP276. TrxR277 is de-activated 
by nitration in myocardial cells from SD rats suffered from 30 min OGD - 3 hr RP. The cellular 
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metabolism is influenced by OGD-RP in a much more complicated way than by MD + MnSODm. 
Despite of the differences in cellular regulation, we still could apply the deduction withdrawn from 
the experiments with MD, MnSODm and AF to interpret the OxDHS and OxDGS data of the OGD-
RP experiment. Larger content of Trx2 enables CA3 to remain a lower H2O2 level and less oxidized 
GSH system than CA1 during RP. 
In Fig. 4-3, we discover that NAD(P)H is continuing to be consumed in CA3 in OGD-RP 
after a short temporal elevation in OGD, but NAD(P)H does not change similarly in CA1, in which 
two elevations of NAD(P)H are found during OGD, and then NAD(P)H oscillates around a 
relatively higher level in RP than its baseline in the control. A rational explanation for the 
NAD(P)H elevation in OGD, is that the complex I is suppressed during OGD. Schuchmann et al.92 
described that a transient stimulus of 1 μΜ rotenone caused an increase in NAD(P)H due to the 
inhibition of complex 1, and transient bath application of 100 μΜ glutamate resulted in an increase 
in NAD(P) due to the activation of citric acid cycle which can replenish NAD(P)H. The elevation 
of NAD(P)H helps maintain mH2O2 and mGSH system at a more reduced state in OGD than CT 
(Fig. 4-1g, h). Due to the similarity in superoxide generation and complex I content, the 
consumption of NADH should be similar between CA1 and CA3. The higher requirement of 
NADPH in CA3 can be attributed to its utilization on restoring the larger pool of Trx2, reducing 
the depletion of thiols in CA3 (Fig. 4-2d) and maintaining the GSH system at a much more reduced 
status during RP (OxDGS, CA1 vs. CA3, 0.489 ± 0.020 vs. 0.241 ± 0.035 in Fig. 4-1h). NADPH 
oscillations in CA1 demonstrates that there are rapid cycles of mitochondrial membrane 
depolarization/hyperpolarization, evenly matched competition between ROS generation and 
annihilation278. As the oscillation could be diminished with a higher ROS scavenging capability278, 
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the absence of oscillation in CA3 indicates its higher reducing capacity to remove ROS by utilizing 
NADPH.    
Our observations support that the Trx system dominates the removal of H2O2 under the 
treatment of 10 μM MD + 20  μM MnSODm and RP, and the GSH system only participates to 
remove a relatively small portion of H2O2 until the Trx system is disabled. The more reducing 
capacity provided by Trx2 in CA3 leads to the higher consumption of NAD(P)H, lower H2O2 
levels and less oxidation in the GSH system during RP, and results in less susceptibility to OGD-
RP. 
In order to correlate the regulation of the H2O2 level and the oxidation status of the GSH 
system with the cell death, we measured the cell death in areas CA1 and CA3 under all the 
treatments that applied in this manuscript (Fig. D-6, 4-7). In general, more cell death is correlated 
with a higher H2O2 level or a more oxidized GSH system. For the MD + MnSODm experiments 
(Fig. 4-4), very little cell death (<10%) with the treatment of 10 μM MD or 20 μM MnSODm (Fig. 
D-6) corresponds to the absence of change in OxDHS and OxDGS with such a treatment in Fig. 4-
4b (II) or Fig. D-4; similar or different cell death (CA1 vs. CA3) with the treatment of 10 μM MD 
+ 20 μM MnSODm, 20 μM MD or 20 μM MD + 20 μM MnSODm) (Fig. D-6) corresponds to 
similar or different values (CA1 vs. CA3) of OxDGS and 𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻]/𝑘𝑘1′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] (Fig. 4-4d, e, g); 
with the treatment of 20 μM MD, higher cell death in CA1 (vs. CA3) is correlated with its larger 
values of OxDHS and k1[H2O2] (Fig. 4-4c, f). For the OGD-RP experiment, compared to CA3, CA1 
has more cell death (Fig. 4-4 – 4-7) corresponding to its larger OxDHS and OxDGS (top, Fig. 4-1g, 
h). A more important correlation that noticed is that the inhibition of Trx by AF increases the cell 
death (Fig. 4-4 – 4-7), OxDHS (Fig. 4-5b) and OxDGS (Fig. 4-5c) induced by 10 μM MD + 20 μM 
MnSODm and removes the difference of those parameters that once existed in CA1 and CA3. This 
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indicates that the administration of the Trx system is critical important for regulation of 
intracellular H2O2 and GSH systems. Moreover, we found that applying AF removes the 
differential cell death in CA1 and CA3 induced by OGD-RP (Fig. 4-4 – 4-7) indicating that the 
Trx system is the key factor which is contributed to the differential susceptibility to OGD-RP 
between the two hippocampal areas. 
Different from our perspectives, Wang et al.54-56 attempted to decipher the scenario of the 
particular sensitivity to oxidative stress of CA1 by collecting transcriptional data of enormous 
amounts of genes (~174 genes) related with oxidative stress, inflammatory, ion channels, and 
excitatory and inhibitory responses. They screened out 5 genes such as Nrf2 and Nqo1, which 
participate in evoking anti-oxidants and have significantly different expression levels in CA1 and 
CA354-56. However, their statement about higher anti-oxidant related gene expression indicates that 
higher ROS in CA1 is a little confusing. To our understanding, their focus is that the post-
regulation of the expression of anti-oxidant genes responds to the overwhelmed antioxidant 
systems by the excessive oxidative stress. In contrast, our research focuses on the presence of ROS 
generating and anti-oxidant capacity when facing ongoing oxidative stress, then extends to the 
post-insult neuronal damage.  It is inappropriate to directly compare our data with Wang et al.’s 
54-56. We are checking into different time scope (us: in ROS stress; Wang: post ROS stress) and 
causal relationship (us: what → ROS stress; Wang: ROS stress → what). For instance, the higher 
anti-oxidant capacity of CA3 is in our case likely not due to activation of the Nrf2 system by OGD. 
The sequence of a putative activation of Nrf2 involves increased ROS in the cytoplasm to a level 
high enough to activate Nrf2, transport of Nrf2 to the nucleus, transcription of Nrf2-regulated 
genes, translation in the cytoplasm and then transport to the mitochondria. We found no evidence 
for an increase in ROS in the cytoplasm where the sequence of Nrf2 activation starts. Even if the 
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Nrf2 system was activated by OGD-RP the time scale in our experiment (70 min) is too short to 
allow for substantial elevated Nrf2-driven anti-oxidant capacity. In vivo oxygen deprivation by 
MCA occlusion causes upregulation of Nrf2-regulated proteins but the maximum and significant 
upregulation were found after 24h while no increases were reported after 8h279,280. In another study 
on global ischemia an upregulation of HO-1, a Nrf2-regulated  protein, was maximal after 72h 
with a small increase observed after 1h (< 10% of maximum)281. In addition, using a similar 
experimental set-up as ours (OGD in OHSCs followed by reoxygenation for 24h), Parada et al. 
found no increase in Nrf2-regulated proteins after 24h and no difference in toxicity between OHCs 
from Nrf2 knock-outs and  normal animals282. 
In summary, CA3 is less vulnerable to OGD-RP than CA1 because it maintains its H2O2 
and mGSH systems at a lower oxidative state when facing the OGD-RP insult, and thus avoids 
long-term damage initiated by excessive ROS 213,215,220-224. CA3 can remove excessive H2O2 better 
due to that it has a larger in Trx2 system and utilizes NADPH to replenish its antioxidants more 
efficaciously. CA3 is also more efficient in producing H2O2 from similar superoxide generation 
(vs.CA1), which does not compromise its capability to keep H2O2 at lower level. These indicates 
that reducing capacity is the determining factor against oxidative stress. In the comparison of the 
two critical reducing pools, the Trx2 and mGSH systems, our data demonstrate that mGSH is 
maintained at a relatively reduced state passively by Trx2 rather than participating in H2O2 
removal. We found that the differential cell death after OGD-RP is dependent on the differential 
H2O2 level and oxidation status of the GSH system in CA1 and CA3. Our evidence show that a 
larger Trx2 system is proposed to result in less vulnerability of CA3 to OGD-RP. 
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5.0  SUMMARY AND FUTURE DIRECTIONS 
A good model for studying cerebral ischemia is oxygen glucose deprivation (OGD)37-39. 
Abundant evidence supports the damaging nature of excess reactive oxygen species (ROS)55 in 
cells, which can be converted into less reactive H2O281; then H2O2 can be scavenged by glutathione 
(GSH), which is oxidized to glutathione disulfide (GSSG)81. Monitoring H2O2 and GSH during 
OGD-reperfusion is a promising way to investigate the course of ischemic injury. We are unaware 
of single-cell investigations in tissue though there is a rich literature about this problem. Thus we 
have developed an approach using the organotypic hippocampal slice culture (OHSC), and employ 
green fluorescent protein (GFP)-based sensors119,132, which are selectively sensitive to H2O2 or 
GSH. In order to precisely control OGD/RP experiment condition and report reliable OxDroGFP2 
and EGSH, we optimized the protocol in several important ways. 1) We improved the delivery of 
oxygen and glucose to the tissue cultures so that the timescale of the changes reflect those found 
in vivo. 2) We optimized the transfection protocol to yield neurons expressing the Grx1-roGFP2 
in a narrow range of depths in OHSCs. The chosen range of depths corresponds to a range in which 
changes in pO2 are reproducible. 3) Deriving OxDroGFP2 and EGSH requires a redox insensitive 
marker to act as a reference intensity during the calibration process following OGD/RP. We 
introduced tdTomato, a redox insensitive fluorescent protein, specifically to exclude the apparent 
effect of changes in cell size on the fluorescent signal of Grx1-roGFP2.  
We tested this optimized protocol on different cell types (HeLa/pyramidal/astrocyte) and 
cellular compartments (mitochondria/cytosol), and found no observable OGD-RP induced changes 
in cytoplasmic GSH in any cell type, but obvious changes in mitochondrial GSH in pyramidal cells 
and astrocytes. Opposite changes in OGD and RP are due to the absence (OGD)/presence (RP) of 
123 
 
ROS and MM depolarization (OGD) and hyperpolarization (RP). The differential performance in 
their GSH system is due to their differences in tendency of MM depolarization, ROS production 
and GSH pool size. 
In order to understand the differential susceptibility of hippocampal pyramidal cells in CA1 
and CA3, we investigated the difference in mitochondrial reactive oxygen species (mROS) 
management by using roGFP-based fluorescent sensors for peroxide and the GSH system79,119,132 
transfected into individual pyramidal neurons in organotypic hippocampal slice cultures. We 
controlled three key steps in  mROS production and removal: 1) superoxide generation at complex 
I  with menadione (MD)254; 2) superoxide dismutation via mitochondrial superoxide dismutase 
(SOD2)81 with its mimic (MnTnBuOE-2-PyP5+, MnSODm)237 ; 3) thioredoxin (Trx2) activity81,82 
with auranofin228. We measured the oxidation degrees of roGFP-based sensors120 for H2O2 
(OxDHS) and GSH (OxDGS). Relative quantitation of complex 1, SOD2 and Trx2 was carried out 
with immunofluorescence and Western blots. We observed similar superoxide generation rates in 
CA1 and CA3 consistent with our finding of similar complex I levels. However, CA1 has less 
SOD2 than CA3 which produces less peroxide. Nonetheless, CA1 has a higher steady-state OxDHS 
and OxDGS than CA3. Inhibition of Trx2 leads to statistically indistinguishable OxDHS and OxDGS 
in CA1 and CA3.The inferiority of CA1’s ROS handling is mainly due to its lower activity of Trx2 
in comparison to CA3. 
Using this optimized protocol, we found that the time dependence of the redox status of 
the H2O2 and GSH system provides new, and perhaps complementary information to that obtained 
by more classical fluorescence-based techniques. This method could be broadly applied to other 
types of studies such as pharmacological investigations of H2O2 and GSH-related enzymes46. 
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APPENDIX A 
1.3  FLUORESCENCE IMAGING FOR MONITORING THE ROS RELATED 
CRITICAL MOLECULES 
This Appendix contains information for section 1.3 Fluorescence imaging for monitoring the ROS 
related critical molecules. 
A.1 Fluorescence imaging of NAD(P)H 
There are more information about Peredox and Frex. 
Table A-1. Fluorescence probes for NAD(P)H. 
Name Exi/Emi Reversible pH sensitive 
b 
(4-9) 
in vivo 
Application REF Reaction Mechanism 
NAD(P)H 340/460 Yes Yes Natural molecule 
94 Molecule itself 
Genetically Coded Protein Sensor 
Peredox 440/510 Yes Yes Transfection 96 NADH-binding protein, Rex 
Frex® 
(Mito/Cyto) 
400&510 
/530 Yes Yes Transfection 
97 NADH-binding protein, Rex 
Superscript b: pH sensitivity of fluorescent spectra (only) of the sensor; Superscript ®: Ratiometric imaging probe 
A NADH/NAD+ redox sensitive sensor, Peredox, is constructed in Yellen group96. Its 
fluorescent intensity (FI) increases with the binding of NADH to its functional subunit, Rex96. 
Normalized fluorescence (NF) is obtained from correcting FI by fluorescence of its incorporated 
red fluorescent protein, mCherry (Exi/Emi: 587/610 nm, internal standard)96.  This sensor is pH 
sensitive. NF96 responds nonlinearly to the ratio of [NADH] × [H+]/[NAD+] in a range of 0 ~ 8×10-
11. This sensor is sensitive enough to detect the redox change of NADH within 1 min, and its  FI 
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is ~58 times brighter than the auto-fluorescence of  NAD(P)H96. However, it is not good to work 
in mitochondria as the mitochondrial [NADH]/[NAD+] is too high and beyond its detection 
range96. The other NADH sensor, Frex, also contains the NADH-binding unit, Rex97. This 
ratiometric sensor is highly selective for NADH, and has no response to NAD+, NADP(H), ATP 
and other abundant adenine nucleotides. Thus its ratio of F510/F400 (F400 and F510 are respective 
fluorescence at excitation 400 and 510 nm) is not a function of [NADH]/[NAD+]97. Frex 
nonlinearly responses to 0 ~ 40 μM NADH, and can be used in mitochondria (~ 30 μM NADH) 
and cytosol (~ 0.12 μM NADH)97. However, F510/F400 of NADH binding Frex is unstable over time 
when [NADH] ≤ 40 μΜ, and its signal decays by more than 50% within 14 min after adding 
NADH, which will compromise its application in real-time measurement of cellular NADH97. 
Moreover, Frex is pH sensitive and its application needs pH control97. 
A.2 Fluorescence imaging of superoxide and H2O2 
2-Me-TeR is not discussed in section 1.3.2. 
Recently a novel ROS sensor, 2-Me-TeR (tellurium containing rhodamine dye), is 
developed in the Nagano Lab283. Its becomes fluorescent once it is oxidized into 2-Me-TeOR283. 
Its advantage over DCFH2 is that it can directly detect the dynamic change of ROS since its 
oxidation/reduction is reversible283. 2-Me-TeOR, have relative pH stability in the range of pH = 5 
– 9, and experience sharp FI drop below pH = 4283. Its pharmacological effects on cellular system 
and potential cellular interference on its application have not been reported.  
 
Table A-2. Fluorescence probes for ROS. 
Name Exi/Emi Reversible pH sensitive 
b 
(4-9) 
in vivo 
Application REF Reaction Mechanism 
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Small Molecule Probe 
DCFH2 493/521 No Yes Staining 98,99 Oxidation 
2-Me-TeR 669/686 Yes slightly Staining 283 Oxidation of Tellurium atom 
Genetically Coded Protein Sensor 
rxYFP 512/523 Yes Yes Transfection 104 Thiol-disulfide redox interchange 
roGFP1® 
(mito/cyto) 
400 & 475/ 
510 Yes No Transfection 
105 Thiol-disulfide redox interchange 
roGFP2 ® 
(mito/cyto) 
400 & 490/ 
510 Yes No Transfection 
106 Thiol-disulfide redox interchange 
Superscript b: pH sensitivity of fluorescent spectra (only) of the sensor; Superscript ®: Ratiometric imaging probe 
Table A-3. Selective fluorescence probes for Superoxide. 
Name Exi/Emi Reversible pH sensitive b (4-9) 
in vivo 
Application REF 
Reaction 
Mechanism 
Small Molecule Probe 
DHE 369/580 No No Staining 109 Oxidation 
MitoSOX 369/580 No No Staining 108 Oxidation 
Genetically Coded Protein Sensor 
mito-
cpYFP® 
405 & 
488/>505 Yes Yes Transfection 
114 unclear 
Superscript b: pH sensitivity of fluorescent spectra (only) of the sensor; Superscript ®: Ratiometric imaging probe 
 
A putative protein superoxide sensor, mito-cpYFP is a reversible probe, and can be used 
for long term imaging. However, Schwarzlander and his colleagues strongly questioned whether 
mito-cpYFP senses superoxide or pH115. They pointed out there is no redox sensitive subunit in 
this protein could direct its reaction with superoxide and cause relative change in its own 
fluorophore115 and the sensor failed to represent the right change of superoxide under some classic 
regulations which have been tested repetitively in past researches284. Unlike mito-cpYFP, DHE 
and MitoSox are unlikely to be pH sensitive and no such records for their pH sensitivity has been 
found so far. 
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Table A-4. Selective fluorescence probes for H2O2 
Name Exi/Emi Reversible 
pH 
sensitive b 
(4-9) 
in vivo 
Application REF 
Reaction 
Mechanism 
Small Molecule Probe 
Amplex Red 560/590 No Yes No 285 Oxidation 
PX-1; PF-1; 
PR-1 a 
350/440; 450/470; 
575/585 No unclear Staining 
286 BDM 
RPF-1 ® a 420/464 &517 No unclear Staining 287 BDM 
PL-1® a 410 & 475/540 No unclear Staining 288 BDM 
PY1; MitoPY1 a 519/548; 510/528 No unclear Staining 289 BDM 
PY1-ME a 515/540 No unclear Staining 290 BDM 
PO1; PF-2;  PF-
3 a 
540/565; 475/511; 
492/515 No unclear Staining 
291 BDM 
PF6-AM a 482/517 No unclear Staining 292 BDM 
PN1 a 750(TP)/425&525 No No Staining 293 BDM 
QCy7 595/635 No unclear Staining 294 BDM 
SHP-Mito 750(TP)/435&565 No No Staining 295 BDM 
FP-H2O2-NO 400/460 No unclear Staining 296 BDM 
Probe 3 400 & 484/566 No Yes Staining 297 BDM 
RF-1 a 495/503 Yes unclear Staining 298 Thiol-disulfide redox exchange 
Genetically Coded Protein Sensor 
Hyper® (mito 
/cyto) 420 & 500/516 Yes Yes Transfection 
116 Thiol-disulfide redox interchange 
Hyper 2® 420 & 500/516 Yes Yes Transfection 117 Thiol-disulfide redox interchange 
Hyper 3® 420 & 500/516 Yes Yes Transfection 118 Thiol-disulfide redox interchange 
roGFP2-Orp1® 
(mito/cyto) 400 & 490/ 510 Yes No Transfection 
119 Thiol-disulfide redox interchange 
Superscript a: from the Chang Lab; Superscript b: pH sensitivity of fluorescent spectra (only) of the sensor; Superscript 
®: Ratiometric imaging probe 
BDM: Boronate deprotection mechanism. 
 
10-Acetyl-3,7-dihydroxyphenoxazine (Amplex red) is a H2O2 sensitive dye that is 
converted to fluorescent resorufin with the aid of Horseradish peroxidase285. This sensor is usually 
used for extracellular H2O2 assay with incubation time of ~10 min285. Amplex red is pH sensitive 
, especially in the range of 4 ~ 9299.  
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There are a series of small molecule H2O2 sensors based on boronate deprotection 
mechanism developed in Chang Lab in the past ten years286-293,298,300-303. Peroxyxanthone-1 (PX1), 
Peroxyfluor-1 (PF1) and Peroxyresorufin-1 (PR1) are blue, green and red fluorescent probes 
reported in 2005. The selective H2O2 deprotection of two boronic ester groups of the xanthenone 
scafold induces fluorescence286. Ratio-Peroxyfluor-1 (RPF1) is a derivative of PF1, which has a 
coumarin donor and boronate protected fluorescein acceptor287. Fluorescence resonance energy 
transfer occurs and causes the fluorescence emission shift from 464 nm to 517 nm (Exi: 420 nm) 
once H2O2 removes the boronate groups287.  The increase in F510/F464 indicates the presence of 
H2O2287. In 2008, Peroxy Lucifer 1 (PL1) is a green fluorescent aminonaphthalimide with 
boronate-based carbamate group before H2O2 cleavage288. Peroxy yellow (PY1), the mitochondrial 
version of PY1 (MitoPY1) are rhodol derivatives289. Its methyl ester form of PY1, PY1-ME, was 
developed to increase the cellular retention after staining290. In 2010 and 2011, Dickinson and his 
colleagues synthesized several boronate protected H2O2 sensors, Peroxy Orange (PO1), 
Peroxyfluor-2 (PF-2), Peroxyfluor-3 (PF-3), Peroxy Emerald 1 (PE1) and Peroxyfluor-6- 
acetoxymethyl ester (PF6-AM)291,292. PF-2, PF-3, and PF6-AM have similar structures (boronate 
protected fluorescein analogs) as PF-1, but have different visible fluorescence spectra upon the 
H2O2 deprotection. PE1 is classified as a rhodol derivative like PY1 and PO1, similar to fluorescein 
in molecular structure291,292. Peroxy Naphthalene 1 (PN1) is a ratiometric H2O2 sensor with 
boronate-based carbamate group, which can be excited by near infrared light293. The kinetic 
response of these sensors in 1~5 μM with 1 ~10 mM H2O2 is slow at 25oC, pH = 7.4. For instance, 
the time for ½ full reaction (t1/2)  with H2O2 is ~ 21, 12 and 19 min for PF1, PR1 and PX1, 
respectively286; t1/2 for RPF1 is ~60 min287;   t1/2 for PL1 = 13 min288; PY1 has t1/2 = 6 min, which 
should be similar in mitoPY1 and PY1-ME289; PO1, PF-2, PF-3, and PF6-AM, t1/2 = 1.4 ~ 3.5 
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min291,292. PN1 t1/2 = 12.1 min293. In practical term, PE1 is most favored for its relative rapid 
reactions with H2O2 (t1/2 = 1.4 min) among these sensors. PO1, PF-2, PF-3, and PF6-AM would 
be dyes with acceptable reaction time with H2O2, ~ 10 - 20 min. Redoxfluor-1 (RF1) is the only 
reversible small-molecule H2O2 sensor discussed here. It is a fluorescein derivative, can be 
reversibly oxidized by H2O2 and reduced by reducing reagents (e.g. tris(2-
carboxyethyl)phosphine, sodium dithionite, and  NaBH4)298. The sensor has a relative rapid 
response to H2O2 (t1/2 = 17 s), which can be used to achieve a H2O2 profile with a time resolution 
of 1 ~ 2 min298.  
Our big concern here is that the pH sensitivity of these sensors from Chang Lab mentioned 
above have not been tested except that PN1 has been proven to be pH insensitive286-293,298,300-303. It 
is highly possible that these sensors are pH sensitive since they mimic the molecular structure of 
fluorescein (a pH sensitive dye)304. 
Irreversible H2O2 sensors have also been developed in other groups in the past three years. 
QCy7 is a boronate protected cyanine dye with t1/2 for reaction with H2O2, ~ 7 min and untested 
pH sensitivity294. SHP-Mito is a ratiometric sensor, which means its yellow and blue fluorescence 
intensities change upon cleavage of boronate containing carbamate group by H2O2 (t1/2 = 11.6 min), 
and it is pH insensitive295. FP-H2O2-NO is coumarin-rhodamine coupled ratiometric dye with 
boronate protected hydroxyl group at 7’ carbon site of the coumarin subunit296. It has three 
independant fluorescence signals responding to H2O2, NO and H2O2/NO, respectively, and needs 
30 min to equilibrate with H2O2296. The pH sensitivity of this sensor has not been tested296.  Probe 
3 (informal name by the author) constructed by Kumar et al. is a boronate protected ratiometric 
sensor297. This sensor is not recommened for biological application because it reacts slowly with 
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H2O2 (predicted t1/2 > 15 min) and experiences drastic changes in its fluorescence spectra under 
various pH297.  
Genetically coded protein sensors, Hyper, Hyper-2, Hyper-3 and roGFP2-Orp1 have been 
discussed in Section 1.3.2.  
A.3 Fluorescence imaging of Glutathione and Thioredoxin 
Firstly, we choose to not to discuss about the probes that could selectively target particular 
thiols such as cysteine (Cys), homocysteine (Hcy) and glutathione (GSH). Several general thiol 
probes have been developed based on different mechanisms. Monobromobimane (mBrB) was first 
reported in 1981, and it yields a fluorescent thiol adduct by replacing a bromide group with a thiol 
group305. General incubation time for derivatizing thiols is ~ 15 min306. mBrB is pH sensitive; 
metallothionein (a thiol) experiences different derivation efficiency under various pHs306. The 
reaction rate of Cys with mBrB varies with different pHs; faster reaction is often achieved under 
basic condition (pH > 7), but its thiol-adduct is unstable when pH > 10.   
 
Table A-5. Fluorescence probes for Thiols 
Name Exi/Emi Reversible 
pH 
sensitive 
b (4-9) 
in vivo 
Application REF 
Reaction 
Mechanism 
Small Molecule Probe 
mBrB 380/480 No Yes Staining 305 nucleophilic substitution 
CPM 390/465 No Yes Staining 121 Michael addition 
Thioglo-1 379/513 No No Staining 124 Michael addition 
Dansyl maleimide 7; 
Coumarin maleimide 
11a, b; Phthalimide 
maleimide 30 
342/530; 
430/480; 
394/458 
No unclear Staining 123 Michael addition 
Thioglo-3; Thioglo-5 378/446; 365/536 No unclear Staining 
307 Michael addition 
o-Maleimide- 
BODIPY 505/520 No No Staining 
128 Michael addition 
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Thiol Probe IV 400/465 No Yes Staining 129 Michael addition 
Probe 1 ® 420/466 &553 No No Staining 130 Michael addition 
Ratio-HPSSC® 350/459 & 658 No Yes Staining 308 Cleavage of  disulfide bond 
SSH-Mito® 740 (TP) /462 & 545 No No Staining 
309 Cleavage of  disulfide bond 
NRFTP ® 488/515&610 No Yes Staining 310 Cleavage of thioester 
Cy-NiSe; Cy-TfSe 635/750; 635/750 No No Staining 
311 Cleavage of Se-N bond 
DNBSCy 600/700 No Yes Staining 312 Cleavage of sulfonate ester 
3-HTC® 370 & 448/500 Yes unclear Staining 313 
Thiol-disulfide 
redox 
interchange 
Cy-O-Eb® 768/794 Yes unclear Staining 314 
Form (Oxidize) 
and break 
(reduce) and the 
Se-N bond 
*Any specific-thiol selective probes are not included; Superscript b: pH sensitivity of fluorescent spectra (only) of the 
sensor; Superscript ®: Ratiometric imaging probe 
 
Most of the thiol dyes based on Michael addition have been discussed in Section 1.3.3. 
Probe 1 (informal name by the author)130 are coumarin-enone based thiol sensors. The addition of 
thiol to enone causes fluorescence129 or spectral shift130. Probe 1 is a slow probe with a reaction 
rate constant, 6.98 × 10-2 M-1·s-1 and t1/2  ≈ 16.6 min under the presence of 10 mΜ thiol, but its 
thiol adduct is pH insensitive130.  
Several thiol probes based on other mechanisms have been developed in the past five years. 
Ratio-HPSSC308 and SSH-Mito309 are ratiometric thiol probes.  Their detection of thiols upon that 
cleavage of disulfide bond causes relative changes at two fluorescence channels308,309.  Both dyes 
equilibrate with 1 mM thiol slowly (Ratio-HPSSC, t1/2  > 10 min; SSH-Mito,  t1/2  ≈ 38.5 min), but 
the difference is that Ratio-HPSSC is pH sensitive, but SSH-Mito is not308,309. NRFTP contains a 
rhodamine and a BODIPY dye linked by a thioester group310. Cleavage of the thioester by thiol 
can modulate the energy transfer between the two dye units causing relative changes of F510 and 
F590. Complete reaction between the dye and thiol requires ~ 23 min310. The dye after thiol 
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incubation is pH stable between 7.4 ~ 10, but is sensitive to pH < 7310. DNBSCy converts 
fluorescent heptamethine cyanine (Cy)-quinone after cleavage of sulfonate ester bond. It can react 
with 2 mM GSH completely less than 1 min, but it is pH sensitive312. Similar to DNBSCy, Cy-
NiSe and Cy-TfSe also have the Cy scaffold with fluorescence turned on after breaking Se-N bond 
by thiols311.  The two sensors (5 μM) completely react with 5 μM GSH in 3 ~ 5 min, and they show 
excellent pH stability311. There are two reversible probes for sensing thiol discussed here: 3-
hetaryl-7-thiol coumarin (3-HTC)313 and heptamethine cyanine-o-ebselen (Cy-o-Eb)314. 3-HTC 
can sense the change of the ratio [GSH]/[GSSG] in the range of 10-3 to 103 based on the disulfide 
exchange313. About ten minutes is required to achieve redox equilibrium with [GSH]/[GSSG]313. 
Cy-o-Eb is not a pure thiol sensor, which has been evaluated with H2O2 (oxidant) and GSH 
(reductant)314. The sensor responds linearly to H2O2 (0 ~ 200 μM) and GSH (0 ~ 20 μM), and takes 
~ 25 min or 5 min to equilibrate with 200 μM H2O2  or 20 μM GSH314. The pH sensitivity of 3-
HTC and Cy-o-Eb has not been tested. 
Table A-6. Selective fluorescence probes for GSH 
Name Exi/Emi Reversible pH sensitive 
b 
(4-9) 
in vivo 
Application REF Reaction Mechanism 
Small Molecule Probe 
mCB 380/470 No unclear Staining 315 nucleophilic substitution 
BODIPY 1a 
® 
550/556 & 
588 No unclear Staining 
316 nucleophilic substitution 
Bis-
spiropyran 1a 446/643 No slightly Staining 
317 GSH binding 
Genetically Coded Protein Sensor 
Grx1-roGFP® 400 & 490/ 510 Yes no Transfection 
132 Thiol-disulfide redox interchange 
Superscript b: pH sensitivity of fluorescent spectra (only) of the sensor; Superscript ®: Ratiometric imaging probe 
In theory, GSH sensors have the potential to react with all types of thiols such as Cys and 
Hcy, but they selectively target GSH or have distinguishable signal of their adduct with GSH than 
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that with other thiols. Monochlorobimane (mCB) and BODIPY 1a are two nucleophilic-
substitution type dyes developed in 1981 and 2012, respectively. mCB is a highly active dye, which 
has been widely used for more than 30 years. In contrast to mBrB, mCB selectively targets GSH . 
The reaction between mCB and GSH is complete in 5 min131. BODIPY 1a is also an active dye 
with 1st order reaction rate constant, 4.6× 10-2 s-1 and t1/2  ≈ 15 s316. Its reaction with GSH can be 
finished within 2 min, and F588/F556 linearly corresponds to GSH in a range of 0 ~ 60 μM316. We 
have not found any information regarding pH sensitivity for mCB and BODIPY 1a. Bis-spiropyran 
1a detects GSH upon the binding of GSH with a high affinity constant317, K = 7.52 × 104 M-1. As 
its reaction with GSH strongly favors association, Bis-spiropyran 1a is unlikely to be a reversible 
dye317. Both this free dye and its-GSH adduct show relative pH stability between pH > 5, but their 
FI change and get enhanced when pH < 5317.  
 
 
Table A-7. Fluorescence probes for Trx 
Name Exi/Emi Reversible pH sensitive 
b (4-
9) 
in vivo 
Application REF 
Reaction 
Mechanism 
Thioredoxin probe 
1 430/535 No unclear Yes 
318 Disulfide cleavage 
Mito-Naph 428/531 No unclear Yes 319 Disulfide cleavage 
Superscript b: pH sensitivity of fluorescent spectra (only) of the sensor; 
There are a very few Trx sensors developed in recent years. Lee et al. constructed two Trx 
probes, Thioredoxin probe 1 (for use in cytosol)318 and Mito-Naph (for use in mitochondria)319. 
Trx attacks the disulfide bond to cleave the carbamate group from the naphthalimide unit 
(fluorescent spectra subject to change). Both of the sensors equilibrate with Trx slowly (~ 30 min 
incubation time needed). The other drawback is that the severe interference from Cys and Hcy is 
unavoidable.   
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APPENDIX B 
2.0  OPTIMIZE SUPERFUSION SYSTEM AND RATIOMETRIC IMAGING ON 
ROGFP2 BASED SENSOR TO MONITOR THE REDOX CHANGE IN ORGANOTYPIC 
HIPPOCAMPUS SLICE CULTURE DURING OGD-RP 
This Appendix contains information for section 2.0 Optimize superfusion system and ratiometric 
imaging on roGFP2 based sensor to monitor the redox change in organotypic hippocampus slice 
culture during OGD-RP. 
 
Figure B-1. Lipofectamine-aided transfection in HeLa cells. 
Red fluorescence protein (RFP), tdTomato is expressed in mitochondria (top row) or cytoplasm (bottom row) in HeLa 
cells. Images are bright field (BF), fluorescence (FL) and merged from left to right. 
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 Figure B-2. Plasmid transfection of CA1 pyramidal cells inside OHSCs 
Plasmid coding for tdTomato is transfected into cells in OHSCs by single cell electroporation (a and b) or gene gun 
(c and d). Images in (a) and (c) are taken with a 5x objective lens to give bright field (BF), fluorescence (FL) and 
merged images. The dotted line indicates approximately the Cornu Ammonis (CA). Electroporation was applied to 
2~3 pyramidal cells in region CA1 per OHSC, and succeeded in 1~2 cells (pointed out by red arrows (FL) and white 
arrows (merge) in (a). Gene gun-enabled transfection on 10~15 cells per OHSC. Cells, highlighted by the blue arrow 
in (a) or by white in (c), are enlarged in (b) and (d), (63x objective lens). The gene gun will introduce gold 
particles(blue arrows in d) into the transfected cells. (e) Grx1-roGFP2 and tdTomato co-expressed in mitochondria or 
cytoplasm in pyramidal cells in OHSCs. Images of merge, tdTomato, 405 nm excitation of Grx1-roGFP2 and 488 nm 
excitation of Grx1-roGFP2 are shown from left to right. 
b 
c d 
e 
a 
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Figure B-3. tdTomato used as internal standard to correct the calibration signal from Grx1-roGFP2 
in HeLa cells. 
Cytosolic Grx1-roGFP2 and tdTomato are co-expressed in HeLa cells. tdTomato is not sensitive to calibrants in HeLa 
cells. Fluorescence emission of tdTomato (excited at 561 nm) and Grx1-roGFP2 (excited at 405 and 488 nm) recorded. 
(a) Top: With no OGD/RP, the cell area does not change during exposure to calibrants H2O2 and DTT. Bottom: 
tdTomato fluorescence emission is not sensitive to H2O2 and DTT. (b) With OGD/RP, Top: cell size changes 
dramatically, does not reach a steady state, and oscillates. Bottom: Fluorescence signal from tdTomato is inversely 
correlated with changes in cell size. (c) The absolute intensities (Top) and ratios (bottom) from the three channels are 
obtained when exposed to ACSF, H2O2 and DTT with no OGD/RP. The Grx1-roGFP2 fluorescence shows dramatic 
changes. No difference in trend are observed when comparing absolute intensities and ratios (I405  vs. Î405 , I488 
vs. Î488). (d) tdTomato calibration is necessary on single channel 405 nm or 488 nm (see the difference in I405 vs. Î405, I488  vs.  Î488  when exposed to DTT) after OHSCs are continuously superfused for ~1.5 h during an OGD/RP 
experiment with the superfusion setup [O+V] as described in Figure 2-1. Fluorescence traces prior to OGD/RP (control) 
and during calibration post-OGD/RP with H2O2 and DTT are shown (note the break in the time axis). Î488Red (I488Red I561Red⁄ .  
See Eq. 2.1, section 2.2.3) in (Bottom, d) is significantly more stable than the I488Red fluorescent signal in (Top, d). The 
137 
 
confounding effects of OGD-induced cell size changes on I488 are corrected by I561 (Equation 2.1, section 2.2.3). Î488Ox  
and Î488Red (the corrected I488 at full oxidation and reduction) are used to calculate the oxidation degree of Grx1-roGFP2, 
OxDroGFP2 (see section 2.2.3 for more details). 
 
pH effect on NADPH/NADP+ and GSH/GSSG system 
 NADP+ + H+ + 2e−   →  NADPH     (Eq. A.1) 
 
∆ENADPH/NADP+ =  RT2F  In [H+]e[H+]s = −30.65 ∆pH (mV) (Eq. A.2) 
 GSSG + 2H+ +  2e−  →  2GSH (Eq. A.3) 
 
∆EGSH/GSSG =  RT2F  In [H+]e2[H+]s2 =  −61.3 ∆pH (mV) (Eq. A.4) 
 NADPH + GSSG + H+  →  2GSH + NADP+ (Eq. A.5) 
 
 ∆E = ∆EGSH/GSSG − ∆ENADPH
NADP +
 =  −30.65 ∆pH (mV) (Eq. A.6) 
 
In which R = 8.315 J K−1mol−1; T = 309.15 K; [H+]s and [H+]e are start and end proton 
concentration with pH change. If pH changes from 8 to 7, ∆E will equal 30.65 mV, indicating the 
reaction in Eq. A5 is favorable. 
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APPENDIX C 
3.0  GSH SYSTEM RESPONDS DIFFERENTLY WITHIN DIFFERENT CELL TYPES 
DURING OGD-RP 
This Appendix contains information for section 3.0 GSH SYSTEM RESPONDS DIFFERENTLY 
WITHIN DIFFERENT CELL TYPES DURING OGD-RP 
 
 
Table C-1. Redox information of Grx1-roGFP2 from various cell types. 
Ratio405/488 
Mitochondria Cytoplasm 
Control OGD RP Control OGD RP 
Pyramidal cell in OHSC 0.328 ± 0.027 0.251 ± 0.026 0.424 ± 0.019 0.255 ± 0.024 0.274 ± 0.016 0.268 ± 0.030 
Astrocyte in OHSC 0.305 ± 0.036 0.280 ± 0.027 0.345 ± 0.038 0.252 ± 0.042 0.255 ± 0.017 0.277 ± 0.077 
HeLa cell 0.296 ± 0.025 0.274 ± 0.024 0.321 ± 0.034 0.271 ± 0.003 0.275 ± 0.005 0.281 ± 0.024 
 
OxDroGFP2 
Mitochondria Cytoplasm 
Control OGD RP Control OGD RP 
Pyramidal cell in OHSC 0.205 ± 0.064 0.039 ± 0.034 0.393 ± 0.027 0.074 ± 0.030 0.126 ± 0.032 0.145 ± 0.041 
Astrocyte in OHSC 0.229 ± 0.061 0.167 ± 0.038 0.305 ± 0.057 0.065 ± 0.028 0.034 ± 0.011 0.152 ± 0.086 
HeLa cell 0.238 ± 0.046 0.185 ± 0.057 0.221 ± 0.068 0.103 ± 0.006 0.109 ± 0.011 0.112 ± 0.029 
 
ln([GSH]2/[GSSG]) Mitochondria Cytoplasm Control OGD RP Control OGD RP 
Pyramidal cell in OHSC 1.50 ± 0.59 -0.54 ± 0.47 2.65 ± 0.11 0.26 ± 0.54 0.59 ± 0.53 0.51 ± 0.61 
Astrocyte in OHSC 1.83 ± 0.37 1.40 ± 0.36 2.24 ± 0.29 0.20 ± 0.56 -0.67 ± 0.64 0.22 ± 0.53 
HeLa cell 1.91 ± 0.26 1.56 ± 0.40 1.79 ± 0.41 1.43 ± 0.11 1.48 ± 0.19 1.51 ± 0.44 
 
EGSH(mV)* 
Mitochondria Cytoplasm 
Control OGD RP Control OGD RP 
Pyramidal cell in OHSC -360.0 ± 7.6 -386.7 ± 3.4 -345.2 ± 1.5 -323.4±15.8 -312.2±15.4 -313.3 ± 7.8 
Astrocyte in OHSC -355.9 ± 4.8 -361.4 ± 4.7 -350.5 ± 3.6 -322.6±16.2 -329.7±10.9 -314.5±24.2 
HeLa cell -354.8 ± 3.4 -359.2 ± 5.2 -356.3 ± 5.3 -301.2 ± 1.5 -300.7± 2.4 -300.4± 5.7 
 
Steady state values in control, OGD and RP from HeLa cells, pyramidal cells and astrocytes are summarized in this 
table, represented as means ± SEMs which were derived from 6 independent measurements. Their full data are shown 
in Figure 3-5. * E values assume pH = 7.00 in cytoplasm and pH = 8.00 in mitochondria. 
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APPENDIX D 
4.0 THE DIFFERENTIAL SUSCEPTIBILITY BETWEEN CA1 AND CA3 PYRAMICAL 
CELLS TO OGD-RP DUE TO THEIR DIFFERENCE IN ROS MANAGEMENT 
This Appendix contains information for section 4.0  THE DIFFERENTIAL SUSCEPTIBILITY 
BETWEEN CA1 AND CA3 PYRAMICAL CELLS TO OGD-RP DUE TO THEIR DIFFERENCE 
IN ROS MANAGEMENT 
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SUPPLEMENTAL DATA 
Supplemental Figures 
 
Figure. D-1. Ratiometric images of pyramidal cells expressing roGFP2-Orp1(Related to Fig. 4-1). 
Ratiometric images of H2O2 sensor expressed in mitochondria (Mito) or cytoplasm (Cyto) of pyramidal cells in CA1 
or CA3 are acquired according to the protocol described in Section 4.2. The value of R405/488 (0 < R405/488 < 1), indicated 
in the calibration color bar, reflects the oxidation degree of the sensor. Cell are fully oxidized by diamide (shown in 
brightest color, R405/488 =1) and fully reduced by DTT (shown in darkest purple, R405/488 ≈ 0.25). Noticeable change in 
oxidation degree (reflected by color) is found in mitochondria, but not in cytoplasm during the OGD-RP experiment. 
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 Figure. D-2. Ratiometric images of pyramidal cells expressing Grx1-roGFP2. (Related to Fig. 4-1) 
Ratiometric images of GSH sensor expressed in mitochondria (Mito) or cytoplasm (Cyto) of pyramidal cells in CA1 
or CA3 are acquired according to the protocol described in Section 4.2. The value of R405/488 (0 < R405/488 < 1), indicated 
in calibration color bar, reflects oxidation degree of the sensor. Cell are fully oxidized by H2O2 (shown in brightest 
color, R405/488 =1) and fully reduced by DTT (shown in darkest purple, R405/488 ≈ 0.18). A larger change in oxidation 
degree (reflected by color) is found in mitochondria of CA1 than CA3 during the OGD-RP experiment.  
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Figure. D-3. Optimizing NAD(P)H and thiols imaging. (Related to Fig. 4-2, 4-3) 
(a) Scan shuttles between CA1 and CA3 to allow fluorescence signals from two areas to be acquired at the same time 
frame. This enables direct comparison between CA1 and CA3without calibration by using internal or external 
standards. (b) The autofocus (ATF) function was applied on the Leica confocal microscope aiming to limit the error 
in the z-direction within ± 1 μm over time. The algorithm of this function is to find the largest fluorescent area (FA) 
and highest fluorescence intensity (FI). Its application depends on the different FA and FI varying in different depths. 
However, The fluorescence images of NAD(P)H and thiols in OHSCs represent honeycomb patterns, which do not 
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show significantly difference of FA and FI in various depths, leading to the failure of the ATF function. (c) tdTomato 
was introduced to a single pyramidal cells in OHSC. The ATF function can easily maintain the focus on the equatorial 
plane (where largest FA and highest FI were found) of this labelled cell with z-axis shift < 1 μm.  
 
 
Figure. D-4. MnSODm cannot affect complex I, but it affects the dismutation of superoxide. (Related 
to Fig. 4-4) 
The ROS pathway is comprised of three steps: (1) superoxide generates at complex I under stimulation; (2) superoxide 
dismutates into H2O2; (3) H2O2 is removed by GSH system. (a) MnSODm has no effect on step (1) in the ROS pathway, 
which is supported by data shown in (b). (b) OHSC is treated with control (CT)/ 20 μM MnSODm/wash out (WO) for 
5 min/15 min/15 min. ACSF buffer is used in CT and WO. Each trace is represented in mean ± SEM, n= 6. No change 
is found in OxD of H2O2 (left) and GSH (right) during the treatment (comparisons among CT/20 μM MnSODm/WO 
are indicated by horizontal lines, black for CA1, red for CA3. One way ANOVA, no significant difference, n.s., p > 
0.05, n = 6). No difference is found between CA1 and CA3 at each period (indicated by vertical lines with t-test results, 
n.s., p> 0.05, n=6). 
a 
b 
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 Figure. D-5. Determine [MnSODm]max. (Related to Fig. 4-4) 
The maximum working concentration of MnSODm for OHSC in superfusion is found at 20 μΜ. OHSC is first 
superfused with ACSF solution as a control (CT), then with menadione (MD) + MnSOD mimic (MnSODm).  MD is 
used to trigger the superoxide formation, while MnSODm works to achieve full conversion of superoxide to H2O2. The 
H2O2 system is recorded in OxDHS in CA1 (a) and CA3 (b). 10 μΜ MD is used in all experiments. Three different 
concentrations of MnSODm are tested here: 10 μΜ MnSODm, 20 μΜ MnSODm and 30 μΜ MnSODm. No further 
change from 20 μM MnSODm to 30 μM MnSODm indicates that 20 μΜ is the proper concentration to apply MnSODm 
in our experiment. All traces are represented in mean ± SEM (n=6). Curves of MD + MnSODm were fitted into the 
first-order exponential equation and all of the fitted parameters were compared and analyzed with a t test with 
bootstrap and one way ANOVA with post hoc test (n.s, no significant difference, p> 0.05, ***p<0.001, n=6). The 
short vertical line indicates the comparison between 20 μM MnSODm and 30 μM MnSODm. The comparison among 
10 μM MnSODm, 20 μM and 30 μM MnSODm is indicated by the long vertical line. Details of curve fitting and 
statistical analysis are described in Section 4.2. 
 
a b 
145 
 
 Figure. D-6. Differential cell death with the treatment of MD or MD + MnSODm. (Related to Fig. 4-4) 
Differential mortality of pyramidale cells in areas CA1 and CA3 are found after the treatment of OGD-RP 
and 10 μΜ MD + 20 μΜ MnSODm. (left) Fluorescence images of OHSCs with different treatments. (right) Data of 
cell death under different treatments are represented and compared in CA1 and CA3 (One-Way ANOVA, ***p < 
0.001, n = 10; no special sign is added if there is no significant difference). Cell death percentage is tested with PI 
stain (Section 4.2). 
 
 
 
 
 
 
 
146 
 
  
Figure. D-7. Quantitative measurement of the target protein in OHSC refering to the internal control 
via immunofluorescence. (Related to Fig. 4-6) 
The content of Trx2 in subfield CA1 from OHSC was normalized to that of the internal standard, α-tubulin. 
(top) α-tubulin labelled with CF568 (Biotium, USA) was imaged with excitation 488 nm, emission 500-530 nm, shown 
in green. (bottom) Trx2 labelled with Alexa Fluor 488(Life Technologies, USA) was imaged at the excitation of 561 
nm and the emission of 575-595 nm, shown in red. Fluorescent images (left column) were processed into the images 
with thresholds in the right column (the measureable area is shown in gray, areas of above and below are in green and 
blue, respectively). The region of interest (ROI) is outlined to only include the pyramidal cells in OHSC (white dashed 
line). Only pixels within the threshold in ROI will be counted. The sum of pixels was calculated for Trx2 and α-tubulin 
here, then the values of Trx2 was normalized by that of α-tubulin to represent the content of Trx2 in the pyramidal 
cell layer in OHSC.  
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(a) Peak analysis 
Table D-1. Parameters of peak in Fig. 4-3. 
Peak parameters Peak 1 Peak 2 Peak 3 
Emerging time (min) 7.41±0.52 11.7±0.80 6.34±0.36 
Peak altitude (NFl) 1.07± 0.01 1.11±0.01 1.10±0.02 
Ascending slope (NFl/min) 10.69±2.08 (×10-3) 20.2±3.7(×10-3) 12.2±3.7(×10-3) 
Descending slope(NFI/min) -5.26±3.21(×10-3) -12.5±1.79(×10-3) 4.71±1.33(×10-3) 
*NFL, normalized fluorescent intensity of NAD(P)H 
(b) Linear fitting 
Table D-2. Data of steady OxDHS in Fig. 4-1g for OGD-RP.   
OxDHS (mean ± SEM) Control OGD RP 
Mito CA1 0.447±0.018 0.250±0.039 0.423±0.028 
Mito CA3 0.340±0.090 0.269±0.045 0.315±0.054 
Cyto CA1 0.266±0.0274 0.342±0.044 0.186±0.023 
Cyto CA3 0.260±0.038 0.260±0.037 0.200±0.019 
 
Table D-3. Data of steady OxDGS in Fig. 4-1h for OGD-RP. 
OxDGS (mean ± SEM) Control OGD RP 
Mito CA1 0.295±0.020 0.137±0.026 0.489±0.020 
Mito CA3 0.317±0.073 0.120±0.031 0.241±0.035 
Cyto CA1 0.234±0.038 0.157±0.028 0.191±0.023 
Cyto CA3 0.302±0.075 0.110±0.031 0.227±0.036 
 
Table D-4. Data of OxD in (I) to (III) in Fig. 4-4b, d for menadione treatment. 
OxD (mean ± SEM) (I) CT (II) 10 μM MD (III) WO 
H2O2 CA1 0.078±0.032 0.079±0.018 0.077±0.010 
H2O2 CA3 0.072±0.036 0.081±0.021 0.073±0.007 
GSH CA1 0.104±0.020 0.115±0.025 0.106±0.036 
GSH CA3 0.091±0.037 0.095±0.021 0.095±0.023 
*only mitochondria is studied for the reason that only OxDHS and OxDGS in mitochondria change to OGD-RP. 
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(c) Nonlinear fitting to first order exponential equation 
Table D-5. Data of fitted parameters for Fig. 4-4b(IV), 4-4c(II) and 4-4c(IV) for MD + 
MnSODm treatment. 
Fitting from 
OxDHS 
CA1 CA3 
𝑘𝑘1[𝐻𝐻2𝑂𝑂2] 𝑘𝑘2[𝑇𝑇𝑂𝑂𝑂𝑂]𝑅𝑅𝑅𝑅𝑅𝑅  [𝑂𝑂𝑂𝑂𝐷𝐷0]𝑝𝑝𝐺𝐺 𝑘𝑘1[𝐻𝐻2𝑂𝑂2] 𝑘𝑘2[𝑇𝑇𝑂𝑂𝑂𝑂]𝑅𝑅𝑅𝑅𝑅𝑅  [𝑂𝑂𝑂𝑂𝐷𝐷0]𝑝𝑝𝐺𝐺 
10 μM MD+20 
μM MnSODm 0.196±0.015 0.136±0.054 0.069±0.047 0.186±0.019 0.137±0.016 0.085±0.067 
20 μM MD 0.192±0.017 0.048±0.007 0.073±0.012 0.082±0.001 0.066±0.001 0.103±0.054 
20 μM MD+20 
μM MnSODm 0.252±0.011 0.013±0.003 0.103±0.045 0.252±0.011 0.011±0.002 0.103±0.045 
*only mitochondria is studied for the reason that only OxDHS and OxDGS in mitochondria change to OGD-RP. 
Table D-6. Data of fitted parameters for Fig. 4-4d(IV), 4-4e(II) and 4-4e(IV) for MD + 
MnSODm treatment. 
Fitting from 
OxDGS 
CA1 CA3 
𝑘𝑘1
′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] 𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻] [𝑂𝑂𝑂𝑂𝐷𝐷0]𝐺𝐺𝐺𝐺 𝑘𝑘1′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] 𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻] [𝑂𝑂𝑂𝑂𝐷𝐷0]𝐺𝐺𝐺𝐺 
10 μM MD+20 
μM MnSODm 
0.274±0.014 0.083±0.010 0.083±0.016 0.091±0.006 0.117±00.012 0.109±0.006 
20 μM MD 0.281±0.006 0.098±0.003 0.103±0.012 0.208±0.061 0.167±0.060 0.093±0.054 
20 μM MD+20 
μM MnSODm 
0.321±0.010 0.071±0.002 0.101±0.080 0.318±0.042 0.077±0.016 0.099±0.076 
*only mitochondria is studied for the reason that only OxDHS and OxDGS in mitochondria change to OGD-RP. 
Table D-7. Data of fitted parameters for Fig. 4-5b for Trx inhibition assay. 
Fitting 
from 
OxDHS 
CA1 CA3 
𝑘𝑘1[𝐻𝐻2𝑂𝑂2] 𝑘𝑘2[𝑇𝑇𝑂𝑂𝑂𝑂]𝑅𝑅𝑅𝑅𝑅𝑅  [𝑂𝑂𝑂𝑂𝐷𝐷0]𝑝𝑝𝐺𝐺 𝑘𝑘1[𝐻𝐻2𝑂𝑂2] 𝑘𝑘2[𝑇𝑇𝑂𝑂𝑂𝑂]𝑅𝑅𝑅𝑅𝑅𝑅  [𝑂𝑂𝑂𝑂𝐷𝐷0]𝑝𝑝𝐺𝐺 
No AF 0.200±0.010 0.136±0.054 0.069±0.047 0.187±0.019 0.138±0.039 0.085±0.067 
AF 0.236±0.012 0.049±0.006 0.109±0.024 0.314±0.02 0.046±0.001 0.106±0.015 
*only mitochondria is studied for the reason that only OxDHS and OxDGS in mitochondria change to OGD-RP. 
 Table D-8. Data of fitted parameters for Fig. 4-5c for Trx inhibition assay. 
Fitting 
from 
OxDGS 
CA1 CA3 
𝑘𝑘1
′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] 𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻] [𝑂𝑂𝑂𝑂𝐷𝐷0]𝐺𝐺𝐺𝐺 𝑘𝑘1′ [𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺] 𝑘𝑘2′ [𝐺𝐺𝐺𝐺𝐻𝐻] [𝑂𝑂𝑂𝑂𝐷𝐷0]𝐺𝐺𝐺𝐺 
No AF 0.274±0.014 0.083±0.010 0.083±0.016 0.091±0.006 0.117±0.011 0.109±0.006 
AF 0.274±0.004 0.065±0.003 0.081±0.015 0.290±0.006 0.065±0.003 0.106±0.008 
*only mitochondria is studied for the reason that only OxDHS and OxDGS in mitochondria change to OGD-RP. 
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